activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,184830,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL81248,,CHEMBL81248,7.85,1,http://www.openphacts.org/units/Nanomolar,143606,=,1,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
,186297,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL82034,,CHEMBL82034,7.75,1,http://www.openphacts.org/units/Nanomolar,143599,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,189892,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL81208,,CHEMBL81208,6.89,0,http://www.openphacts.org/units/Nanomolar,143609,=,1,1,=,,IC50,nM,,128.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.128
,191184,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(C2CCCCC2)nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL264385,,CHEMBL264385,7.82,1,http://www.openphacts.org/units/Nanomolar,143604,=,1,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
,194645,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2cccs2)nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL77502,LY-510929,CHEMBL77502,8.00,1,http://www.openphacts.org/units/Nanomolar,143597,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,194651,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL312717,,CHEMBL312717,6.77,0,http://www.openphacts.org/units/Nanomolar,143600,=,1,1,=,,IC50,nM,,169.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.16900001
,196959,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2cccs2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL82602,,CHEMBL82602,7.62,0,http://www.openphacts.org/units/Nanomolar,143598,=,1,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
,197950,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2cccs2)nc1CCOc1ccc(C[C@@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL79426,,CHEMBL79426,6.53,1,http://www.openphacts.org/units/Nanomolar,143605,=,1,1,=,,IC50,nM,,297.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.29700002
,202931,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCCC(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)(Oc1ccccc1)C(=O)O,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL82193,,CHEMBL82193,5.65,0,http://www.openphacts.org/units/Nanomolar,143608,=,1,1,=,,IC50,nM,,2241.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.2410002
,206560,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL412371,,CHEMBL412371,6.41,1,http://www.openphacts.org/units/Nanomolar,143607,=,1,1,=,,IC50,nM,,388.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.388
,207758,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)(Cc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL81592,,CHEMBL81592,6.31,1,http://www.openphacts.org/units/Nanomolar,143602,=,1,1,=,,IC50,nM,,491.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.49100003
,207764,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCC(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)(Oc1ccccc1)C(=O)O,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL78529,,CHEMBL78529,6.54,0,http://www.openphacts.org/units/Nanomolar,143603,=,1,1,=,,IC50,nM,,290.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.29000002
,212425,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2cccc(-c3ccccc3)c2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL81676,,CHEMBL81676,7.15,0,http://www.openphacts.org/units/Nanomolar,143610,=,1,1,=,,IC50,nM,,71.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.071
,220751,[],CHEMBL760384,Displacement of PPARgamma agonist from human PPAR gamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(C2CCCCC2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1148303,J Med Chem,2004,,CHEMBL309882,,CHEMBL309882,7.29,0,http://www.openphacts.org/units/Nanomolar,143601,=,1,1,=,,IC50,nM,,51.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.051000003
,541035,[],CHEMBL759456,Inhibitory concentration of the PPAR gamma),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CCc2c(-c3ccccc3)[nH]c3ccc(CC(=O)O)cc23)cc1,,,CHEMBL1132133,Bioorg Med Chem Lett,1999,"{'bei': '18.94', 'le': '0.34', 'lle': '2.04', 'sei': '11.72'}",CHEMBL320553,,CHEMBL320553,7.30,0,http://www.openphacts.org/units/Nanomolar,212861,=,1,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
,907914,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(CCCc2ccc(OC(C)(C)C(=O)O)cc2)nn(Cc2ccc(C)cc2)c1=O,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '11.76', 'le': '0.22', 'lle': '1.08', 'sei': '6.15'}",CHEMBL149676,,CHEMBL149676,5.31,1,http://www.openphacts.org/units/Nanomolar,289129,=,1,1,=,,IC50,nM,,4900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.9
,924270,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)n(C)c2=O)cc1C,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '13.19', 'le': '0.25', 'lle': '2.11', 'sei': '6.68'}",CHEMBL344282,,CHEMBL344282,5.77,1,http://www.openphacts.org/units/Nanomolar,289125,=,1,1,=,,IC50,nM,,1700.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.7
,927129,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCCCN(CCc1ccc(SC(C)(C)C(=O)O)cc1)C(=O)Nc1ccc(F)cc1F,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '12.71', 'le': '0.25', 'lle': '-0.71', 'sei': '8.99'}",CHEMBL278590,GSK-9578,CHEMBL278590,6.26,0,http://www.openphacts.org/units/Nanomolar,289131,=,1,1,=,,IC50,nM,,550.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.55
,927135,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)nc2O)cc1,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '12.67', 'le': '0.24', 'lle': '1.43', 'sei': '5.32'}",CHEMBL424133,LY-518674,CHEMBL424133,5.19,1,http://www.openphacts.org/units/Nanomolar,289122,=,1,1,=,,IC50,nM,,6500.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.5000005
,928645,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)n(CC(=O)O)c2=O)cc1,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '10.91', 'le': '0.20', 'lle': '2.20', 'sei': '4.13'}",CHEMBL147086,,CHEMBL147086,5.10,0,http://www.openphacts.org/units/Nanomolar,289123,=,1,1,=,,IC50,nM,,7900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,7.9000006
,936974,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(CCCc2ccc(OC(C)(C)C(=O)O)cc2)nn(Cc2cccc(OC)c2)c1=O,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '11.14', 'le': '0.21', 'lle': '1.28', 'sei': '5.45'}",CHEMBL345721,,CHEMBL345721,5.21,1,http://www.openphacts.org/units/Nanomolar,289120,=,1,1,=,,IC50,nM,,6200.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.2000003
,939615,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)n(CCO)c2=O)cc1,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '11.50', 'le': '0.22', 'lle': '2.40', 'sei': '4.89'}",CHEMBL148774,,CHEMBL148774,5.21,1,http://www.openphacts.org/units/Nanomolar,289124,=,1,1,=,,IC50,nM,,6100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.1000004
,943522,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(CCCc2ccc(OC(C)(C)C(=O)O)cc2)nn(Cc2ccc(C(C)(C)C)cc2)c1=O,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '13.50', 'le': '0.25', 'lle': '1.94', 'sei': '7.28'}",CHEMBL148639,,CHEMBL148639,6.28,1,http://www.openphacts.org/units/Nanomolar,289126,=,1,1,=,,IC50,nM,,520.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.52000004
,946195,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(CCCc2ccc(OC(C)(C)C(=O)O)cc2)nn(C(C)c2ccccc2)c1=O,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '11.55', 'le': '0.22', 'lle': '0.73', 'sei': '6.04'}",CHEMBL356170,,CHEMBL356170,5.21,0,http://www.openphacts.org/units/Nanomolar,289128,=,1,1,=,,IC50,nM,,6100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.1000004
,946201,[],CHEMBL759455,Inhibitory activity of compound against the binding of human Peroxisome proliferator activated receptor gamma was determined,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(CCCc2ccc(OC(C)(C)C(=O)O)cc2)nn(CC2CCCCC2)c1=O,,,CHEMBL1145902,J Med Chem,2003,"{'bei': '13.01', 'le': '0.25', 'lle': '1.32', 'sei': '6.68'}",CHEMBL149438,,CHEMBL149438,5.77,1,http://www.openphacts.org/units/Nanomolar,289127,=,1,1,=,,IC50,nM,,1700.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.7
,1036449,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CC2SC(=O)NC2=O)cc1C(=O)NCc1ccc(C(F)(F)F)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '14.45', 'le': '0.29', 'lle': '2.79', 'sei': '7.50'}",CHEMBL24458,,CHEMBL24458,6.33,0,http://www.openphacts.org/units/Nanomolar,111086,=,1,1,=,,IC50,nM,,463.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.46300003
,1038634,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '13.34', 'le': '0.26', 'lle': '1.52', 'sei': '6.94'}",CHEMBL408,TROGLITAZONE,CHEMBL408,5.89,1,http://www.openphacts.org/units/Nanomolar,111087,=,1,1,=,,IC50,nM,,1285.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.2850001
,1046190,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(OC(C)(C)C(=O)O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '13.68', 'le': '0.25', 'lle': '0.08', 'sei': '7.66'}",CHEMBL25259,,CHEMBL25259,6.26,0,http://www.openphacts.org/units/Nanomolar,111088,=,1,1,=,,IC50,nM,,548.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.54800004
,1048559,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OCC(=O)O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '14.08', 'le': '0.26', 'lle': '1.25', 'sei': '6.08'}",CHEMBL294807,,CHEMBL294807,4.97,0,http://www.openphacts.org/units/Nanomolar,111079,=,1,1,=,,IC50,nM,,10591.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.591001
,1050896,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC2SC(=O)NC2=O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '19.23', 'le': '0.37', 'lle': '3.68', 'sei': '9.64'}",CHEMBL59132,,CHEMBL59132,7.85,0,http://www.openphacts.org/units/Nanomolar,111085,=,1,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
,1052142,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(Br)cc2)nc1CCOc1ccc(OC(C)(C)C(=O)O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '11.60', 'le': '0.25', 'lle': '0.06', 'sei': '6.53'}",CHEMBL65458,,CHEMBL65458,5.34,0,http://www.openphacts.org/units/Nanomolar,111082,=,1,1,=,,IC50,nM,,4556.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.556
,1054570,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)C(=O)O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '14.99', 'le': '0.28', 'lle': '1.39', 'sei': '6.73'}",CHEMBL64972,,CHEMBL64972,5.51,0,http://www.openphacts.org/units/Nanomolar,111080,=,1,1,=,,IC50,nM,,3120.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.1200001
,1060787,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)(C)C(=O)O)cc1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '14.47', 'le': '0.27', 'lle': '1.01', 'sei': '6.75'}",CHEMBL66206,,CHEMBL66206,5.52,0,http://www.openphacts.org/units/Nanomolar,111081,=,1,1,=,,IC50,nM,,3017.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.0170002
,1062273,[],CHEMBL824659,Binding affinity at human peroxidase proliferator activated receptor gamma (hPPARgamma),B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1134506,J Med Chem,2001,"{'bei': '20.48', 'le': '0.40', 'lle': '4.83', 'sei': '10.23'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.32,1,http://www.openphacts.org/units/Nanomolar,111083,=,1,1,=,,IC50,nM,,48.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.048
,1158824,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(/C(CC)=N/O)c1O,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '15.71', 'le': '0.32', 'lle': '1.55', 'sei': '7.37'}",CHEMBL23874,,CHEMBL23874,7.32,0,http://www.openphacts.org/units/Nanomolar,32460,=,1,1,=,,IC50,nM,,48.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.048
,1161495,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '14.05', 'le': '0.29', 'lle': '0.21', 'sei': '9.45'}",CHEMBL23296,,CHEMBL23296,6.85,1,http://www.openphacts.org/units/Nanomolar,32458,=,1,1,=,,IC50,nM,,140.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.14
,1168364,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(CC)coc12,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '13.99', 'le': '0.28', 'lle': '-0.54', 'sei': '10.48'}",CHEMBL23670,,CHEMBL23670,6.25,1,http://www.openphacts.org/units/Nanomolar,32459,=,1,1,=,,IC50,nM,,560.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.56
,1174738,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(CC)noc12,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '15.53', 'le': '0.32', 'lle': '0.78', 'sei': '9.59'}",CHEMBL279053,L-165461,CHEMBL279053,6.96,1,http://www.openphacts.org/units/Nanomolar,32457,=,1,1,=,,IC50,nM,,110.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.11000001
,1177469,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(-c3ccccc3)coc12,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '14.19', 'le': '0.28', 'lle': '-0.86', 'sei': '11.78'}",CHEMBL278994,L-796449,CHEMBL278994,7.03,1,http://www.openphacts.org/units/Nanomolar,32455,=,1,1,=,,IC50,nM,,94.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.094000004
,1178656,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '18.68', 'le': '0.36', 'lle': '4.19', 'sei': '9.34'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.68,1,http://www.openphacts.org/units/Nanomolar,32454,=,1,1,=,,IC50,nM,,210.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.21000001
,1179951,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(C(C)=O)c1O,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '14.27', 'le': '0.29', 'lle': '0.85', 'sei': '7.44'}",CHEMBL23881,,CHEMBL23881,6.24,1,http://www.openphacts.org/units/Nanomolar,32453,=,1,1,=,,IC50,nM,,580.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.58000004
,1179957,[],CHEMBL759454,In vitro binding affinity for human PPAR gamma in SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(C(=O)CC)c1O,,,CHEMBL1136679,Bioorg Med Chem Lett,2003,"{'bei': '14.46', 'le': '0.30', 'lle': '0.74', 'sei': '7.78'}",CHEMBL25710,,CHEMBL25710,6.52,1,http://www.openphacts.org/units/Nanomolar,32456,=,1,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
,1435582,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C[C@H](OC)C(=O)O)ccc1OCCCOc1ccc(Oc2ccccc2)cc1,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '17.43', 'le': '0.33', 'lle': '2.91', 'sei': '9.45'}",CHEMBL180504,,CHEMBL180504,7.89,1,http://www.openphacts.org/units/Nanomolar,371052,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,1435590,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(OCCCOc2ccc(C(=O)c3ccccc3)cc2)c(Cl)c1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '17.70', 'le': '0.34', 'lle': '3.24', 'sei': '10.12'}",CHEMBL181644,,CHEMBL181644,8.30,1,http://www.openphacts.org/units/Nanomolar,371057,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,1435598,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(C#CCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '18.94', 'le': '0.35', 'lle': '2.95', 'sei': '12.13'}",CHEMBL181656,,CHEMBL181656,7.89,1,http://www.openphacts.org/units/Nanomolar,371062,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,1436147,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(C#CCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '18.94', 'le': '0.35', 'lle': '2.82', 'sei': '12.55'}",CHEMBL182230,,CHEMBL182230,8.15,1,http://www.openphacts.org/units/Nanomolar,371066,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,1436861,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '20.02', 'le': '0.39', 'lle': '4.66', 'sei': '10.00'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.16,0,http://www.openphacts.org/units/Nanomolar,371011,=,1,1,=,,IC50,nM,,70.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07
,1436867,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,,CHEMBL981,FENOFIBRIC ACID,CHEMBL981,,1,http://www.openphacts.org/units/Nanomolar,371012,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1437420,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(OCCCOc2ccc(-c3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '18.89', 'le': '0.35', 'lle': '2.84', 'sei': '11.81'}",CHEMBL182884,,CHEMBL182884,7.68,1,http://www.openphacts.org/units/Nanomolar,371026,=,1,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
,1437428,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '17.68', 'le': '0.33', 'lle': '2.50', 'sei': '10.06'}",CHEMBL181954,NAVEGLITAZAR,CHEMBL181954,7.47,1,http://www.openphacts.org/units/Nanomolar,371035,=,1,1,=,,IC50,nM,,34.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.034
,1437436,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CO[C@@H](Cc1ccc(OCCCOc2ccc(C(=O)c3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '19.11', 'le': '0.35', 'lle': '3.89', 'sei': '10.12'}",CHEMBL363532,,CHEMBL363532,8.30,1,http://www.openphacts.org/units/Nanomolar,371041,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,1437559,[],CHEMBL828105,Mean inhibitory concentration against human peroxisome proliferator-activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCO[C@@H](Cc1ccc(OCCCOc2ccc(Oc3ccccc3)cc2)cc1)C(=O)O,,,CHEMBL1145231,Bioorg Med Chem Lett,2005,"{'bei': '16.85', 'le': '0.31', 'lle': '2.00', 'sei': '9.91'}",CHEMBL360368,,CHEMBL360368,7.36,1,http://www.openphacts.org/units/Nanomolar,371047,=,1,1,=,,IC50,nM,,44.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.044000003
,1495889,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-n2c(C)c(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3cc(OC(F)(F)F)ccc32)cc1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '18.02', 'le': '0.34', 'lle': '2.71', 'sei': '12.87'}",CHEMBL192691,,CHEMBL192691,9.00,0,http://www.openphacts.org/units/Nanomolar,388748,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,1495892,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2cc(OC(F)(F)F)ccc2n1-c1ccccn1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '13.46', 'le': '0.25', 'lle': '0.65', 'sei': '8.61'}",CHEMBL373142,,CHEMBL373142,6.33,0,http://www.openphacts.org/units/Nanomolar,388404,=,1,1,=,,IC50,nM,,466.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.46600002
,1495893,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2nc(-n3c(C)c(Cc4cccc(O[C@@H](C)C(=O)O)c4)c4cc(OC(F)(F)F)ccc43)ccc2c1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '12.48', 'le': '0.23', 'lle': '0.03', 'sei': '8.30'}",CHEMBL370747,,CHEMBL370747,6.87,0,http://www.openphacts.org/units/Nanomolar,388451,=,1,1,=,,IC50,nM,,135.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.135
,1495894,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2ncc(-n3c(C)c(Cc4cccc(O[C@@H](C)C(=O)O)c4)c4cc(OC(F)(F)F)ccc43)cc2c1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '13.69', 'le': '0.26', 'lle': '0.70', 'sei': '9.10'}",CHEMBL365387,,CHEMBL365387,7.54,0,http://www.openphacts.org/units/Nanomolar,388468,=,1,1,=,,IC50,nM,,29.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.029000001
,1495897,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Oc2cccc(O[C@@H](C)C(=O)O)c2)c2cc(OC(F)(F)F)ccc2n1-c1noc2cc(Cl)ccc12,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '13.68', 'le': '0.27', 'lle': '0.20', 'sei': '7.80'}",CHEMBL192646,,CHEMBL192646,7.48,0,http://www.openphacts.org/units/Nanomolar,389328,=,1,1,=,,IC50,nM,,33.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.033
,1495903,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)cccc1O[C@@H](C)C(=O)O,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '10.52', 'le': '0.21', 'lle': '-2.04', 'sei': '6.45'}",CHEMBL370074,,CHEMBL370074,6.19,0,http://www.openphacts.org/units/Nanomolar,389274,=,1,1,=,,IC50,nM,,641.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.64100003
,1495904,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Oc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2cc(OC(F)(F)F)ccc2n1-c1noc2cc(Cl)ccc12,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '14.28', 'le': '0.29', 'lle': '0.37', 'sei': '8.65'}",CHEMBL363805,,CHEMBL363805,8.30,0,http://www.openphacts.org/units/Nanomolar,389514,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,1495907,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Oc2cc(Cl)cc(O[C@@H](C)C(=O)O)c2)c2cc(OC(F)(F)F)ccc2n1-c1noc2cc(Cl)ccc12,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '11.98', 'le': '0.24', 'lle': '-0.97', 'sei': '7.26'}",CHEMBL192919,,CHEMBL192919,6.96,0,http://www.openphacts.org/units/Nanomolar,389563,=,1,1,=,,IC50,nM,,109.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.109000005
,1495910,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1ccc(Oc2c(C)n(-c3noc4cc(Cl)ccc34)c3ccc(OC(F)(F)F)cc23)cc1O[C@@H](C)C(=O)O,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '13.07', 'le': '0.26', 'lle': '-0.53', 'sei': '8.02'}",CHEMBL365315,,CHEMBL365315,7.70,0,http://www.openphacts.org/units/Nanomolar,389559,=,1,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
,1496013,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Oc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2cc(OC(F)(F)F)ccc2n1-c1noc2cc(Cl)ccc12,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '15.48', 'le': '0.32', 'lle': '1.07', 'sei': '9.38'}",CHEMBL371341,,CHEMBL371341,9.00,0,http://www.openphacts.org/units/Nanomolar,389463,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,1496016,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)n2c(C)c(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3cc(OC(F)(F)F)ccc32)cc1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '16.49', 'le': '0.31', 'lle': '2.71', 'sei': '10.00'}",CHEMBL179330,,CHEMBL179330,8.70,0,http://www.openphacts.org/units/Nanomolar,389412,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,1496019,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(C)c(Cc4cc(O[C@H](C)C(=O)O)ccc4Cl)c4cc(OC(F)(F)F)ccc43)noc2c1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '15.13', 'le': '0.30', 'lle': '1.62', 'sei': '9.07'}",CHEMBL364894,,CHEMBL364894,8.70,0,http://www.openphacts.org/units/Nanomolar,389339,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,1496024,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)n2c(C)c(Cc3cccc(OCC#N)c3)c3cc(OC(F)(F)F)ccc32)cc1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '14.92', 'le': '0.28', 'lle': '1.34', 'sei': '10.04'}",CHEMBL191087,,CHEMBL191087,7.38,0,http://www.openphacts.org/units/Nanomolar,389637,=,1,1,=,,IC50,nM,,42.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.042000003
,1496027,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCOc1cccc(Cc2c(C)n(C(=O)c3ccc(OC)cc3)c3ccc(OC(F)(F)F)cc23)c1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '14.61', 'le': '0.27', 'lle': '1.06', 'sei': '14.51'}",CHEMBL372913,,CHEMBL372913,7.21,0,http://www.openphacts.org/units/Nanomolar,389296,=,1,1,=,,IC50,nM,,62.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.062000003
,1496030,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C(=O)SC(Cc2ccc(OCCN(C)c3ccccn3)cc2)C1=O,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,,CHEMBL195367,,CHEMBL195367,,0,http://www.openphacts.org/units/Nanomolar,389345,>,1,1,>,,IC50,nM,,50000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,50.000004
,1497804,[],CHEMBL830853,Inhibition of human peroxisome proliferator activated receptor gamma binding,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1145238,Bioorg Med Chem Lett,2005,"{'bei': '18.47', 'le': '0.36', 'lle': '4.11', 'sei': '9.23'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.60,1,http://www.openphacts.org/units/Nanomolar,388746,=,1,1,=,,IC50,nM,,250.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.25
,1600332,[],CHEMBL881517,Binding affinity towards peroxisome proliferator activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)(C)C(=O)O)cc1,,,CHEMBL1140446,J Med Chem,2005,"{'bei': '14.66', 'le': '0.27', 'lle': '1.08', 'sei': '6.83'}",CHEMBL66206,,CHEMBL66206,5.59,0,http://www.openphacts.org/units/Nanomolar,400158,=,1,1,=,,IC50,nM,,2570.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.5700002
,1600352,[],CHEMBL881517,Binding affinity towards peroxisome proliferator activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)(Cc2ccccc2)C(=O)O)cc1,,,CHEMBL1140446,J Med Chem,2005,"{'bei': '13.79', 'le': '0.25', 'lle': '0.57', 'sei': '7.71'}",CHEMBL81592,,CHEMBL81592,6.31,1,http://www.openphacts.org/units/Nanomolar,400169,=,1,1,=,,IC50,nM,,491.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.49100003
,1600374,[],CHEMBL881517,Binding affinity towards peroxisome proliferator activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL1140446,J Med Chem,2005,"{'bei': '16.93', 'le': '0.31', 'lle': '2.00', 'sei': '9.47'}",CHEMBL82034,,CHEMBL82034,7.75,1,http://www.openphacts.org/units/Nanomolar,400180,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,1613074,[],CHEMBL881517,Binding affinity towards peroxisome proliferator activated receptor gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(Cc1ccccc1)(Oc1ccc(Cl)cc1)C(=O)O,,,CHEMBL1140446,J Med Chem,2005,"{'bei': '18.60', 'le': '0.37', 'lle': '1.61', 'sei': '11.62'}",CHEMBL199225,,CHEMBL199225,5.41,0,http://www.openphacts.org/units/Nanomolar,403721,=,1,1,=,,IC50,nM,,3900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.9
,1698380,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Oc1ccc(OCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '12.65', 'le': '0.25', 'lle': '-0.35', 'sei': '8.10'}",CHEMBL206794,,CHEMBL206794,6.01,1,http://www.openphacts.org/units/Nanomolar,439953,=,1,1,=,,IC50,nM,,981.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.98100007
,1698413,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)CCc1ccc(OCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '11.67', 'le': '0.23', 'lle': '-0.95', 'sei': '7.99'}",CHEMBL204057,,CHEMBL204057,5.19,0,http://www.openphacts.org/units/Nanomolar,439958,=,1,1,=,,IC50,nM,,6440.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.4400005
,1698471,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)C1=CC(C)(C)Oc2cc(OCCCOc3ccc(CC(C)(C)C(=O)O)cc3)c(Cl)cc21,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '11.77', 'le': '0.23', 'lle': '-1.32', 'sei': '8.82'}",CHEMBL1783064,,CHEMBL1783064,5.73,1,http://www.openphacts.org/units/Nanomolar,439983,=,1,1,=,,IC50,nM,,1845.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.845
,1698479,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Cc1ccc(OCCCOc2ccc(C3CCC(C)(C)CC3)cc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '11.17', 'le': '0.22', 'lle': '-2.48', 'sei': '9.76'}",CHEMBL202739,,CHEMBL202739,5.44,1,http://www.openphacts.org/units/Nanomolar,439975,=,1,1,=,,IC50,nM,,3610.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.6100001
,1698480,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Cc1ccc(OCCCOc2ccc(C3CCCCC3)cc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '12.49', 'le': '0.24', 'lle': '-1.55', 'sei': '10.28'}",CHEMBL424685,,CHEMBL424685,5.73,0,http://www.openphacts.org/units/Nanomolar,439974,=,1,1,=,,IC50,nM,,1851.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.8510001
,1698481,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Cc1ccc(OCCCOc2ccc(CC(F)(F)F)cc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,,CHEMBL206202,,CHEMBL206202,,0,http://www.openphacts.org/units/Nanomolar,439973,>,1,1,>,,IC50,nM,,6000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.0000005
,1698486,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Cc1ccc(OCCCOc2ccccc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '16.11', 'le': '0.32', 'lle': '0.84', 'sei': '10.89'}",CHEMBL205665,,CHEMBL205665,6.07,1,http://www.openphacts.org/units/Nanomolar,439968,=,1,1,=,,IC50,nM,,851.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.851
,1698491,[],CHEMBL867229,Binding affinity to human PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(C)(Cc1ccc(OCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1)C(=O)O,,,CHEMBL1139027,Bioorg Med Chem Lett,2006,"{'bei': '12.13', 'le': '0.24', 'lle': '-1.25', 'sei': '9.09'}",CHEMBL203621,,CHEMBL203621,5.91,0,http://www.openphacts.org/units/Nanomolar,439963,=,1,1,=,,IC50,nM,,1240.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.24
,1711864,[],CHEMBL860010,Displacement of [3H]rosiglitazone from PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1ccc(-c2cc(C(F)(F)F)on2)s1,,,CHEMBL1147659,J Med Chem,2006,"{'bei': '12.50', 'le': '0.26', 'lle': '0.48', 'sei': '7.51'}",CHEMBL383233,,CHEMBL383233,6.76,0,http://www.openphacts.org/units/Nanomolar,469776,=,1,1,=,,IC50,nM,,175.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.17500001
,1711876,[],CHEMBL860010,Displacement of [3H]rosiglitazone from PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,,,CHEMBL1147659,J Med Chem,2006,"{'bei': '14.28', 'le': '0.30', 'lle': '1.06', 'sei': '11.95'}",CHEMBL208472,,CHEMBL208472,7.64,0,http://www.openphacts.org/units/Nanomolar,469777,=,1,1,=,,IC50,nM,,22.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022700002
,1711971,[],CHEMBL860010,Displacement of [3H]rosiglitazone from PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cccc(F)c1,,,CHEMBL1147659,J Med Chem,2006,"{'bei': '15.07', 'le': '0.31', 'lle': '1.61', 'sei': '9.83'}",CHEMBL378160,,CHEMBL378160,6.29,1,http://www.openphacts.org/units/Nanomolar,469778,=,1,1,=,,IC50,nM,,512.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.512
,1726642,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '13.75', 'le': '0.29', 'lle': '0.07', 'sei': '9.25'}",CHEMBL23296,,CHEMBL23296,6.71,1,http://www.openphacts.org/units/Nanomolar,496517,=,1,1,=,,IC50,nM,,195.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.19500001
,1726643,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCN(C)c2ccc(CC(=O)O)c(C)c2)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '11.49', 'le': '0.22', 'lle': '-0.30', 'sei': '7.04'}",CHEMBL427040,,CHEMBL427040,5.34,1,http://www.openphacts.org/units/Nanomolar,496539,=,1,1,=,,IC50,nM,,4600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.6000004
,1726644,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCN(C)c2ccc(CC(=O)O)cc2C)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '13.64', 'le': '0.26', 'lle': '0.70', 'sei': '8.36'}",CHEMBL209563,,CHEMBL209563,6.34,1,http://www.openphacts.org/units/Nanomolar,496538,=,1,1,=,,IC50,nM,,460.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.46
,1726645,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCn2ccc3cc(CCC(=O)O)ccc32)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '12.48', 'le': '0.24', 'lle': '-0.32', 'sei': '7.64'}",CHEMBL207907,,CHEMBL207907,5.92,1,http://www.openphacts.org/units/Nanomolar,496536,=,1,1,=,,IC50,nM,,1200.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.2
,1726646,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCn2ccc3cc(CC(=O)O)ccc32)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '12.43', 'le': '0.24', 'lle': '-0.13', 'sei': '7.38'}",CHEMBL383728,,CHEMBL383728,5.72,1,http://www.openphacts.org/units/Nanomolar,496530,=,1,1,=,,IC50,nM,,1900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.9000001
,1726647,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCN(C)c2cccc(CC(=O)O)c2)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '12.26', 'le': '0.24', 'lle': '0.19', 'sei': '7.29'}",CHEMBL207442,,CHEMBL207442,5.52,1,http://www.openphacts.org/units/Nanomolar,496527,=,1,1,=,,IC50,nM,,3000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.0000002
,1726648,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCNc2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '16.02', 'le': '0.31', 'lle': '1.68', 'sei': '8.27'}",CHEMBL207103,,CHEMBL207103,6.99,1,http://www.openphacts.org/units/Nanomolar,496523,=,1,1,=,,IC50,nM,,102.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.102000006
,1726649,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCN(C)c2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '12.29', 'le': '0.24', 'lle': '0.21', 'sei': '7.31'}",CHEMBL207019,,CHEMBL207019,5.54,1,http://www.openphacts.org/units/Nanomolar,496522,=,1,1,=,,IC50,nM,,2900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.9
,1726650,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCOc2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '15.02', 'le': '0.29', 'lle': '1.30', 'sei': '8.03'}",CHEMBL210973,,CHEMBL210973,6.57,1,http://www.openphacts.org/units/Nanomolar,496519,=,1,1,=,,IC50,nM,,270.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.27
,1726651,[],CHEMBL870177,Inhibition of PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1c(OCCCOc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL1148661,Bioorg Med Chem Lett,2006,"{'bei': '13.89', 'le': '0.28', 'lle': '0.62', 'sei': '8.01'}",CHEMBL210768,,CHEMBL210768,6.55,1,http://www.openphacts.org/units/Nanomolar,496518,=,1,1,=,,IC50,nM,,280.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.28
,1762811,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OCCCOc2ccc(OC(C)(C)C(=O)O)cc2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.04', 'le': '0.30', 'lle': '1.85', 'sei': '9.04'}",CHEMBL213314,,CHEMBL213314,7.42,1,http://www.openphacts.org/units/Nanomolar,565229,=,1,1,=,,IC50,nM,,38.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.038000003
,1764540,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '20.07', 'le': '0.39', 'lle': '4.68', 'sei': '10.03'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.17,1,http://www.openphacts.org/units/Nanomolar,565244,=,1,1,=,,IC50,nM,,67.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.067
,1764541,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(OCC[C@@H](C)Oc2ccc(Cl)cc2Oc2ccccc2)ccc1CCC(=O)O,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.46', 'le': '0.32', 'lle': '0.77', 'sei': '11.88'}",CHEMBL215701,,CHEMBL215701,7.72,1,http://www.openphacts.org/units/Nanomolar,565243,=,1,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
,1764542,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CCOc1ccc(CCC(=O)O)c(F)c1)Oc1ccc(Cl)cc1Oc1ccccc1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '15.69', 'le': '0.31', 'lle': '0.67', 'sei': '11.08'}",CHEMBL215245,,CHEMBL215245,7.20,1,http://www.openphacts.org/units/Nanomolar,565242,=,1,1,=,,IC50,nM,,63.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.063
,1764543,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](CCOc1ccc(CCC(=O)O)c(C(F)(F)F)c1)Oc1ccc(Cl)cc1Oc1ccccc1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '14.18', 'le': '0.28', 'lle': '-0.19', 'sei': '11.10'}",CHEMBL213361,,CHEMBL213361,7.21,1,http://www.openphacts.org/units/Nanomolar,565241,=,1,1,=,,IC50,nM,,61.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.061000004
,1764544,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC[C@@H](C)Oc2ccc(C(F)(F)F)cc2Oc2ccccc2)ccc1CCC(=O)O,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.83', 'le': '0.32', 'lle': '1.16', 'sei': '12.65'}",CHEMBL213315,,CHEMBL213315,8.22,1,http://www.openphacts.org/units/Nanomolar,565240,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,1764545,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC[C@@H](C)Oc2ccc(OC(F)(F)F)cc2Oc2ccccc2)ccc1CCC(=O)O,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.30', 'le': '0.31', 'lle': '1.28', 'sei': '11.08'}",CHEMBL214921,,CHEMBL214921,8.22,1,http://www.openphacts.org/units/Nanomolar,565239,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,1764546,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC[C@@H](C)Oc2ccc(Cl)cc2Oc2ccccc2)ccc1CCC(=O)O,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '17.20', 'le': '0.33', 'lle': '1.13', 'sei': '12.04'}",CHEMBL214026,,CHEMBL214026,7.82,1,http://www.openphacts.org/units/Nanomolar,565238,=,1,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
,1764547,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(Oc2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '18.33', 'le': '0.34', 'lle': '1.62', 'sei': '12.65'}",CHEMBL377660,,CHEMBL377660,8.22,1,http://www.openphacts.org/units/Nanomolar,565237,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,1764548,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OC(C)CCOc2ccc(CCC(=O)O)c(C)c2)c(Cc2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.19', 'le': '0.30', 'lle': '0.83', 'sei': '12.96'}",CHEMBL212591,,CHEMBL212591,7.23,0,http://www.openphacts.org/units/Nanomolar,565236,=,1,1,=,,IC50,nM,,59.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.059000004
,1764549,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(CCOc1ccc(CCC(=O)O)c(C)c1)Oc1ccc(CC)cc1C(=O)c1ccccc1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '13.06', 'le': '0.24', 'lle': '-0.44', 'sei': '8.76'}",CHEMBL212023,,CHEMBL212023,6.38,0,http://www.openphacts.org/units/Nanomolar,565235,=,1,1,=,,IC50,nM,,417.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.41700003
,1764550,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OC(CC)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '16.32', 'le': '0.30', 'lle': '1.31', 'sei': '10.63'}",CHEMBL215127,,CHEMBL215127,7.75,0,http://www.openphacts.org/units/Nanomolar,565234,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,1764551,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '12.91', 'le': '0.24', 'lle': '-0.09', 'sei': '8.17'}",CHEMBL215126,,CHEMBL215126,5.95,0,http://www.openphacts.org/units/Nanomolar,565233,=,1,1,=,,IC50,nM,,1130.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.13
,1764552,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '18.02', 'le': '0.33', 'lle': '2.26', 'sei': '11.40'}",CHEMBL212911,,CHEMBL212911,8.30,1,http://www.openphacts.org/units/Nanomolar,565232,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,1764553,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OC(C)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '17.20', 'le': '0.32', 'lle': '1.88', 'sei': '10.88'}",CHEMBL378068,,CHEMBL378068,7.92,0,http://www.openphacts.org/units/Nanomolar,565231,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,1764554,[],CHEMBL911538,Displacement of [3H]2-methyl-2-(4-{3-[propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma by SPA,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(OC(C)CCOc2ccc(OC(C)(C)C(=O)O)cc2)c(C(=O)c2ccccc2)c1,,,CHEMBL1149342,J Med Chem,2006,"{'bei': '17.25', 'le': '0.32', 'lle': '2.26', 'sei': '10.02'}",CHEMBL215582,,CHEMBL215582,8.22,0,http://www.openphacts.org/units/Nanomolar,565230,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,1806323,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(C(=O)NS(=O)(=O)c3ccccc3)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '15.10', 'le': '0.29', 'lle': '2.02', 'sei': '11.01'}",CHEMBL376627,,CHEMBL376627,8.52,0,http://www.openphacts.org/units/Nanomolar,622137,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,1806324,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '19.71', 'le': '0.38', 'lle': '4.56', 'sei': '9.85'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.05,1,http://www.openphacts.org/units/Nanomolar,622166,=,1,1,=,,IC50,nM,,90.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.09
,1806325,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2cc(O)ccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '11.55', 'le': '0.23', 'lle': '0.72', 'sei': '7.09'}",CHEMBL374657,,CHEMBL374657,6.27,0,http://www.openphacts.org/units/Nanomolar,622165,=,1,1,=,,IC50,nM,,540.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.54
,1806326,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2cc(OCc3ccccc3)ccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '9.66', 'le': '0.19', 'lle': '-1.31', 'sei': '7.90'}",CHEMBL385585,,CHEMBL385585,6.11,0,http://www.openphacts.org/units/Nanomolar,622164,=,1,1,=,,IC50,nM,,770.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.77000004
,1806327,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2cc(Cl)ccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '11.56', 'le': '0.24', 'lle': '-0.02', 'sei': '9.51'}",CHEMBL218230,,CHEMBL218230,6.48,0,http://www.openphacts.org/units/Nanomolar,622163,=,1,1,=,,IC50,nM,,330.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.33
,1806328,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(Cn2c(C(=O)NS(=O)(=O)c3cccc(C(F)(F)F)c3)cc3ccccc32)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.60', 'le': '0.25', 'lle': '0.36', 'sei': '9.51'}",CHEMBL218841,,CHEMBL218841,6.48,0,http://www.openphacts.org/units/Nanomolar,622162,=,1,1,=,,IC50,nM,,330.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.33
,1806329,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1cc(Cl)ccc1Cl,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.17', 'le': '0.26', 'lle': '0.29', 'sei': '9.42'}",CHEMBL374705,,CHEMBL374705,6.42,0,http://www.openphacts.org/units/Nanomolar,622161,=,1,1,=,,IC50,nM,,380.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.38000003
,1806330,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1ccccc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.29', 'le': '0.28', 'lle': '1.72', 'sei': '9.61'}",CHEMBL218840,,CHEMBL218840,6.55,0,http://www.openphacts.org/units/Nanomolar,622160,=,1,1,=,,IC50,nM,,280.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.28
,1806331,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1cccc(OCc2ccccc2)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.93', 'le': '0.25', 'lle': '0.89', 'sei': '9.43'}",CHEMBL218789,,CHEMBL218789,7.30,0,http://www.openphacts.org/units/Nanomolar,622159,=,1,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
,1806332,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.15', 'le': '0.24', 'lle': '0.55', 'sei': '9.39'}",CHEMBL218122,,CHEMBL218122,6.40,0,http://www.openphacts.org/units/Nanomolar,622158,=,1,1,=,,IC50,nM,,400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.4
,1806333,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1c(C(=O)NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc2ccccc21,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.16', 'le': '0.28', 'lle': '1.81', 'sei': '8.23'}",CHEMBL376051,,CHEMBL376051,5.61,0,http://www.openphacts.org/units/Nanomolar,622157,=,1,1,=,,IC50,nM,,2440.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.44
,1806334,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1C(=O)c1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '9.30', 'le': '0.19', 'lle': '-0.46', 'sei': '5.90'}",CHEMBL435317,,CHEMBL435317,5.03,0,http://www.openphacts.org/units/Nanomolar,622156,=,1,1,=,,IC50,nM,,9400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,9.400001
,1806335,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1cccc(OC(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.99', 'le': '0.26', 'lle': '1.32', 'sei': '9.10'}",CHEMBL222165,,CHEMBL222165,7.05,0,http://www.openphacts.org/units/Nanomolar,622155,=,1,1,=,,IC50,nM,,90.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.09
,1806336,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Cn2c(C(=O)NS(=O)(=O)c3cccc(C(F)(F)F)c3)cc3ccccc32)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.03', 'le': '0.28', 'lle': '2.01', 'sei': '8.86'}",CHEMBL436337,,CHEMBL436337,6.85,0,http://www.openphacts.org/units/Nanomolar,622154,=,1,1,=,,IC50,nM,,140.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.14
,1806337,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1cc2ccccc2n1Cc1ccc(C(F)(F)F)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '11.69', 'le': '0.23', 'lle': '0.30', 'sei': '9.03'}",CHEMBL374363,,CHEMBL374363,6.16,0,http://www.openphacts.org/units/Nanomolar,622153,=,1,1,=,,IC50,nM,,700.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.70000005
,1806338,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,CS(=O)(=O)NC(=O)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '15.56', 'le': '0.31', 'lle': '2.77', 'sei': '9.05'}",CHEMBL386504,,CHEMBL386504,6.17,0,http://www.openphacts.org/units/Nanomolar,622152,=,1,1,=,,IC50,nM,,680.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.68
,1806339,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc(Cl)s1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.22', 'le': '0.30', 'lle': '1.56', 'sei': '10.41'}",CHEMBL447538,,CHEMBL447538,7.10,0,http://www.openphacts.org/units/Nanomolar,622151,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,1806340,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '13.48', 'le': '0.27', 'lle': '1.25', 'sei': '10.41'}",CHEMBL386307,,CHEMBL386307,7.10,0,http://www.openphacts.org/units/Nanomolar,622150,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,1806341,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc2ccccc2c1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '13.86', 'le': '0.27', 'lle': '1.07', 'sei': '10.34'}",CHEMBL222026,,CHEMBL222026,7.05,0,http://www.openphacts.org/units/Nanomolar,622149,=,1,1,=,,IC50,nM,,90.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.09
,1806342,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1S(=O)(=O)NC(=O)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.27', 'le': '0.28', 'lle': '1.60', 'sei': '9.89'}",CHEMBL220537,,CHEMBL220537,6.75,0,http://www.openphacts.org/units/Nanomolar,622148,=,1,1,=,,IC50,nM,,180.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.18
,1806343,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(S(=O)(=O)NC(=O)c2cc3ccccc3n2Cc2cccc(C(F)(F)F)c2)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '13.84', 'le': '0.27', 'lle': '1.40', 'sei': '9.59'}",CHEMBL220475,,CHEMBL220475,6.54,0,http://www.openphacts.org/units/Nanomolar,622147,=,1,1,=,,IC50,nM,,290.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.29000002
,1806344,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '13.48', 'le': '0.27', 'lle': '1.25', 'sei': '10.41'}",CHEMBL221342,,CHEMBL221342,7.10,0,http://www.openphacts.org/units/Nanomolar,622146,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,1806345,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '13.29', 'le': '0.27', 'lle': '1.07', 'sei': '9.61'}",CHEMBL218176,,CHEMBL218176,6.55,0,http://www.openphacts.org/units/Nanomolar,622145,=,1,1,=,,IC50,nM,,280.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.28
,1806346,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccc(F)cc1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '12.89', 'le': '0.25', 'lle': '1.17', 'sei': '9.01'}",CHEMBL218175,,CHEMBL218175,6.14,0,http://www.openphacts.org/units/Nanomolar,622144,=,1,1,=,,IC50,nM,,720.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.72
,1806347,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NS(=O)(=O)c1ccccc1)c1cc2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.26', 'le': '0.28', 'lle': '1.71', 'sei': '9.59'}",CHEMBL374189,,CHEMBL374189,6.54,0,http://www.openphacts.org/units/Nanomolar,622143,=,1,1,=,,IC50,nM,,290.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.29000002
,1806348,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(C(=O)NS(C)(=O)=O)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '17.31', 'le': '0.34', 'lle': '3.63', 'sei': '11.24'}",CHEMBL221580,,CHEMBL221580,8.70,0,http://www.openphacts.org/units/Nanomolar,622142,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,1806349,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(C(=O)NS(=O)(=O)c3ccccc3C)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.09', 'le': '0.27', 'lle': '1.34', 'sei': '10.54'}",CHEMBL217962,,CHEMBL217962,8.15,0,http://www.openphacts.org/units/Nanomolar,622141,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,1806350,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccccc1S(=O)(=O)NC(=O)c1c(-c2ccc(OC)cc2)c2ccccc2n1Cc1cccc(C(F)(F)F)c1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.46', 'le': '0.28', 'lle': '2.71', 'sei': '8.68'}",CHEMBL218258,,CHEMBL218258,9.00,0,http://www.openphacts.org/units/Nanomolar,622140,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,1806351,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(C(=O)NS(=O)(=O)c3cccc(C(F)(F)F)c3)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '11.42', 'le': '0.22', 'lle': '-0.30', 'sei': '9.33'}",CHEMBL267881,,CHEMBL267881,7.22,0,http://www.openphacts.org/units/Nanomolar,622139,=,1,1,=,,IC50,nM,,60.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.060000002
,1806352,[],CHEMBL855083,Displacement of Fluormone from PPAR gamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(-c2c(C(=O)NS(=O)(=O)c3ccc(F)cc3)n(Cc3cccc(C(F)(F)F)c3)c3ccccc23)cc1,,,CHEMBL1139678,Bioorg Med Chem Lett,2006,"{'bei': '14.00', 'le': '0.27', 'lle': '1.51', 'sei': '10.54'}",CHEMBL218231,,CHEMBL218231,8.15,0,http://www.openphacts.org/units/Nanomolar,622138,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,1813092,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,,CHEMBL981,FENOFIBRIC ACID,CHEMBL981,,1,http://www.openphacts.org/units/Nanomolar,624113,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1813099,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '20.48', 'le': '0.40', 'lle': '4.83', 'sei': '10.23'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.32,0,http://www.openphacts.org/units/Nanomolar,624104,=,1,1,=,,IC50,nM,,48.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.048
,1813107,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '13.91', 'le': '0.25', 'lle': '0.99', 'sei': '7.48'}",CHEMBL107367,FARGLITAZAR,CHEMBL107367,7.60,0,http://www.openphacts.org/units/Nanomolar,624106,=,1,1,=,,IC50,nM,,25.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.025
,1813109,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '13.34', 'le': '0.26', 'lle': '1.52', 'sei': '6.94'}",CHEMBL408,TROGLITAZONE,CHEMBL408,5.89,0,http://www.openphacts.org/units/Nanomolar,624105,=,1,1,=,,IC50,nM,,1285.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.2850001
,1813119,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '13.50', 'le': '0.25', 'lle': '0.74', 'sei': '6.61'}",CHEMBL220622,,CHEMBL220622,7.33,0,http://www.openphacts.org/units/Nanomolar,624107,=,1,1,=,,IC50,nM,,47.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.047000002
,1813131,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(CCC(=O)O)c2c1CCN(C(=O)OCC(C)(C)C)C2,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '12.54', 'le': '0.23', 'lle': '-0.02', 'sei': '7.33'}",CHEMBL387373,,CHEMBL387373,7.48,0,http://www.openphacts.org/units/Nanomolar,624112,=,1,1,=,,IC50,nM,,33.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.033
,1813133,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c2c1CCN(C(=O)OCC(C)C)C2,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '15.34', 'le': '0.29', 'lle': '2.33', 'sei': '7.61'}",CHEMBL446365,,CHEMBL446365,7.77,0,http://www.openphacts.org/units/Nanomolar,624111,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,1813135,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,C#CCOC(=O)N1CCc2c(OCCc3nc(-c4ccccc4)oc3C)ccc(CCC(=O)O)c2C1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '15.60', 'le': '0.29', 'lle': '3.20', 'sei': '7.46'}",CHEMBL223434,,CHEMBL223434,7.62,0,http://www.openphacts.org/units/Nanomolar,624110,=,1,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
,1813137,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCOC(=O)N1CCc2c(OCCc3nc(-c4ccc(-c5ccccc5)cc4)oc3C)ccc(CCC(=O)O)c2C1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '13.50', 'le': '0.25', 'lle': '0.82', 'sei': '7.52'}",CHEMBL219836,,CHEMBL219836,7.68,0,http://www.openphacts.org/units/Nanomolar,624109,=,1,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
,1813139,[],CHEMBL912531,Displacement of tritium labeled ligand from human PPARgamma by SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCOC(=O)N1CCc2c(OCCc3nc(-c4ccccc4)oc3C)ccc(CCC(=O)O)c2C1,,,CHEMBL1146163,Bioorg Med Chem Lett,2006,"{'bei': '16.16', 'le': '0.30', 'lle': '2.77', 'sei': '7.79'}",CHEMBL376460,,CHEMBL376460,7.96,0,http://www.openphacts.org/units/Nanomolar,624108,=,1,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
,1813181,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OCc2ccccc2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.68', 'le': '0.25', 'lle': '1.32', 'sei': '6.35'}",CHEMBL441554,,CHEMBL441554,7.04,0,http://www.openphacts.org/units/Nanomolar,624117,=,1,1,=,,IC50,nM,,91.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.091000006
,1813185,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1sc(N2CCOCC2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '15.58', 'le': '0.31', 'lle': '4.10', 'sei': '6.95'}",CHEMBL223351,,CHEMBL223351,7.66,0,http://www.openphacts.org/units/Nanomolar,624127,=,1,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
,1813186,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)Oc2cnccn2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.11', 'le': '0.24', 'lle': '1.56', 'sei': '5.55'}",CHEMBL374344,,CHEMBL374344,7.58,0,http://www.openphacts.org/units/Nanomolar,624126,=,1,1,=,,IC50,nM,,26.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.026
,1813187,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)Oc2cnccn2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '15.46', 'le': '0.29', 'lle': '3.40', 'sei': '5.68'}",CHEMBL223350,,CHEMBL223350,7.77,0,http://www.openphacts.org/units/Nanomolar,624125,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,1813188,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ncccn3)cc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.41', 'le': '0.25', 'lle': '1.92', 'sei': '5.34'}",CHEMBL223128,,CHEMBL223128,7.30,0,http://www.openphacts.org/units/Nanomolar,624124,=,1,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
,1813189,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(Oc3ccccc3)cc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.07', 'le': '0.24', 'lle': '0.58', 'sei': '6.08'}",CHEMBL373685,,CHEMBL373685,7.30,0,http://www.openphacts.org/units/Nanomolar,624123,=,1,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
,1813190,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccc(-c3ccccc3)cc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.50', 'le': '0.25', 'lle': '0.74', 'sei': '6.61'}",CHEMBL220622,,CHEMBL220622,7.33,1,http://www.openphacts.org/units/Nanomolar,624122,=,1,1,=,,IC50,nM,,47.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.047000002
,1813191,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)OC(C)C)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '16.26', 'le': '0.30', 'lle': '2.67', 'sei': '6.84'}",CHEMBL219824,,CHEMBL219824,7.58,0,http://www.openphacts.org/units/Nanomolar,624121,=,1,1,=,,IC50,nM,,26.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.026
,1813192,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNS(=O)(=O)Cc2ccccc2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.36', 'le': '0.26', 'lle': '2.23', 'sei': '6.02'}",CHEMBL219773,,CHEMBL219773,7.14,0,http://www.openphacts.org/units/Nanomolar,624120,=,1,1,=,,IC50,nM,,72.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.072000004
,1813193,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)CCc2ccccc2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '13.25', 'le': '0.24', 'lle': '1.25', 'sei': '6.68'}",CHEMBL223349,,CHEMBL223349,6.79,0,http://www.openphacts.org/units/Nanomolar,624119,=,1,1,=,,IC50,nM,,161.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.16100001
,1813194,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCC(=O)O)c(CNC(=O)NCc2ccccc2)c1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '11.98', 'le': '0.22', 'lle': '0.86', 'sei': '5.41'}",CHEMBL223379,,CHEMBL223379,6.15,0,http://www.openphacts.org/units/Nanomolar,624118,=,1,1,=,,IC50,nM,,706.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.70600003
,1813195,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,,CHEMBL981,FENOFIBRIC ACID,CHEMBL981,,0,http://www.openphacts.org/units/Nanomolar,624129,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1813196,[],CHEMBL912551,Displacement of [3H]2-methyl-2-(4-{3-propyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-pro-pyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1146164,Bioorg Med Chem Lett,2006,"{'bei': '20.07', 'le': '0.39', 'lle': '4.68', 'sei': '10.03'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.17,1,http://www.openphacts.org/units/Nanomolar,624128,=,1,1,=,,IC50,nM,,67.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.067
,1967814,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OCC(=O)O)c(C)cc1SCc1ccc(OCc2ccc(C(F)(F)F)cc2)cc1,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '9.39', 'le': '0.19', 'lle': '-1.73', 'sei': '7.12'}",CHEMBL234659,,CHEMBL234659,4.63,1,http://www.openphacts.org/units/Nanomolar,657660,=,1,1,=,,IC50,nM,,23600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,23.6
,1967835,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)ccc1OCC(=O)O,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,,CHEMBL234660,,CHEMBL234660,,0,http://www.openphacts.org/units/Nanomolar,657661,>,1,1,>,,IC50,nM,,11000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,11.000001
,1967875,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)COc1ccc(SCc2ccc(OCc3ccc(F)cc3C(F)(F)F)cc2)c2c1CCC2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,,CHEMBL392950,,CHEMBL392950,,0,http://www.openphacts.org/units/Nanomolar,657673,<,1,1,<,,IC50,nM,,11100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,11.1
,1967878,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)COc1ccc(SCc2ccc(OCc3ccccc3)cc2)c2c1CCC2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '12.18', 'le': '0.23', 'lle': '-0.39', 'sei': '9.18'}",CHEMBL234663,,CHEMBL234663,5.12,0,http://www.openphacts.org/units/Nanomolar,657670,=,1,1,=,,IC50,nM,,7570.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,7.57
,1967880,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(COc2ccc(CSc3ccc(OCC(=O)O)c4c3CCC4)cc2)cc1,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '10.79', 'le': '0.21', 'lle': '-0.66', 'sei': '7.48'}",CHEMBL234662,,CHEMBL234662,4.86,1,http://www.openphacts.org/units/Nanomolar,657668,=,1,1,=,,IC50,nM,,13800.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,13.8
,1967883,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c2c(c1OCC(=O)O)CCC2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '9.28', 'le': '0.18', 'lle': '-2.17', 'sei': '8.37'}",CHEMBL232396,,CHEMBL232396,4.67,1,http://www.openphacts.org/units/Nanomolar,657665,=,1,1,=,,IC50,nM,,21600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,21.6
,1967884,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c2c(c1OCC(=O)O)CCCO2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '8.63', 'le': '0.17', 'lle': '-2.19', 'sei': '6.89'}",CHEMBL391479,,CHEMBL391479,4.48,1,http://www.openphacts.org/units/Nanomolar,657664,=,1,1,=,,IC50,nM,,33300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,33.300003
,1967885,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)COc1ccc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c2c1CCCO2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '10.42', 'le': '0.21', 'lle': '-1.12', 'sei': '8.09'}",CHEMBL232395,,CHEMBL232395,5.25,1,http://www.openphacts.org/units/Nanomolar,657663,=,1,1,=,,IC50,nM,,5560.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.5600004
,1967886,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c(Cl)cc1OCC(=O)O,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,"{'bei': '10.14', 'le': '0.21', 'lle': '-1.96', 'sei': '9.04'}",CHEMBL391478,,CHEMBL391478,5.04,1,http://www.openphacts.org/units/Nanomolar,657662,=,1,1,=,,IC50,nM,,9120.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,9.120001
,1967890,[],CHEMBL896363,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA assay",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)COc1ccc(SCc2ccc(OCc3ccc(OC(F)(F)F)cc3)cc2)c2c1CCC2,,,CHEMBL1148881,Bioorg Med Chem Lett,2007,,CHEMBL233177,,CHEMBL233177,,0,http://www.openphacts.org/units/Nanomolar,657679,<,1,1,<,,IC50,nM,,11100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,11.1
,1968718,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1csc2cc(OCc3cc(-c4ccc(Cl)cc4)on3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL233978,,CHEMBL233978,,0,http://www.openphacts.org/units/Nanomolar,657870,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968719,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(F)(F)F)sc1CSc1ccc2c(ccn2CC(=O)O)c1,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL231690,,CHEMBL231690,,0,http://www.openphacts.org/units/Nanomolar,657894,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968720,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cn1ccc2cc(OCc3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)ccc21,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL393373,,CHEMBL393373,,0,http://www.openphacts.org/units/Nanomolar,657893,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968721,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cn1ccc2cc(OCc3cccc(COc4ccc(C(F)(F)F)cc4)c3)ccc21,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL231689,,CHEMBL231689,,0,http://www.openphacts.org/units/Nanomolar,657892,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968722,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cn1ccc2cc(OCc3ccccc3COc3ccc(C(F)(F)F)cc3)ccc21,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL231688,,CHEMBL231688,,0,http://www.openphacts.org/units/Nanomolar,657891,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968723,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cn1ccc2cc(OCc3cc(-c4ccc(C(F)(F)F)cc4)on3)ccc21,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL393767,,CHEMBL393767,,0,http://www.openphacts.org/units/Nanomolar,657890,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968724,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(F)(F)F)sc1COc1ccc2c(ccn2CC(=O)O)c1,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234801,,CHEMBL234801,,0,http://www.openphacts.org/units/Nanomolar,657889,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968725,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1coc2cc(OCc3ccc(COc4ccc(C(F)(F)F)cc4)cc3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234800,,CHEMBL234800,,0,http://www.openphacts.org/units/Nanomolar,657888,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968726,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1coc2cc(OCc3cccc(COc4ccc(C(F)(F)F)cc4)c3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '11.54', 'le': '0.22', 'lle': '-0.97', 'sei': '7.65'}",CHEMBL234799,,CHEMBL234799,5.27,1,http://www.openphacts.org/units/Nanomolar,657887,=,1,1,=,,IC50,nM,,5400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.4
,1968727,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1coc2cc(OCc3ccccc3COc3ccc(C(F)(F)F)cc3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL393766,,CHEMBL393766,,0,http://www.openphacts.org/units/Nanomolar,657886,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968728,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1csc2cc(OCc3ccc(COc4ccc(C(F)(F)F)cc4)cc3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '11.49', 'le': '0.22', 'lle': '-1.28', 'sei': '9.74'}",CHEMBL234589,,CHEMBL234589,5.43,1,http://www.openphacts.org/units/Nanomolar,657885,=,1,1,=,,IC50,nM,,3730.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.7300003
,1968729,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1csc2cc(OCc3cccc(COc4ccc(C(F)(F)F)cc4)c3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '11.08', 'le': '0.22', 'lle': '-1.47', 'sei': '9.39'}",CHEMBL234588,,CHEMBL234588,5.24,1,http://www.openphacts.org/units/Nanomolar,657884,=,1,1,=,,IC50,nM,,5790.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.7900004
,1968730,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(CC(=O)O)csc2cc1OCc1ccccc1COc1ccc(C(F)(F)F)cc1,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '10.52', 'le': '0.21', 'lle': '-1.89', 'sei': '9.18'}",CHEMBL234587,,CHEMBL234587,5.12,1,http://www.openphacts.org/units/Nanomolar,657883,=,1,1,=,,IC50,nM,,7580.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,7.5800004
,1968731,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1csc2cc(OCc3ccccc3COc3ccc(C(F)(F)F)cc3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234383,,CHEMBL234383,,0,http://www.openphacts.org/units/Nanomolar,657882,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968732,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCc2cc(-c3ccc(C(F)(F)F)cc3)on2)cc2scc(CC(=O)O)c12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234382,,CHEMBL234382,,0,http://www.openphacts.org/units/Nanomolar,657880,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968733,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCc2cc(-c3ccc(Cl)cc3)on2)cc2scc(CC(=O)O)c12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '12.23', 'le': '0.25', 'lle': '-0.66', 'sei': '6.98'}",CHEMBL391085,,CHEMBL391085,5.06,1,http://www.openphacts.org/units/Nanomolar,657877,=,1,1,=,,IC50,nM,,8660.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,8.660001
,1968734,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1COc1cc(Cl)c2c(CC(=O)O)csc2c1,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234169,,CHEMBL234169,,0,http://www.openphacts.org/units/Nanomolar,657876,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968735,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(CC(=O)O)csc2cc1OCc1sc(-c2ccc(C(F)(F)F)cc2)nc1C,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,"{'bei': '10.90', 'le': '0.22', 'lle': '-1.67', 'sei': '8.76'}",CHEMBL391084,,CHEMBL391084,5.20,1,http://www.openphacts.org/units/Nanomolar,657875,=,1,1,=,,IC50,nM,,6260.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.26
,1968736,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1coc2cc(OCc3cc(-c4ccc(C(F)(F)F)cc4)on3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL234168,,CHEMBL234168,,0,http://www.openphacts.org/units/Nanomolar,657874,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968737,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)Cc1coc2cc(OCc3cc(-c4ccc(Cl)cc4)on3)ccc12,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL391068,,CHEMBL391068,,0,http://www.openphacts.org/units/Nanomolar,657873,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,1968738,[],CHEMBL896468,"Displacement of [3H]5-(4-(3-(5-methyl-2-phenyloxazol-4-yl)propanoyl)benzyl)thiazolidine-2,4-dione from human PPARgamma after 2 hrs by SPA",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1COc1ccc2c(CC(=O)O)csc2c1,,,CHEMBL1149526,Bioorg Med Chem Lett,2007,,CHEMBL233976,,CHEMBL233976,,0,http://www.openphacts.org/units/Nanomolar,657869,>,1,1,>,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,2007774,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.89', 'le': '0.30', 'lle': '1.76', 'sei': '9.13'}",CHEMBL392058,,CHEMBL392058,7.75,1,http://www.openphacts.org/units/Nanomolar,667632,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,2007805,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '20.07', 'le': '0.39', 'lle': '4.68', 'sei': '10.03'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.17,1,http://www.openphacts.org/units/Nanomolar,667663,=,1,1,=,,IC50,nM,,67.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.067
,2007806,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(Oc2cc(F)cc([C@@H](C)NC(=O)c3sc4ccc(Cl)cc4c3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '13.52', 'le': '0.27', 'lle': '-0.57', 'sei': '9.65'}",CHEMBL401236,,CHEMBL401236,7.30,1,http://www.openphacts.org/units/Nanomolar,667662,=,1,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
,2007807,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(Oc2cc(F)cc([C@@H](C)NC(=O)c3c(C)c4cc(Cl)ccc4n3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '13.80', 'le': '0.27', 'lle': '0.27', 'sei': '9.20'}",CHEMBL238357,,CHEMBL238357,7.41,1,http://www.openphacts.org/units/Nanomolar,667661,=,1,1,=,,IC50,nM,,39.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.039
,2007808,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3c(C)c4cc(Cl)ccc4n3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.19', 'le': '0.29', 'lle': '1.27', 'sei': '9.26'}",CHEMBL238152,,CHEMBL238152,7.46,0,http://www.openphacts.org/units/Nanomolar,667660,=,1,1,=,,IC50,nM,,35.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.035
,2007809,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3[nH]c4ccc(Cl)cc4c3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.87', 'le': '0.30', 'lle': '1.39', 'sei': '8.28'}",CHEMBL235143,,CHEMBL235143,7.57,1,http://www.openphacts.org/units/Nanomolar,667659,=,1,1,=,,IC50,nM,,27.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.027
,2007810,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4cc(Cl)ccc4n3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.69', 'le': '0.28', 'lle': '1.13', 'sei': '8.70'}",CHEMBL399417,,CHEMBL399417,7.01,0,http://www.openphacts.org/units/Nanomolar,667658,=,1,1,=,,IC50,nM,,98.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.098000005
,2007811,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4cc(Cl)c(Cl)cc4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.12', 'le': '0.28', 'lle': '0.50', 'sei': '7.68'}",CHEMBL399217,,CHEMBL399217,7.02,1,http://www.openphacts.org/units/Nanomolar,667657,=,1,1,=,,IC50,nM,,95.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.095000006
,2007812,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4cccc(Br)c4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.65', 'le': '0.31', 'lle': '1.45', 'sei': '8.13'}",CHEMBL236218,,CHEMBL236218,7.43,1,http://www.openphacts.org/units/Nanomolar,667656,=,1,1,=,,IC50,nM,,37.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.037
,2007813,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4cc(Br)ccc4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.96', 'le': '0.34', 'lle': '2.12', 'sei': '8.86'}",CHEMBL237485,,CHEMBL237485,8.10,1,http://www.openphacts.org/units/Nanomolar,667655,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,2007814,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4ccc(Cl)cc4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.33', 'le': '0.27', 'lle': '0.76', 'sei': '7.26'}",CHEMBL237484,,CHEMBL237484,6.63,1,http://www.openphacts.org/units/Nanomolar,667654,=,1,1,=,,IC50,nM,,233.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.23300001
,2007815,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4cc(Cl)ccc4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '17.04', 'le': '0.33', 'lle': '2.02', 'sei': '8.63'}",CHEMBL237277,,CHEMBL237277,7.89,1,http://www.openphacts.org/units/Nanomolar,667653,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,2007816,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3cc4c(Cl)cccc4[nH]3)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.23', 'le': '0.27', 'lle': '0.72', 'sei': '7.21'}",CHEMBL392718,,CHEMBL392718,6.59,0,http://www.openphacts.org/units/Nanomolar,667652,=,1,1,=,,IC50,nM,,258.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.25800002
,2007817,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3C)c2)ccc1CCC(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.63', 'le': '0.28', 'lle': '0.84', 'sei': '9.12'}",CHEMBL237730,,CHEMBL237730,6.90,0,http://www.openphacts.org/units/Nanomolar,667651,=,1,1,=,,IC50,nM,,126.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.126
,2007818,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2ccc(F)c(CNC(=O)c3ccc(C(F)(F)F)cc3F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.47', 'le': '0.30', 'lle': '1.84', 'sei': '9.54'}",CHEMBL237520,,CHEMBL237520,8.10,1,http://www.openphacts.org/units/Nanomolar,667650,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,2007819,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cc(F)cc(CNC(=O)c3ccc(C(F)(F)F)cc3F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.47', 'le': '0.30', 'lle': '1.84', 'sei': '9.54'}",CHEMBL392717,,CHEMBL392717,8.10,1,http://www.openphacts.org/units/Nanomolar,667649,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,2007820,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Oc2ccc(OC(C)(C)C(=O)O)c(C)c2)cc1CNC(=O)c1ccc(C(F)(F)F)cc1F,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.96', 'le': '0.29', 'lle': '1.34', 'sei': '9.16'}",CHEMBL237519,,CHEMBL237519,7.77,1,http://www.openphacts.org/units/Nanomolar,667648,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,2007821,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(CNC(=O)c2ccc(C(F)(F)F)cc2F)cc(Oc2ccc(OC(C)(C)C(=O)O)c(C)c2)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.25', 'le': '0.29', 'lle': '1.49', 'sei': '9.33'}",CHEMBL237518,,CHEMBL237518,7.92,1,http://www.openphacts.org/units/Nanomolar,667647,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,2007822,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CNC(=O)c2ccc(C(F)(F)F)cc2F)cc1Oc1ccc(OC(C)(C)C(=O)O)c(C)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.98', 'le': '0.31', 'lle': '1.87', 'sei': '9.78'}",CHEMBL237307,,CHEMBL237307,8.30,1,http://www.openphacts.org/units/Nanomolar,667646,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,2007823,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccccc3C)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '17.76', 'le': '0.33', 'lle': '2.43', 'sei': '9.07'}",CHEMBL393940,,CHEMBL393940,7.70,0,http://www.openphacts.org/units/Nanomolar,667645,=,1,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
,2007824,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(C(=O)NCc2cccc(Oc3ccc(OC(C)(C)C(=O)O)c(C)c3)c2)c(C)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '17.47', 'le': '0.33', 'lle': '2.82', 'sei': '8.61'}",CHEMBL237306,,CHEMBL237306,8.10,1,http://www.openphacts.org/units/Nanomolar,667644,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,2007825,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(OC(F)(F)F)cc3C)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.16', 'le': '0.27', 'lle': '1.16', 'sei': '7.79'}",CHEMBL237305,,CHEMBL237305,7.33,1,http://www.openphacts.org/units/Nanomolar,667643,=,1,1,=,,IC50,nM,,47.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.047000002
,2007826,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(Cl)cc3C)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '17.19', 'le': '0.33', 'lle': '2.13', 'sei': '9.48'}",CHEMBL237086,,CHEMBL237086,8.05,1,http://www.openphacts.org/units/Nanomolar,667642,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,2007827,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(C(=O)NCc2cccc(Oc3ccc(OC(C)(C)C(=O)O)c(C)c3)c2)c(C)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '18.22', 'le': '0.34', 'lle': '2.57', 'sei': '9.61'}",CHEMBL393939,,CHEMBL393939,8.15,1,http://www.openphacts.org/units/Nanomolar,667641,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,2007828,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(F)(F)F)ccc1C(=O)NCc1cccc(Oc2ccc(OC(C)(C)C(=O)O)c(C)c2)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.76', 'le': '0.30', 'lle': '2.16', 'sei': '8.67'}",CHEMBL237085,,CHEMBL237085,8.15,1,http://www.openphacts.org/units/Nanomolar,667640,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,2007829,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3Oc3ccccc3)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '11.98', 'le': '0.23', 'lle': '-0.83', 'sei': '7.38'}",CHEMBL237710,,CHEMBL237710,6.94,1,http://www.openphacts.org/units/Nanomolar,667639,=,1,1,=,,IC50,nM,,114.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.11400001
,2007830,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3C(F)(F)F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '12.05', 'le': '0.23', 'lle': '-0.31', 'sei': '7.89'}",CHEMBL237084,,CHEMBL237084,6.69,1,http://www.openphacts.org/units/Nanomolar,667638,=,1,1,=,,IC50,nM,,203.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.20300001
,2007831,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3Br)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '13.99', 'le': '0.30', 'lle': '1.18', 'sei': '9.33'}",CHEMBL236877,,CHEMBL236877,7.92,1,http://www.openphacts.org/units/Nanomolar,667637,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,2007832,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.67', 'le': '0.30', 'lle': '1.80', 'sei': '9.33'}",CHEMBL236876,,CHEMBL236876,7.92,1,http://www.openphacts.org/units/Nanomolar,667636,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,2007833,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3Cl)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '14.99', 'le': '0.30', 'lle': '1.19', 'sei': '9.22'}",CHEMBL393938,,CHEMBL393938,7.82,1,http://www.openphacts.org/units/Nanomolar,667635,=,1,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
,2007834,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(C(F)(F)F)ccc1C(=O)NCc1cccc(Oc2ccc(OC(C)(C)C(=O)O)c(C)c2)c1,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '15.52', 'le': '0.30', 'lle': '1.46', 'sei': '9.43'}",CHEMBL236875,,CHEMBL236875,8.00,1,http://www.openphacts.org/units/Nanomolar,667634,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,2007835,[],CHEMBL902597,Displacement of [3H]2-methyl-2-(4-{3-{propyl-(5-pyridin-2-yl-thiophene-2-sulfonyl)-amino}-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3C)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL1138336,Bioorg Med Chem Lett,2007,"{'bei': '16.04', 'le': '0.31', 'lle': '1.76', 'sei': '9.48'}",CHEMBL236664,,CHEMBL236664,8.05,1,http://www.openphacts.org/units/Nanomolar,667633,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,2015795,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '18.02', 'le': '0.33', 'lle': '2.26', 'sei': '11.40'}",CHEMBL212911,,CHEMBL212911,8.30,1,http://www.openphacts.org/units/Nanomolar,669667,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,2015796,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '20.07', 'le': '0.39', 'lle': '4.68', 'sei': '10.03'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.17,0,http://www.openphacts.org/units/Nanomolar,669683,=,1,1,=,,IC50,nM,,67.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.067
,2015797,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1cc(OCC[C@@H](C)Oc2ccc(C(F)(F)F)cc2-c2ccccn2)ccc1CCC(=O)O,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '15.99', 'le': '0.30', 'lle': '1.22', 'sei': '11.36'}",CHEMBL238970,,CHEMBL238970,7.80,1,http://www.openphacts.org/units/Nanomolar,669682,=,1,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
,2015798,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(CC)c2)c(-c2ccccn2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '16.66', 'le': '0.31', 'lle': '1.33', 'sei': '10.86'}",CHEMBL241479,,CHEMBL241479,7.46,1,http://www.openphacts.org/units/Nanomolar,669681,=,1,1,=,,IC50,nM,,35.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.035
,2015799,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC[C@@H](C)Oc2ccc(C(F)(F)F)cc2-c2ccccn2)ccc1CCC(=O)O,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '16.26', 'le': '0.31', 'lle': '1.37', 'sei': '11.21'}",CHEMBL241478,,CHEMBL241478,7.70,1,http://www.openphacts.org/units/Nanomolar,669680,=,1,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
,2015800,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(OCC[C@@H](C)Oc2ccc(Cl)cc2-c2ccccn2)ccc1CCC(=O)O,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '16.04', 'le': '0.31', 'lle': '1.10', 'sei': '10.28'}",CHEMBL241299,,CHEMBL241299,7.06,0,http://www.openphacts.org/units/Nanomolar,669679,=,1,1,=,,IC50,nM,,88.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.08800001
,2015801,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ncco2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.91', 'le': '0.28', 'lle': '0.85', 'sei': '7.72'}",CHEMBL391470,,CHEMBL391470,6.32,1,http://www.openphacts.org/units/Nanomolar,669678,=,1,1,=,,IC50,nM,,483.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.483
,2015802,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2cocn2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.19', 'le': '0.26', 'lle': '0.54', 'sei': '7.35'}",CHEMBL241298,,CHEMBL241298,6.01,1,http://www.openphacts.org/units/Nanomolar,669677,=,1,1,=,,IC50,nM,,979.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.97900003
,2015803,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2nccs2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '13.23', 'le': '0.26', 'lle': '-0.11', 'sei': '8.47'}",CHEMBL400024,,CHEMBL400024,5.82,0,http://www.openphacts.org/units/Nanomolar,669676,=,1,1,=,,IC50,nM,,1530.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.5300001
,2015804,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2cscn2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.70', 'le': '0.28', 'lle': '0.53', 'sei': '9.41'}",CHEMBL241286,,CHEMBL241286,6.46,1,http://www.openphacts.org/units/Nanomolar,669675,=,1,1,=,,IC50,nM,,346.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.34600002
,2015805,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccncc2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.49', 'le': '0.27', 'lle': '0.41', 'sei': '9.15'}",CHEMBL391283,,CHEMBL391283,6.28,0,http://www.openphacts.org/units/Nanomolar,669674,=,1,1,=,,IC50,nM,,520.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.52000004
,2015806,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2cccnc2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '16.66', 'le': '0.31', 'lle': '1.35', 'sei': '10.52'}",CHEMBL241472,,CHEMBL241472,7.22,0,http://www.openphacts.org/units/Nanomolar,669673,=,1,1,=,,IC50,nM,,60.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.060000002
,2015807,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccccn2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '16.92', 'le': '0.31', 'lle': '1.47', 'sei': '10.69'}",CHEMBL241471,,CHEMBL241471,7.34,1,http://www.openphacts.org/units/Nanomolar,669672,=,1,1,=,,IC50,nM,,46.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.046000004
,2015808,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccco2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.26', 'le': '0.27', 'lle': '-0.04', 'sei': '8.75'}",CHEMBL391264,,CHEMBL391264,6.03,1,http://www.openphacts.org/units/Nanomolar,669671,=,1,1,=,,IC50,nM,,940.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.94000006
,2015809,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2cccs2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '13.59', 'le': '0.26', 'lle': '-0.58', 'sei': '10.69'}",CHEMBL241078,,CHEMBL241078,5.96,1,http://www.openphacts.org/units/Nanomolar,669670,=,1,1,=,,IC50,nM,,1090.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.09
,2015810,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccsc2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '14.24', 'le': '0.28', 'lle': '-0.29', 'sei': '11.20'}",CHEMBL392063,,CHEMBL392063,6.25,1,http://www.openphacts.org/units/Nanomolar,669669,=,1,1,=,,IC50,nM,,568.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.568
,2015811,[],CHEMBL885568,Displacement of [3H]2-methyl-2-(4-{3-[porpyl-(5-pyridin-2yl-thiophene-2-sulfonyl)-amino]-propyl}-phenoxy)-propionic acid from human PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccccc2)c1,,,CHEMBL1139045,Bioorg Med Chem Lett,2007,"{'bei': '15.41', 'le': '0.28', 'lle': '0.19', 'sei': '11.96'}",CHEMBL393926,,CHEMBL393926,6.67,0,http://www.openphacts.org/units/Nanomolar,669668,=,1,1,=,,IC50,nM,,215.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.215
,2257885,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1ccccc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '22.58', 'le': '0.45', 'lle': '2.81', 'sei': '13.55'}",CHEMBL443343,,CHEMBL443343,5.88,0,http://www.openphacts.org/units/Nanomolar,804826,=,1,1,=,,IC50,nM,,1326.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.3260001
,2257889,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1ccc2ccccc2c1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '19.21', 'le': '0.37', 'lle': '1.74', 'sei': '13.75'}",CHEMBL469938,,CHEMBL469938,5.96,0,http://www.openphacts.org/units/Nanomolar,804951,=,1,1,=,,IC50,nM,,1088.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.088
,2257893,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(OS(=O)(=O)/C=C/c2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '23.29', 'le': '0.46', 'lle': '3.02', 'sei': '14.73'}",CHEMBL469939,,CHEMBL469939,6.39,0,http://www.openphacts.org/units/Nanomolar,804952,=,1,1,=,,IC50,nM,,407.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.407
,2257897,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(OS(=O)(=O)/C=C/c2ccccc2)c1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '21.60', 'le': '0.43', 'lle': '2.56', 'sei': '13.66'}",CHEMBL467711,,CHEMBL467711,5.93,0,http://www.openphacts.org/units/Nanomolar,804953,=,1,1,=,,IC50,nM,,1187.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.187
,2257901,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1ccc(Cl)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '22.12', 'le': '0.47', 'lle': '2.80', 'sei': '15.03'}",CHEMBL469940,,CHEMBL469940,6.52,0,http://www.openphacts.org/units/Nanomolar,804954,=,1,1,=,,IC50,nM,,302.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.30200002
,2257905,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1c(Cl)cc(Cl)cc1Cl,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '16.06', 'le': '0.38', 'lle': '0.81', 'sei': '13.47'}",CHEMBL451531,,CHEMBL451531,5.84,0,http://www.openphacts.org/units/Nanomolar,804955,=,1,1,=,,IC50,nM,,1439.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.439
,2257909,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(OS(=O)(=O)/C=C/c2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '20.28', 'le': '0.40', 'lle': '2.82', 'sei': '11.19'}",CHEMBL469941,,CHEMBL469941,5.89,0,http://www.openphacts.org/units/Nanomolar,804956,=,1,1,=,,IC50,nM,,1294.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.294
,2257913,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1ccc(OCc2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '16.79', 'le': '0.32', 'lle': '1.50', 'sei': '11.70'}",CHEMBL471828,,CHEMBL471828,6.15,0,http://www.openphacts.org/units/Nanomolar,805030,=,1,1,=,,IC50,nM,,703.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.703
,2257917,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1ccc(OS(=O)(=O)/C=C/c2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '18.43', 'le': '0.36', 'lle': '2.89', 'sei': '8.79'}",CHEMBL471829,,CHEMBL471829,6.13,0,http://www.openphacts.org/units/Nanomolar,805031,=,1,1,=,,IC50,nM,,747.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.74700004
,2257921,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=Cc1ccc(OS(=O)(=O)/C=C/c2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '19.69', 'le': '0.39', 'lle': '2.80', 'sei': '9.39'}",CHEMBL471830,,CHEMBL471830,5.68,0,http://www.openphacts.org/units/Nanomolar,805032,=,1,1,=,,IC50,nM,,2098.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.098
,2257925,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1ccc(OS(=O)(=O)/C=C/c2ccccc2)cc1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '15.66', 'le': '0.31', 'lle': '1.95', 'sei': '6.86'}",CHEMBL470574,,CHEMBL470574,4.97,0,http://www.openphacts.org/units/Nanomolar,805033,=,1,1,=,,IC50,nM,,10712.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.712001
,2257929,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(/C=C/c1ccccc1)Oc1cccc(Oc2ccccc2)c1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '18.21', 'le': '0.35', 'lle': '1.56', 'sei': '12.20'}",CHEMBL513215,,CHEMBL513215,6.42,0,http://www.openphacts.org/units/Nanomolar,805034,=,1,1,=,,IC50,nM,,382.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.38200003
,2257933,[],CHEMBL1008816,Displacement of [3H]BRL49653 from PPARgamma ligand binding domain by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1cccc(OS(=O)(=O)/C=C/c2ccccc2)c1,,,CHEMBL1152223,Bioorg Med Chem Lett,2008,"{'bei': '16.00', 'le': '0.32', 'lle': '2.11', 'sei': '6.04'}",CHEMBL470575,,CHEMBL470575,4.87,0,http://www.openphacts.org/units/Nanomolar,805035,=,1,1,=,,IC50,nM,,13521.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,13.521001
,2376354,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '16.92', 'le': '0.33', 'lle': '2.37', 'sei': '11.57'}",CHEMBL452051,,CHEMBL452051,9.00,1,http://www.openphacts.org/units/Nanomolar,721901,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2376361,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(C(F)(F)F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '14.20', 'le': '0.29', 'lle': '0.30', 'sei': '10.41'}",CHEMBL517436,,CHEMBL517436,7.66,0,http://www.openphacts.org/units/Nanomolar,722288,=,1,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
,2376362,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(Cl)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '16.85', 'le': '0.35', 'lle': '1.52', 'sei': '11.58'}",CHEMBL461944,,CHEMBL461944,8.52,0,http://www.openphacts.org/units/Nanomolar,722212,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,2376363,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(F)nc2n1Cc1ccc(F)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '16.15', 'le': '0.32', 'lle': '1.67', 'sei': '10.38'}",CHEMBL461379,,CHEMBL461379,7.64,0,http://www.openphacts.org/units/Nanomolar,722211,=,1,1,=,,IC50,nM,,23.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.023000002
,2376364,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(F)nc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.42', 'le': '0.35', 'lle': '2.04', 'sei': '11.58'}",CHEMBL518499,,CHEMBL518499,8.52,0,http://www.openphacts.org/units/Nanomolar,722210,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,2376365,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(F)nc2n1Cc1cc(O[C@@H](C)C(=O)O)ccc1Cl,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '15.99', 'le': '0.32', 'lle': '1.34', 'sei': '10.63'}",CHEMBL461378,,CHEMBL461378,7.82,0,http://www.openphacts.org/units/Nanomolar,722209,=,1,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
,2376366,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3ccc(Cl)c(O[C@@H](C)C(=O)O)c3)c3nc(OC)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,,CHEMBL459466,,CHEMBL459466,,0,http://www.openphacts.org/units/Nanomolar,722136,<,1,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2376367,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cc(O[C@@H](C)C(=O)O)ccc3Cl)c3nc(OC)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.09', 'le': '0.33', 'lle': '3.55', 'sei': '8.71'}",CHEMBL460073,,CHEMBL460073,8.70,0,http://www.openphacts.org/units/Nanomolar,722135,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,2376368,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3ccc(F)c(O[C@@H](C)C(=O)O)c3)c3nc(OC)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '18.27', 'le': '0.34', 'lle': '4.37', 'sei': '9.01'}",CHEMBL460072,,CHEMBL460072,9.00,0,http://www.openphacts.org/units/Nanomolar,722134,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2376369,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cc(O[C@@H](C)C(=O)O)ccc3F)c3nc(OC)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.66', 'le': '0.33', 'lle': '4.07', 'sei': '8.71'}",CHEMBL462378,,CHEMBL462378,8.70,0,http://www.openphacts.org/units/Nanomolar,722133,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,2376370,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cc(O[C@@H](C)C(=O)O)ccc3F)c3nc(C)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.62', 'le': '0.33', 'lle': '3.47', 'sei': '9.26'}",CHEMBL509236,,CHEMBL509236,8.40,0,http://www.openphacts.org/units/Nanomolar,722053,=,1,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
,2376371,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3nc(C)ccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.00', 'le': '0.31', 'lle': '3.01', 'sei': '8.60'}",CHEMBL510180,,CHEMBL510180,7.80,0,http://www.openphacts.org/units/Nanomolar,722052,=,1,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
,2376372,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2cccnc2n1Cc1ccc(F)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '15.33', 'le': '0.30', 'lle': '1.14', 'sei': '9.48'}",CHEMBL455130,,CHEMBL455130,6.97,0,http://www.openphacts.org/units/Nanomolar,722051,=,1,1,=,,IC50,nM,,106.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.106000006
,2376373,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2cccnc2n1Cc1cc(O[C@@H](C)C(=O)O)ccc1F,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '15.98', 'le': '0.31', 'lle': '1.44', 'sei': '9.88'}",CHEMBL509369,,CHEMBL509369,7.27,0,http://www.openphacts.org/units/Nanomolar,722050,=,1,1,=,,IC50,nM,,54.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.054
,2376374,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2cccnc2n1Cc1cc(O[C@@H](C)C(=O)O)ccc1Cl,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '16.13', 'le': '0.32', 'lle': '1.26', 'sei': '10.33'}",CHEMBL452054,,CHEMBL452054,7.60,0,http://www.openphacts.org/units/Nanomolar,721983,=,1,1,=,,IC50,nM,,25.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.025
,2376375,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3ccc(F)c(O[C@@H](C)C(=O)O)c3)c3ncccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.30', 'le': '0.32', 'lle': '3.38', 'sei': '8.83'}",CHEMBL507477,,CHEMBL507477,8.00,0,http://www.openphacts.org/units/Nanomolar,721982,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,2376376,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cc(O[C@@H](C)C(=O)O)ccc3F)c3ncccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '17.95', 'le': '0.33', 'lle': '3.68', 'sei': '9.16'}",CHEMBL455127,,CHEMBL455127,8.30,0,http://www.openphacts.org/units/Nanomolar,721981,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,2376377,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3ncccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '16.15', 'le': '0.30', 'lle': '2.70', 'sei': '7.92'}",CHEMBL455126,,CHEMBL455126,7.18,0,http://www.openphacts.org/units/Nanomolar,721980,=,1,1,=,,IC50,nM,,66.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.066
,2376378,[],CHEMBL980782,Displacement of [3H]2AD-5075 from GST-tagged human PPARgamma receptor expressed in Escherichia coli BL21,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cccc(O[C@H](C)C(=O)O)c3)c3ncccc23)cc1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008,"{'bei': '13.81', 'le': '0.25', 'lle': '1.66', 'sei': '6.77'}",CHEMBL452299,,CHEMBL452299,6.14,0,http://www.openphacts.org/units/Nanomolar,721902,=,1,1,=,,IC50,nM,,726.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.726
,2633519,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)n2c(C)c(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3cc(OC(F)(F)F)ccc32)cc1,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '17.06', 'le': '0.32', 'lle': '3.01', 'sei': '10.35'}",CHEMBL179330,,CHEMBL179330,9.00,0,http://www.openphacts.org/units/Nanomolar,784439,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2633520,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2cc(OC(F)(F)F)ccc2n1-c1noc2cc(Cl)ccc12,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '14.14', 'le': '0.29', 'lle': '0.29', 'sei': '8.57'}",CHEMBL363805,,CHEMBL363805,8.22,0,http://www.openphacts.org/units/Nanomolar,784440,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,2633521,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(C(=O)c2c(C)n(Cc3cccc(O[C@@H](C)C(=O)O)c3)c3cc(OC(F)(F)F)ccc23)cc1,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '17.06', 'le': '0.32', 'lle': '3.01', 'sei': '10.35'}",CHEMBL489651,,CHEMBL489651,9.00,0,http://www.openphacts.org/units/Nanomolar,784441,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2633522,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(-c3c(C)n(Cc4cc(O[C@@H](C)C(=O)O)ccc4Cl)c4cc(OC(F)(F)F)ccc34)noc2c1,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '15.13', 'le': '0.30', 'lle': '1.48', 'sei': '9.07'}",CHEMBL519060,,CHEMBL519060,8.70,0,http://www.openphacts.org/units/Nanomolar,783087,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,2633523,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Oc2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1ccc(Cl)c(O[C@@H](C)C(=O)O)c1,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '16.24', 'le': '0.33', 'lle': '1.15', 'sei': '12.87'}",CHEMBL522772,,CHEMBL522772,9.00,0,http://www.openphacts.org/units/Nanomolar,783088,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2633525,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '18.74', 'le': '0.37', 'lle': '4.21', 'sei': '9.37'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.70,1,http://www.openphacts.org/units/Nanomolar,783090,=,1,1,=,,IC50,nM,,200.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.2
,2634245,[],CHEMBL940691,Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARgamma expressed in Escherichia coli by scintillation proximity assay,B,,,BAO_0000190,BAO_0000019,assay format,CC[C@@H](Oc1cccc(-n2c(C)c(C(=O)c3ccc(OC)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1137013,J Med Chem,2009,"{'bei': '15.25', 'le': '0.29', 'lle': '1.73', 'sei': '9.25'}",CHEMBL490029,MK-0533,CHEMBL490029,8.05,0,http://www.openphacts.org/units/Nanomolar,783089,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,2649222,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,,,CHEMBL1158459,J Med Chem,2009,,CHEMBL672,FENOFIBRATE,CHEMBL672,,0,http://www.openphacts.org/units/Nanomolar,815526,>,1,1,>,,IC50,nM,,5000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.0
,2649223,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '18.74', 'le': '0.37', 'lle': '4.21', 'sei': '9.37'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.70,1,http://www.openphacts.org/units/Nanomolar,815525,=,1,1,=,,IC50,nM,,200.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.2
,2649224,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(OC2(C(=O)O)CCC2)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '13.97', 'le': '0.27', 'lle': '0.63', 'sei': '10.03'}",CHEMBL560830,,CHEMBL560830,7.80,0,http://www.openphacts.org/units/Nanomolar,815524,=,1,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
,2649225,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.82', 'le': '0.29', 'lle': '0.89', 'sei': '10.68'}",CHEMBL558083,,CHEMBL558083,8.30,0,http://www.openphacts.org/units/Nanomolar,815523,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,2649226,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@](C)(Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.37', 'le': '0.28', 'lle': '0.64', 'sei': '10.35'}",CHEMBL558083,,CHEMBL558083,8.05,0,http://www.openphacts.org/units/Nanomolar,815446,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,2649227,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@@H](C(=O)O)C(C)C)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.29', 'le': '0.28', 'lle': '0.73', 'sei': '10.29'}",CHEMBL562864,,CHEMBL562864,8.00,0,http://www.openphacts.org/units/Nanomolar,815445,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,2649228,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C(=O)O)C(C)C)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '13.87', 'le': '0.27', 'lle': '0.50', 'sei': '9.99'}",CHEMBL564902,,CHEMBL564902,7.77,0,http://www.openphacts.org/units/Nanomolar,815444,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,2649229,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H](Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.15', 'le': '0.28', 'lle': '0.51', 'sei': '10.19'}",CHEMBL564036,,CHEMBL564036,7.92,0,http://www.openphacts.org/units/Nanomolar,816597,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,2649230,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.46', 'le': '0.28', 'lle': '0.69', 'sei': '10.41'}",CHEMBL560160,,CHEMBL560160,8.10,0,http://www.openphacts.org/units/Nanomolar,816596,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,2649231,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.74', 'le': '0.29', 'lle': '1.03', 'sei': '10.35'}",CHEMBL552240,,CHEMBL552240,8.05,0,http://www.openphacts.org/units/Nanomolar,816595,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,2649232,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c3ccc(OC(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '15.38', 'le': '0.30', 'lle': '1.38', 'sei': '10.80'}",CHEMBL549746,,CHEMBL549746,8.40,0,http://www.openphacts.org/units/Nanomolar,816497,=,1,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
,2649233,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '14.96', 'le': '0.29', 'lle': '1.33', 'sei': '10.23'}",CHEMBL461571,,CHEMBL461571,7.96,0,http://www.openphacts.org/units/Nanomolar,816496,=,1,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
,2649234,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@@H](C)C(=O)O)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '16.92', 'le': '0.33', 'lle': '2.37', 'sei': '11.57'}",CHEMBL452051,,CHEMBL452051,9.00,0,http://www.openphacts.org/units/Nanomolar,816495,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,2649235,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(OCC(=O)O)c1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '16.80', 'le': '0.33', 'lle': '2.46', 'sei': '11.19'}",CHEMBL559567,,CHEMBL559567,8.70,0,http://www.openphacts.org/units/Nanomolar,816424,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,2649236,[],CHEMBL1035292,Inhibition of human PPARgamma receptor by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(Cc2cccc(OCC(=O)O)c2)c2cc(OC(F)(F)F)ccc2n1C(=O)c1ccc(Cl)cc1,,,CHEMBL1158459,J Med Chem,2009,"{'bei': '17.38', 'le': '0.34', 'lle': '2.76', 'sei': '11.57'}",CHEMBL556073,,CHEMBL556073,9.00,0,http://www.openphacts.org/units/Nanomolar,816423,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,3222687,[],CHEMBL1110295,Antagonist activity at PPARgamma co-transfected with GAL4-PPAR fusion protein assessed as inhibition of TIPP703-induced response by luciferase reporter gene assay,F,,,BAO_0000190,BAO_0000019,assay format,CCCCOc1ccc(-c2ccc(C(=O)O)cc2C)cc1CNC(=O)c1ccc(C(F)(F)F)cc1F,,,CHEMBL1154383,Bioorg Med Chem Lett,2009,,CHEMBL1082079,,CHEMBL1082079,8.00,0,http://www.openphacts.org/units/Nanomolar,891242,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,3252984,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccc(Cl)cc4)oc3C)cc2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '12.80', 'le': '0.25', 'lle': '0.53', 'sei': '6.71'}",CHEMBL1089176,,CHEMBL1089176,6.85,0,http://www.openphacts.org/units/Nanomolar,902173,=,1,1,=,,IC50,nM,,141.4,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.1414
,3252985,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCc3nc(-c4ccc(Cl)cc4)oc3C)cc2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '12.68', 'le': '0.24', 'lle': '0.33', 'sei': '6.47'}",CHEMBL1088910,,CHEMBL1088910,6.61,0,http://www.openphacts.org/units/Nanomolar,902250,=,1,1,=,,IC50,nM,,247.8,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.24780001
,3252986,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCCc3nc(-c4ccc(Cl)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '12.69', 'le': '0.24', 'lle': '0.47', 'sei': '6.65'}",CHEMBL1088911,,CHEMBL1088911,6.79,0,http://www.openphacts.org/units/Nanomolar,902251,=,1,1,=,,IC50,nM,,162.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.162
,3252987,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(Cl)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.66', 'le': '0.21', 'lle': '-0.73', 'sei': '5.44'}",CHEMBL1089210,,CHEMBL1089210,5.55,0,http://www.openphacts.org/units/Nanomolar,902252,=,1,1,=,,IC50,nM,,2789.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.789
,3252988,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3oc(-c4ccc(Cl)cc4)nc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.46', 'le': '0.20', 'lle': '-0.83', 'sei': '5.34'}",CHEMBL1090211,,CHEMBL1090211,5.45,0,http://www.openphacts.org/units/Nanomolar,902327,=,1,1,=,,IC50,nM,,3546.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.5460002
,3252989,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3sc(-c4ccc(Cl)cc4)nc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.04', 'le': '0.20', 'lle': '-1.35', 'sei': '6.06'}",CHEMBL1090212,,CHEMBL1090212,5.39,0,http://www.openphacts.org/units/Nanomolar,902328,=,1,1,=,,IC50,nM,,4057.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.057
,3252990,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(Cl)cc4)sc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.19', 'le': '0.20', 'lle': '-1.27', 'sei': '6.15'}",CHEMBL1091664,,CHEMBL1091664,5.47,0,http://www.openphacts.org/units/Nanomolar,902329,=,1,1,=,,IC50,nM,,3362.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.3620002
,3252991,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccccc4Cl)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.49', 'le': '0.22', 'lle': '-0.30', 'sei': '5.86'}",CHEMBL1091980,,CHEMBL1091980,5.98,0,http://www.openphacts.org/units/Nanomolar,902330,=,1,1,=,,IC50,nM,,1039.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.039
,3252992,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4cccc(Cl)c4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '12.31', 'le': '0.24', 'lle': '0.14', 'sei': '6.28'}",CHEMBL1092931,,CHEMBL1092931,6.42,0,http://www.openphacts.org/units/Nanomolar,902407,=,1,1,=,,IC50,nM,,384.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.384
,3252993,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(F)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.18', 'le': '0.21', 'lle': '-0.12', 'sei': '5.52'}",CHEMBL1089164,,CHEMBL1089164,5.64,0,http://www.openphacts.org/units/Nanomolar,902409,=,1,1,=,,IC50,nM,,2300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.3000002
,3252994,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C(C)(C)C)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.64', 'le': '0.22', 'lle': '-0.60', 'sei': '6.19'}",CHEMBL1090187,,CHEMBL1090187,6.32,0,http://www.openphacts.org/units/Nanomolar,902484,=,1,1,=,,IC50,nM,,483.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.483
,3252995,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(-c5ccccc5)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.13', 'le': '0.19', 'lle': '-1.59', 'sei': '5.58'}",CHEMBL1089969,,CHEMBL1089969,5.70,0,http://www.openphacts.org/units/Nanomolar,902485,=,1,1,=,,IC50,nM,,1988.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.988
,3252996,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(N5CCOCC5)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.36', 'le': '0.19', 'lle': '0.46', 'sei': '5.17'}",CHEMBL1089970,,CHEMBL1089970,5.92,0,http://www.openphacts.org/units/Nanomolar,902486,=,1,1,=,,IC50,nM,,1194.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.194
,3252997,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C#N)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.05', 'le': '0.18', 'lle': '-0.35', 'sei': '4.08'}",CHEMBL1090188,,CHEMBL1090188,5.14,0,http://www.openphacts.org/units/Nanomolar,902487,=,1,1,=,,IC50,nM,,7257.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,7.2570004
,3252998,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(-c2nc(COc3cccc(CN(CC(=O)O)C(=O)Oc4ccc(C)cc4)c3)c(C)o2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.73', 'le': '0.22', 'lle': '0.43', 'sei': '5.44'}",CHEMBL1090189,,CHEMBL1090189,6.06,0,http://www.openphacts.org/units/Nanomolar,902488,=,1,1,=,,IC50,nM,,873.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.873
,3252999,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.72', 'le': '0.22', 'lle': '-0.06', 'sei': '5.75'}",CHEMBL1090877,,CHEMBL1090877,5.87,0,http://www.openphacts.org/units/Nanomolar,902582,=,1,1,=,,IC50,nM,,1361.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.3610001
,3253000,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C(C)C)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '11.92', 'le': '0.22', 'lle': '-0.45', 'sei': '6.17'}",CHEMBL1090878,,CHEMBL1090878,6.30,0,http://www.openphacts.org/units/Nanomolar,902583,=,1,1,=,,IC50,nM,,497.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.497
,3253001,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OC(=O)N(CC(=O)O)Cc2cccc(OCc3nc(-c4ccc(C(F)(F)F)cc4)oc3C)c2)cc1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.03', 'le': '0.19', 'lle': '-1.08', 'sei': '5.45'}",CHEMBL1091218,,CHEMBL1091218,5.56,0,http://www.openphacts.org/units/Nanomolar,902584,=,1,1,=,,IC50,nM,,2737.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.7370002
,3253002,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(CN(CC(=O)O)C(=O)OC2CCCCC2)c1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.42', 'le': '0.20', 'lle': '-0.89', 'sei': '5.24'}",CHEMBL1092235,,CHEMBL1092235,5.35,0,http://www.openphacts.org/units/Nanomolar,902722,=,1,1,=,,IC50,nM,,4498.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.498
,3253003,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(CN(CC(=O)O)C(=O)OC2CCCC2)c1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.07', 'le': '0.20', 'lle': '-0.83', 'sei': '4.92'}",CHEMBL1092236,,CHEMBL1092236,5.03,0,http://www.openphacts.org/units/Nanomolar,902723,=,1,1,=,,IC50,nM,,9444.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,9.444
,3253004,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(CN(CC(=O)O)C(=O)OC2CCC2)c1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.88', 'le': '0.21', 'lle': '-0.18', 'sei': '5.17'}",CHEMBL1092237,,CHEMBL1092237,5.28,0,http://www.openphacts.org/units/Nanomolar,902724,=,1,1,=,,IC50,nM,,5293.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.293
,3253005,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccc(Cl)cc2)nc1COc1cccc(CN(CC(=O)O)C(=O)OCC2CC2)c1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.87', 'le': '0.21', 'lle': '-0.05', 'sei': '5.16'}",CHEMBL1091196,,CHEMBL1091196,5.27,0,http://www.openphacts.org/units/Nanomolar,902725,=,1,1,=,,IC50,nM,,5336.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.3360004
,3253006,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,CCCOC(=O)N(CC(=O)O)Cc1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,,,CHEMBL1156340,J Med Chem,2010,"{'bei': '10.54', 'le': '0.21', 'lle': '-0.33', 'sei': '4.88'}",CHEMBL1089500,,CHEMBL1089500,4.99,0,http://www.openphacts.org/units/Nanomolar,902795,=,1,1,=,,IC50,nM,,10310.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.31
,3253007,[],CHEMBL1110807,Binding affinity to human His-tagged PPARgamma LBD (Q203-Y477) expressed in Escherichia coli BL21 (DE3) by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N(CC(=O)O)Cc1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,,,CHEMBL1156340,J Med Chem,2010,,CHEMBL1089501,,CHEMBL1089501,,0,http://www.openphacts.org/units/Nanomolar,902797,>,1,1,>,,IC50,nM,,15000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,15.000001
,3259303,[],CHEMBL1114526,Agonist activity at N-terminal His-tagged human PPARgamma ligand binding domain by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)CCN1C(=O)/C(=C\c2ccc(Cl)cc2Cl)SC1=S,,,CHEMBL1156253,Eur J Med Chem,2010,"{'bei': '16.72', 'le': '0.39', 'lle': '2.39', 'sei': '10.51'}",CHEMBL1093405,,CHEMBL1093405,6.06,0,http://www.openphacts.org/units/Nanomolar,899863,=,1,1,=,,IC50,nM,,876.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.87600005
,3259304,[],CHEMBL1114526,Agonist activity at N-terminal His-tagged human PPARgamma ligand binding domain by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(COc2ccccc2/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1,,,CHEMBL1156253,Eur J Med Chem,2010,"{'bei': '14.22', 'le': '0.29', 'lle': '1.63', 'sei': '8.80'}",CHEMBL1090443,,CHEMBL1090443,5.88,0,http://www.openphacts.org/units/Nanomolar,899958,=,1,1,=,,IC50,nM,,1319.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.319
,3259379,[],CHEMBL1114526,Agonist activity at N-terminal His-tagged human PPARgamma ligand binding domain by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1156253,Eur J Med Chem,2010,"{'bei': '18.39', 'le': '0.36', 'lle': '4.08', 'sei': '9.19'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.57,0,http://www.openphacts.org/units/Nanomolar,900047,=,1,1,=,,IC50,nM,,267.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.26700002
,5097689,[],CHEMBL1638638,Displacement of fluormone PPAR-green from N-terminal His-tagged human PPARgamma-LBD after 2 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Oc1ccc([N+](=O)[O-])cc1)c1cn(-c2ccccc2)nc1-c1ccccc1,,,CHEMBL1629419,Bioorg Med Chem,2010,"{'bei': '15.60', 'le': '0.28', 'lle': '1.34', 'sei': '6.89'}",CHEMBL1629930,,CHEMBL1629930,6.01,0,http://www.openphacts.org/units/Nanomolar,1312617,=,1,1,=,,IC50,nM,,973.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.97300005
,5097690,[],CHEMBL1638638,Displacement of fluormone PPAR-green from N-terminal His-tagged human PPARgamma-LBD after 2 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(Nc1cc(-c2cccs2)nn1-c1ccc(F)cc1)c1cccc(F)c1,,,CHEMBL1629419,Bioorg Med Chem,2010,"{'bei': '15.07', 'le': '0.31', 'lle': '1.61', 'sei': '9.83'}",CHEMBL378160,,CHEMBL378160,6.29,0,http://www.openphacts.org/units/Nanomolar,1312594,=,1,1,=,,IC50,nM,,512.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.512
,5097691,[],CHEMBL1638638,Displacement of fluormone PPAR-green from N-terminal His-tagged human PPARgamma-LBD after 2 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,,,CHEMBL1629419,Bioorg Med Chem,2010,"{'bei': '17.02', 'le': '0.33', 'lle': '2.91', 'sei': '8.89'}",CHEMBL595,PIOGLITAZONE,CHEMBL595,6.07,0,http://www.openphacts.org/units/Nanomolar,1312593,=,1,1,=,,IC50,nM,,855.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.855
,5097692,[],CHEMBL1638638,Displacement of fluormone PPAR-green from N-terminal His-tagged human PPARgamma-LBD after 2 hrs by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1629419,Bioorg Med Chem,2010,"{'bei': '18.75', 'le': '0.37', 'lle': '4.21', 'sei': '9.37'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,6.70,0,http://www.openphacts.org/units/Nanomolar,1312592,=,1,1,=,,IC50,nM,,199.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.19900002
,6232122,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(OC2CCCCC2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783031,,CHEMBL1783031,7.43,0,http://www.openphacts.org/units/Nanomolar,1427685,=,1,1,=,,IC50,nM,,37.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.037
,6232123,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(C(=O)CC)c1O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL25710,,CHEMBL25710,6.52,1,http://www.openphacts.org/units/Nanomolar,1427686,=,1,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
,6232124,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccccc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL94306,,CHEMBL94306,7.24,0,http://www.openphacts.org/units/Nanomolar,1427687,=,1,1,=,,IC50,nM,,57.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.057000004
,6232125,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(OC2CCCCCC2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783032,,CHEMBL1783032,7.07,0,http://www.openphacts.org/units/Nanomolar,1427688,=,1,1,=,,IC50,nM,,85.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.085
,6232126,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(/C(CC)=N\O)c1O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783033,,CHEMBL1783033,7.32,1,http://www.openphacts.org/units/Nanomolar,1427690,=,1,1,=,,IC50,nM,,48.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.048
,6232127,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=C1NC(=O)[C@H](c2cccc(OCCCOc3ccc(Oc4ccccc4)cc3)c2)S1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783034,,CHEMBL1783034,7.12,1,http://www.openphacts.org/units/Nanomolar,1427691,=,1,1,=,,IC50,nM,,76.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.076000005
,6232128,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(OC2CCCC2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783035,,CHEMBL1783035,7.20,0,http://www.openphacts.org/units/Nanomolar,1427692,=,1,1,=,,IC50,nM,,63.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.063
,6232129,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(CC)noc12,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL279053,L-165461,CHEMBL279053,6.96,1,http://www.openphacts.org/units/Nanomolar,1427693,=,1,1,=,,IC50,nM,,110.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.11000001
,6232130,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccccc2)ccc1OCCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783036,,CHEMBL1783036,6.71,0,http://www.openphacts.org/units/Nanomolar,1427694,=,1,1,=,,IC50,nM,,195.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.19500001
,6232131,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C(=O)c2ccccc2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL331071,,CHEMBL331071,7.72,0,http://www.openphacts.org/units/Nanomolar,1427695,=,1,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
,6232132,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL23296,,CHEMBL23296,6.85,0,http://www.openphacts.org/units/Nanomolar,1427696,=,1,1,=,,IC50,nM,,140.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.14
,6232133,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(C(C)C)cc2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783037,,CHEMBL1783037,6.77,0,http://www.openphacts.org/units/Nanomolar,1427697,=,1,1,=,,IC50,nM,,170.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.17
,6232134,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C(=O)c2ccc(Cl)cc2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1782067,,CHEMBL1782067,6.84,0,http://www.openphacts.org/units/Nanomolar,1427698,=,1,1,=,,IC50,nM,,144.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.14400001
,6232135,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(CC)coc12,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL23670,,CHEMBL23670,6.25,1,http://www.openphacts.org/units/Nanomolar,1427699,=,1,1,=,,IC50,nM,,560.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.56
,6232136,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(C(C)(C)C)cc2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783038,,CHEMBL1783038,6.47,0,http://www.openphacts.org/units/Nanomolar,1427700,=,1,1,=,,IC50,nM,,335.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.335
,6232137,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(-c2noc3ccccc23)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783039,,CHEMBL1783039,7.52,0,http://www.openphacts.org/units/Nanomolar,1427701,=,1,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
,6232138,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(-c3ccccc3)coc12,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL278994,L-796449,CHEMBL278994,7.03,1,http://www.openphacts.org/units/Nanomolar,1427689,=,1,1,=,,IC50,nM,,94.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.094000004
,6232139,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(CC(C)C)cc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783040,,CHEMBL1783040,6.54,0,http://www.openphacts.org/units/Nanomolar,1427702,=,1,1,=,,IC50,nM,,291.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.291
,6232140,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C(=O)C2CCCCC2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783041,,CHEMBL1783041,7.34,0,http://www.openphacts.org/units/Nanomolar,1427703,=,1,1,=,,IC50,nM,,46.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.046000004
,6232141,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CN(CCOc1ccc(C[C@@H]2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL121106,,CHEMBL121106,6.68,0,http://www.openphacts.org/units/Nanomolar,1427704,=,1,1,=,,IC50,nM,,210.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.21000001
,6232142,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C=C2CCCCC2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783042,,CHEMBL1783042,6.82,0,http://www.openphacts.org/units/Nanomolar,1427705,=,1,1,=,,IC50,nM,,150.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.15
,6232143,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(-c3ccccc3)cc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783043,,CHEMBL1783043,6.65,0,http://www.openphacts.org/units/Nanomolar,1427706,=,1,1,=,,IC50,nM,,226.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.22600001
,6232144,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(F)cc2)ccc1OCCCOc1ccc([C@H]2SC(=O)NC2=O)cc1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783044,,CHEMBL1783044,6.13,0,http://www.openphacts.org/units/Nanomolar,1427707,=,1,1,=,,IC50,nM,,735.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.735
,6232145,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(CC2CCCCC2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783045,,CHEMBL1783045,7.23,0,http://www.openphacts.org/units/Nanomolar,1427708,=,1,1,=,,IC50,nM,,59.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.059000004
,6232146,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(Cl)cc2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783046,,CHEMBL1783046,7.14,0,http://www.openphacts.org/units/Nanomolar,1427709,=,1,1,=,,IC50,nM,,73.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07300001
,6232147,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(F)cc2)ccc1OCCCOc1ccc(CC(C)(C)C(=O)O)cc1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783047,,CHEMBL1783047,5.96,0,http://www.openphacts.org/units/Nanomolar,1427710,=,1,1,=,,IC50,nM,,1087.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.087
,6232148,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCCCC2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783048,,CHEMBL1783048,6.47,0,http://www.openphacts.org/units/Nanomolar,1427711,=,1,1,=,,IC50,nM,,340.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.34
,6232149,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(F)cc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783049,,CHEMBL1783049,7.11,0,http://www.openphacts.org/units/Nanomolar,1427712,=,1,1,=,,IC50,nM,,77.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07700001
,6232150,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Oc1ccc(OCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1)C(=O)O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL206794,,CHEMBL206794,6.01,1,http://www.openphacts.org/units/Nanomolar,1427713,=,1,1,=,,IC50,nM,,981.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.98100007
,6232151,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCCCC2)ccc1OCCCOc1cccc([C@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783050,,CHEMBL1783050,6.31,0,http://www.openphacts.org/units/Nanomolar,1427714,=,1,1,=,,IC50,nM,,490.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.49
,6232152,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(OC)cc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783051,,CHEMBL1783051,6.52,0,http://www.openphacts.org/units/Nanomolar,1427715,=,1,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
,6232153,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Oc1ccc(OCCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1)C(=O)O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL377508,,CHEMBL377508,5.11,0,http://www.openphacts.org/units/Nanomolar,1427716,=,1,1,=,,IC50,nM,,7690.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,7.6900005
,6232154,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(-c2ccccc2)ccc1OCCCOc1cccc([C@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783052,,CHEMBL1783052,6.35,0,http://www.openphacts.org/units/Nanomolar,1427717,=,1,1,=,,IC50,nM,,450.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.45000002
,6232155,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(O)cc2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783053,,CHEMBL1783053,7.52,0,http://www.openphacts.org/units/Nanomolar,1427718,=,1,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
,6232156,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCCCCC2)ccc1OCCCOc1cccc([C@@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783054,,CHEMBL1783054,6.19,0,http://www.openphacts.org/units/Nanomolar,1427719,=,1,1,=,,IC50,nM,,640.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.64000005
,6232157,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(Cl)c(Cl)c2)ccc1OCCCOc1cccc(C2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL318684,,CHEMBL318684,7.19,0,http://www.openphacts.org/units/Nanomolar,1427720,=,1,1,=,,IC50,nM,,64.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.064
,6232158,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(Cl)c(C)c2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783055,,CHEMBL1783055,7.25,0,http://www.openphacts.org/units/Nanomolar,1427721,=,1,1,=,,IC50,nM,,56.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.056
,6232159,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCC(=O)CC2)ccc1OCCCOc1cccc([C@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783056,,CHEMBL1783056,5.94,0,http://www.openphacts.org/units/Nanomolar,1427722,=,1,1,=,,IC50,nM,,1160.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.1600001
,6232160,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(F)c(C)c2)ccc1OCCCOc1cccc([C@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783057,,CHEMBL1783057,7.11,0,http://www.openphacts.org/units/Nanomolar,1427723,=,1,1,=,,IC50,nM,,78.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.078
,6232161,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(OCCCOc2ccc(CCC(=O)O)cc2)c(Cl)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783058,,CHEMBL1783058,5.19,0,http://www.openphacts.org/units/Nanomolar,1427724,=,1,1,=,,IC50,nM,,6440.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.4400005
,6232162,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc([C@H]2CC[C@H](O)CC2)ccc1OCCCOc1cccc([C@@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783059,,CHEMBL1783059,6.75,0,http://www.openphacts.org/units/Nanomolar,1427725,=,1,1,=,,IC50,nM,,180.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.18
,6232163,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCC(F)(F)CC2)ccc1OCCCOc1cccc([C@@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783060,,CHEMBL1783060,6.27,0,http://www.openphacts.org/units/Nanomolar,1427726,=,1,1,=,,IC50,nM,,540.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.54
,6232164,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCC(C)(C)CC2)ccc1OCCCOc1cccc([C@@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783061,,CHEMBL1783061,5.75,0,http://www.openphacts.org/units/Nanomolar,1427727,=,1,1,=,,IC50,nM,,1760.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.7600001
,6232165,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(C2CCOCC2)ccc1OCCCOc1cccc([C@@H]2OC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783062,,CHEMBL1783062,6.12,0,http://www.openphacts.org/units/Nanomolar,1427728,=,1,1,=,,IC50,nM,,750.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.75000006
,6232166,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC[C@](C)(Cc1ccc(OCCCOc2ccc(C3CCCCC3)cc2Cl)cc1)C(=O)O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783063,,CHEMBL1783063,5.73,0,http://www.openphacts.org/units/Nanomolar,1427729,=,1,1,=,,IC50,nM,,1851.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.8510001
,6232167,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC[C@@](C)(Cc1ccc(OCCCOc2ccc(C3CCC(C)(C)CC3)cc2Cl)cc1)C(=O)O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL202739,,CHEMBL202739,5.44,0,http://www.openphacts.org/units/Nanomolar,1427730,=,1,1,=,,IC50,nM,,3610.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.6100001
,6232168,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)C1=CC(C)(C)Oc2cc(OCCCOc3ccc(CC(C)(C)C(=O)O)cc3)c(Cl)cc21,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783064,,CHEMBL1783064,5.73,0,http://www.openphacts.org/units/Nanomolar,1427731,=,1,1,=,,IC50,nM,,1845.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.845
,6232169,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)C=C(c2cccc(C(F)(F)F)c2)c2ccc(OCCCOc3ccc(CC(C)(C)C(=O)O)cc3)cc2O1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783065,,CHEMBL1783065,5.73,0,http://www.openphacts.org/units/Nanomolar,1427732,=,1,1,=,,IC50,nM,,1845.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.845
,6232170,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccccc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783066,,CHEMBL1783066,7.24,0,http://www.openphacts.org/units/Nanomolar,1427733,=,1,1,=,,IC50,nM,,57.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.057000004
,6232171,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc(C(C)=O)c1O,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL23881,,CHEMBL23881,6.24,1,http://www.openphacts.org/units/Nanomolar,1427734,=,1,1,=,,IC50,nM,,580.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.58000004
,6232172,[],CHEMBL1786324,Displacement of radio-labeled full agonist from PPARgamma receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccccc2)ccc1OCCCOc1ccc([C@H]2SC(=O)NC2=O)cc1,,,CHEMBL1782050,Eur J Med Chem,2011,,CHEMBL1783067,,CHEMBL1783067,6.75,0,http://www.openphacts.org/units/Nanomolar,1427735,=,1,1,=,,IC50,nM,,180.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.18
,7988986,[],CHEMBL1936610,Displacement of [3H]-AD-5061 from human GST-tagged PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCS(=O)(=O)NC(=O)/C=C/c1cc(C2CC2)nn1Cc1ccc(C(F)(F)F)cc1Cl,,,CHEMBL1932914,Bioorg Med Chem,2012,"{'bei': '15.72', 'le': '0.33', 'lle': '2.79', 'sei': '9.77'}",CHEMBL1933845,,CHEMBL1933845,7.92,0,http://www.openphacts.org/units/Nanomolar,1567712,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,7988987,[],CHEMBL1936610,Displacement of [3H]-AD-5061 from human GST-tagged PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)CCS(=O)(=O)NC(=O)/C=C/c1cc(OC(C)C)nn1Cc1ccc(C(F)(F)F)cc1Cl,,,CHEMBL1932914,Bioorg Med Chem,2012,"{'bei': '14.99', 'le': '0.31', 'lle': '2.92', 'sei': '8.67'}",CHEMBL1933842,,CHEMBL1933842,7.82,0,http://www.openphacts.org/units/Nanomolar,1567709,=,1,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
,7988988,[],CHEMBL1936610,Displacement of [3H]-AD-5061 from human GST-tagged PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCS(=O)(=O)NC(=O)/C=C/c1cc(OC(C)C)nn1Cc1ccc(C(F)(F)F)cc1Cl,,,CHEMBL1932914,Bioorg Med Chem,2012,"{'bei': '14.63', 'le': '0.31', 'lle': '2.60', 'sei': '8.46'}",CHEMBL1933841,,CHEMBL1933841,7.64,0,http://www.openphacts.org/units/Nanomolar,1567708,=,1,1,=,,IC50,nM,,23.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.023000002
,7988989,[],CHEMBL1936610,Displacement of [3H]-AD-5061 from human GST-tagged PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCS(=O)(=O)NC(=O)CCc1cc(OC(C)C)nn1Cc1ccc(C(F)(F)F)cc1Cl,,,CHEMBL1932914,Bioorg Med Chem,2012,"{'bei': '14.65', 'le': '0.31', 'lle': '2.72', 'sei': '8.50'}",CHEMBL1933822,,CHEMBL1933822,7.68,0,http://www.openphacts.org/units/Nanomolar,1567688,=,1,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
,8019021,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(Cc3ccc(Cl)cc3)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '9.86', 'le': '0.20', 'lle': '-0.76', 'sei': '7.24'}",CHEMBL1946566,,CHEMBL1946566,5.32,0,http://www.openphacts.org/units/Nanomolar,1575895,=,1,1,=,,IC50,nM,,4800.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.8
,8019022,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(C(=O)c3ccc(Cl)cc3)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '11.92', 'le': '0.24', 'lle': '0.87', 'sei': '7.28'}",CHEMBL1946567,,CHEMBL1946567,6.59,0,http://www.openphacts.org/units/Nanomolar,1575896,=,1,1,=,,IC50,nM,,255.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.25500003
,8019023,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(-c3ccc(C(C)(C)C)cc3)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '12.42', 'le': '0.24', 'lle': '0.13', 'sei': '9.25'}",CHEMBL1946568,,CHEMBL1946568,6.79,0,http://www.openphacts.org/units/Nanomolar,1575897,=,1,1,=,,IC50,nM,,161.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.16100001
,8019024,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(-c3nc4ccc(Cl)cc4s3)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '10.07', 'le': '0.21', 'lle': '-0.77', 'sei': '6.79'}",CHEMBL1946569,,CHEMBL1946569,5.86,0,http://www.openphacts.org/units/Nanomolar,1575898,=,1,1,=,,IC50,nM,,1374.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.3740001
,8019025,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(-c3noc4cc(Cl)ccc34)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '12.66', 'le': '0.26', 'lle': '1.01', 'sei': '7.20'}",CHEMBL1946570,,CHEMBL1946570,7.17,0,http://www.openphacts.org/units/Nanomolar,1575899,=,1,1,=,,IC50,nM,,68.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.068
,8019026,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)noc12,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.72', 'le': '0.29', 'lle': '2.23', 'sei': '8.08'}",CHEMBL1946571,,CHEMBL1946571,8.04,0,http://www.openphacts.org/units/Nanomolar,1575900,=,1,1,=,,IC50,nM,,9.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0092
,8019027,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2onc(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)c2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.56', 'le': '0.29', 'lle': '2.14', 'sei': '7.99'}",CHEMBL1946572,,CHEMBL1946572,7.95,0,http://www.openphacts.org/units/Nanomolar,1575901,=,1,1,=,,IC50,nM,,11.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0112000005
,8019028,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.38', 'le': '0.28', 'lle': '2.04', 'sei': '7.89'}",CHEMBL1946753,,CHEMBL1946753,7.85,0,http://www.openphacts.org/units/Nanomolar,1576128,=,1,1,=,,IC50,nM,,14.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0142
,8019029,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](Oc1cc(Cn2c(=O)n(-c3noc4ccc(Cl)cc34)c3ccc(C(F)(F)F)cc32)ccc1Cl)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '13.16', 'le': '0.27', 'lle': '1.29', 'sei': '7.49'}",CHEMBL1946754,,CHEMBL1946754,7.45,0,http://www.openphacts.org/units/Nanomolar,1576129,=,1,1,=,,IC50,nM,,35.4,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.035400003
,8019030,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.93', 'le': '0.29', 'lle': '2.88', 'sei': '7.71'}",CHEMBL1946755,,CHEMBL1946755,8.39,0,http://www.openphacts.org/units/Nanomolar,1576130,=,1,1,=,,IC50,nM,,4.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0041
,8019031,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4cc(OC(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.70', 'le': '0.29', 'lle': '3.10', 'sei': '7.20'}",CHEMBL1946756,,CHEMBL1946756,8.49,0,http://www.openphacts.org/units/Nanomolar,1576131,=,1,1,=,,IC50,nM,,3.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0032000002
,8019032,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4ccc(C(F)(F)F)cc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '15.37', 'le': '0.30', 'lle': '3.13', 'sei': '7.95'}",CHEMBL1946757,,CHEMBL1946757,8.64,0,http://www.openphacts.org/units/Nanomolar,1576132,=,1,1,=,,IC50,nM,,2.3,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0023
,8019033,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4ccc(OC(F)(F)F)cc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.51', 'le': '0.29', 'lle': '3.00', 'sei': '7.11'}",CHEMBL1946758,,CHEMBL1946758,8.39,0,http://www.openphacts.org/units/Nanomolar,1576133,=,1,1,=,,IC50,nM,,4.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0041
,8019034,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '12.78', 'le': '0.25', 'lle': '1.67', 'sei': '6.60'}",CHEMBL1946952,,CHEMBL1946952,7.18,0,http://www.openphacts.org/units/Nanomolar,1576368,=,1,1,=,,IC50,nM,,66.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.066
,8019035,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cc(O[C@H](C)C(=O)O)ccc4Cl)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.31', 'le': '0.28', 'lle': '2.53', 'sei': '7.40'}",CHEMBL1946953,,CHEMBL1946953,8.04,0,http://www.openphacts.org/units/Nanomolar,1576369,=,1,1,=,,IC50,nM,,9.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0091
,8019036,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cccc(O[C@H](C)C(=O)O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '11.44', 'le': '0.22', 'lle': '1.17', 'sei': '5.55'}",CHEMBL1946954,,CHEMBL1946954,6.03,0,http://www.openphacts.org/units/Nanomolar,1576370,=,1,1,=,,IC50,nM,,924.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.924
,8019037,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](Oc1cccc(Cn2c(=O)n(-c3noc4cc(OC)ccc34)c3ccc(C(F)(F)F)cc32)c1)C(=O)O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '10.04', 'le': '0.19', 'lle': '0.19', 'sei': '5.00'}",CHEMBL1946955,,CHEMBL1946955,5.44,0,http://www.openphacts.org/units/Nanomolar,1576371,=,1,1,=,,IC50,nM,,3657.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.657
,8019038,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccccc4[C@@]4(C)OC(=O)NC4=O)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '9.37', 'le': '0.18', 'lle': '0.69', 'sei': '4.40'}",CHEMBL1947138,,CHEMBL1947138,5.18,0,http://www.openphacts.org/units/Nanomolar,1576601,=,1,1,=,,IC50,nM,,6633.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.6330004
,8019039,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc([C@@]5(C)OC(=O)NC5=O)cc4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '10.25', 'le': '0.19', 'lle': '1.17', 'sei': '4.82'}",CHEMBL1947139,,CHEMBL1947139,5.66,0,http://www.openphacts.org/units/Nanomolar,1576602,=,1,1,=,,IC50,nM,,2177.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.177
,8019040,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cccc([C@@]5(C)OC(=O)NC5=O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '12.73', 'le': '0.24', 'lle': '2.54', 'sei': '5.98'}",CHEMBL1947140,,CHEMBL1947140,7.03,0,http://www.openphacts.org/units/Nanomolar,1576603,=,1,1,=,,IC50,nM,,93.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.093
,8019041,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(-c4cccc([C@@]5(C)OC(=O)NC5=O)c4)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '9.58', 'le': '0.18', 'lle': '0.73', 'sei': '4.39'}",CHEMBL1947141,,CHEMBL1947141,5.16,0,http://www.openphacts.org/units/Nanomolar,1576604,=,1,1,=,,IC50,nM,,6935.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.9350004
,8019042,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cc([C@@]5(C)OC(=O)NC5=O)ccc4Cl)c4cc(C(F)(F)F)ccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '13.82', 'le': '0.27', 'lle': '2.97', 'sei': '6.90'}",CHEMBL1947142,,CHEMBL1947142,8.11,0,http://www.openphacts.org/units/Nanomolar,1576605,=,1,1,=,,IC50,nM,,7.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0077
,8019043,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4ccc(Cl)c(O[C@H](C)C(=O)O)c4)c4ccccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '16.52', 'le': '0.32', 'lle': '3.66', 'sei': '7.51'}",CHEMBL1947143,,CHEMBL1947143,8.16,0,http://www.openphacts.org/units/Nanomolar,1576606,=,1,1,=,,IC50,nM,,6.9,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0069000004
,8019044,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cccc([C@@]5(C)OC(=O)NC5=O)c4)c4ccccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.61', 'le': '0.27', 'lle': '3.61', 'sei': '6.02'}",CHEMBL1947144,,CHEMBL1947144,7.08,0,http://www.openphacts.org/units/Nanomolar,1576607,=,1,1,=,,IC50,nM,,83.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.083100006
,8019045,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@]1(c2cccc(Cn3c(=O)n(-c4noc5cc(Cl)ccc45)c4ccccc43)c2)OC(=O)NC1=O,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '14.95', 'le': '0.29', 'lle': '3.19', 'sei': '6.75'}",CHEMBL1947145,,CHEMBL1947145,7.31,0,http://www.openphacts.org/units/Nanomolar,1576608,=,1,1,=,,IC50,nM,,49.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0491
,8019046,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cc(O[C@H](C)C(=O)O)ccc4Cl)c4ccccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '15.92', 'le': '0.31', 'lle': '3.36', 'sei': '7.23'}",CHEMBL1947146,,CHEMBL1947146,7.86,0,http://www.openphacts.org/units/Nanomolar,1576609,=,1,1,=,,IC50,nM,,13.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0137
,8019047,[],CHEMBL1947820,Binding affinity to human PPARgamma by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(-n3c(=O)n(Cc4cc([C@@]5(C)OC(=O)NC5=O)ccc4Cl)c4ccccc43)noc2c1,,,CHEMBL1944523,J Med Chem,2011,"{'bei': '15.43', 'le': '0.30', 'lle': '3.87', 'sei': '6.81'}",CHEMBL1947147,,CHEMBL1947147,8.00,0,http://www.openphacts.org/units/Nanomolar,1576610,=,1,1,=,,IC50,nM,,9.9,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0099
,10872640,[],CHEMBL2027047,Displacement of [3H]-AD-5061 from human GST-tagged PPARgamma,B,,,BAO_0000190,BAO_0000357,single protein format,CCCCCS(=O)(=O)NC(=O)/C=C/c1ccc(OCCOC)cc1Oc1ncc(C(F)(F)F)cc1Cl,,,CHEMBL2021860,Bioorg Med Chem,2012,"{'bei': '11.76', 'le': '0.25', 'lle': '1.26', 'sei': '6.24'}",CHEMBL2024606,,CHEMBL2024606,6.48,0,http://www.openphacts.org/units/Nanomolar,1640494,=,1,1,=,,IC50,nM,,330.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.33
,10897713,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(C(=O)c2ccccc2)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL212911,,CHEMBL212911,8.30,0,http://www.openphacts.org/units/Nanomolar,1647098,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,10897734,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(Oc2ccc(OC(C)(C)C(=O)O)c(C)c2)cc1CNC(=O)c1ccc(C(F)(F)F)cc1F,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL237519,,CHEMBL237519,7.77,0,http://www.openphacts.org/units/Nanomolar,1647083,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,10898625,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(CNC(=O)c2ccc(C(F)(F)F)cc2F)cc1Oc1ccc(OC(C)(C)C(=O)O)c(C)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL237307,,CHEMBL237307,8.30,0,http://www.openphacts.org/units/Nanomolar,1647104,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,10898643,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(Oc2ccc(F)c(CNC(=O)c3ccc(C(F)(F)F)cc3F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL237520,,CHEMBL237520,8.10,0,http://www.openphacts.org/units/Nanomolar,1647109,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,10898694,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(OCC(=O)O)c(C)cc1SCc1ccc(OCc2ccc(C(F)(F)F)cc2)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL234659,,CHEMBL234659,4.63,0,http://www.openphacts.org/units/Nanomolar,1647125,=,1,1,=,,IC50,nM,,23600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,23.6
,10898700,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(COc2ccc(CSc3ccc(OCC(=O)O)c4c3CCC4)cc2)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL234662,,CHEMBL234662,4.86,0,http://www.openphacts.org/units/Nanomolar,1647126,=,1,1,=,,IC50,nM,,13800.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,13.8
,10898706,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL81248,,CHEMBL81248,7.85,0,http://www.openphacts.org/units/Nanomolar,1647127,=,1,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
,10898712,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCC[C@@](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)(Oc1ccccc1)C(=O)O,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL2037005,,CHEMBL2037005,5.65,0,http://www.openphacts.org/units/Nanomolar,1647128,=,1,1,=,,IC50,nM,,2241.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.2410002
,10898718,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2cccs2)nc1CCOc1ccc(C[C@](C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL77502,LY-510929,CHEMBL77502,8.00,0,http://www.openphacts.org/units/Nanomolar,1647129,=,1,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
,10898727,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Oc2ccccc2)C(=O)O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL2037006,,CHEMBL2037006,6.89,0,http://www.openphacts.org/units/Nanomolar,1647131,=,1,1,=,,IC50,nM,,128.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.128
,10898733,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(CC(C)(Oc2ccccc2)C(=O)O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL82034,,CHEMBL82034,7.75,0,http://www.openphacts.org/units/Nanomolar,1647132,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,10898739,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1oc(-c2ccccc2)nc1CCOc1ccc(OC(C)(Cc2ccccc2)C(=O)O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL81592,,CHEMBL81592,6.31,0,http://www.openphacts.org/units/Nanomolar,1647133,=,1,1,=,,IC50,nM,,491.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.49100003
,10898766,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)Cc1cc(Oc2ccccc2)ccc1OCCCOc1ccc([C@@H]2SC(=O)NC2=O)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL2037009,,CHEMBL2037009,6.32,0,http://www.openphacts.org/units/Nanomolar,1647141,=,1,1,=,,IC50,nM,,480.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.48000002
,10898784,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(Oc2ccc(O)cc2)ccc1OCCCOc1cccc([C@@H]2SC(=O)NC2=O)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL2037010,,CHEMBL2037010,7.52,0,http://www.openphacts.org/units/Nanomolar,1647146,=,1,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
,10898802,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)[C@@H]1CCc2ccc(OCCCOc3ccc(OCC(F)(F)F)cc3Cl)cc2O1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL2037079,,CHEMBL2037079,5.39,0,http://www.openphacts.org/units/Nanomolar,1647274,=,1,1,=,,IC50,nM,,4100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.1000004
,10898820,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CC[C@]1(C(=O)O)CCc2ccc(OCCCOc3ccc(Cl)cc3Cl)cc2O1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL435343,,CHEMBL435343,5.54,0,http://www.openphacts.org/units/Nanomolar,1647279,=,1,1,=,,IC50,nM,,2900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.9
,10898826,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc(C[C@H](OC)C(=O)O)ccc1OCCCOc1ccc(Oc2ccccc2)cc1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL180504,,CHEMBL180504,7.89,0,http://www.openphacts.org/units/Nanomolar,1647280,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,10898832,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,O=C(O)COc1ccc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c2c1CCCO2,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL232395,,CHEMBL232395,5.25,0,http://www.openphacts.org/units/Nanomolar,1647281,=,1,1,=,,IC50,nM,,5560.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.5600004
,10898838,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(SCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)c2c(c1OCC(=O)O)CCCO2,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL391479,,CHEMBL391479,4.48,0,http://www.openphacts.org/units/Nanomolar,1647282,=,1,1,=,,IC50,nM,,33300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,33.300003
,10898895,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CC[C@]1(C(=O)O)CCc2ccc(OCCCOc3ccc(OC(F)(F)F)cc3Cl)cc2O1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL361424,,CHEMBL361424,5.58,0,http://www.openphacts.org/units/Nanomolar,1647303,=,1,1,=,,IC50,nM,,2600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.6000001
,10898919,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCNc2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL207103,,CHEMBL207103,6.99,0,http://www.openphacts.org/units/Nanomolar,1647310,=,1,1,=,,IC50,nM,,102.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.102000006
,10899562,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCn2ccc3cc(CC(=O)O)ccc32)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL383728,,CHEMBL383728,5.72,0,http://www.openphacts.org/units/Nanomolar,1647311,=,1,1,=,,IC50,nM,,1900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.9000001
,10899568,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCN(C)c2ccc(CC(=O)O)cc2C)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL209563,,CHEMBL209563,6.34,0,http://www.openphacts.org/units/Nanomolar,1647270,=,1,1,=,,IC50,nM,,460.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.46
,10899574,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCOc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL210768,,CHEMBL210768,6.55,0,http://www.openphacts.org/units/Nanomolar,1647285,=,1,1,=,,IC50,nM,,280.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.28
,10899580,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCOc2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL210973,,CHEMBL210973,6.57,0,http://www.openphacts.org/units/Nanomolar,1647313,=,1,1,=,,IC50,nM,,270.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.27
,10899589,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCN(C)c2cccc(CC(=O)O)c2)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL207442,,CHEMBL207442,5.52,0,http://www.openphacts.org/units/Nanomolar,1647314,=,1,1,=,,IC50,nM,,3000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.0000002
,10899595,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCN(C)c2ccc(CC(=O)O)cc2)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL207019,,CHEMBL207019,5.54,0,http://www.openphacts.org/units/Nanomolar,1647315,=,1,1,=,,IC50,nM,,2900.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.9
,10899619,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2ccco2)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL391264,,CHEMBL391264,6.03,0,http://www.openphacts.org/units/Nanomolar,1647293,=,1,1,=,,IC50,nM,,940.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.94000006
,10899631,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(Oc1ccc(OCCCOc2ccc(Oc3ccc(F)cc3)cc2Cl)cc1)C(=O)O,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL206794,,CHEMBL206794,6.01,0,http://www.openphacts.org/units/Nanomolar,1647323,=,1,1,=,,IC50,nM,,981.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.98100007
,10899637,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(C(F)(F)F)noc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL23296,,CHEMBL23296,6.71,0,http://www.openphacts.org/units/Nanomolar,1647324,=,1,1,=,,IC50,nM,,195.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.19500001
,10899643,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(OCCCSc2ccc(CC(=O)O)cc2Cl)ccc2c(CC)coc12,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL23670,,CHEMBL23670,6.25,0,http://www.openphacts.org/units/Nanomolar,1647325,=,1,1,=,,IC50,nM,,560.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.56
,10899649,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(O[C@H](C)CCOc2ccc(CCC(=O)O)c(C)c2)c(-c2cccs2)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL241078,,CHEMBL241078,5.96,0,http://www.openphacts.org/units/Nanomolar,1647326,=,1,1,=,,IC50,nM,,1090.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.09
,10899697,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(C(=O)NCc2cccc(Oc3ccc(OC(C)(C)C(=O)O)c(C)c3)c2)c(C)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL393939,,CHEMBL393939,8.15,0,http://www.openphacts.org/units/Nanomolar,1647440,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,10899715,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3Oc3ccccc3)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL237710,,CHEMBL237710,6.94,0,http://www.openphacts.org/units/Nanomolar,1647457,=,1,1,=,,IC50,nM,,114.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.11400001
,10899730,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1cc(Oc2cccc(CNC(=O)c3ccc(C(F)(F)F)cc3C(F)(F)F)c2)ccc1OC(C)(C)C(=O)O,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL237084,,CHEMBL237084,6.69,0,http://www.openphacts.org/units/Nanomolar,1647461,=,1,1,=,,IC50,nM,,203.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.20300001
,10899751,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(NC(=O)c2cccc(S(=O)(=O)n3ccc4c(C)cccc43)c2)c(C(=O)O)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL495904,,CHEMBL495904,5.70,0,http://www.openphacts.org/units/Nanomolar,1647096,=,1,1,=,,IC50,nM,,1995.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.9950001
,10899757,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(NC(=O)c2cccc(S(=O)(=O)n3ccc4c(Br)cccc43)c2)c(C(=O)O)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL495905,,CHEMBL495905,5.90,0,http://www.openphacts.org/units/Nanomolar,1647465,=,1,1,=,,IC50,nM,,1259.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.2590001
,10899763,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(NC(=O)c2cccc(S(=O)(=O)n3ccc4cc(Cl)ccc43)c2)c(C(=O)O)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL498172,,CHEMBL498172,5.80,0,http://www.openphacts.org/units/Nanomolar,1647466,=,1,1,=,,IC50,nM,,1585.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.585
,10899769,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(ccn2S(=O)(=O)c2cccc(C(=O)Nc3ccc(C)cc3C(=O)O)c2)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL525552,,CHEMBL525552,5.00,0,http://www.openphacts.org/units/Nanomolar,1647467,=,1,1,=,,IC50,nM,,10000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,10.0
,10899793,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1ccc(Cl)cc1C(=O)O)c1cccc(S(=O)(=O)N2CCc3ccccc3C2)c1,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL485088,,CHEMBL485088,5.40,0,http://www.openphacts.org/units/Nanomolar,1647474,=,1,1,=,,IC50,nM,,3981.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,3.9810002
,10899838,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2c(c1)CCN(S(=O)(=O)c1cccc(C(=O)Nc3ccc(Cl)cc3C(=O)O)c1)C2,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL524829,,CHEMBL524829,5.20,0,http://www.openphacts.org/units/Nanomolar,1647488,=,1,1,=,,IC50,nM,,6310.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.3100004
,10899850,[],CHEMBL2038597,Agonist activity at PPARgamma,F,,,BAO_0000190,BAO_0000019,assay format,Cc1c(Cl)ccc2c1CN(S(=O)(=O)c1cccc(C(=O)Nc3ccc(Cl)cc3C(=O)O)c1)CC2,,,CHEMBL2034870,Bioorg Med Chem,2012,,CHEMBL496933,,CHEMBL496933,5.30,0,http://www.openphacts.org/units/Nanomolar,1647491,=,1,1,=,,IC50,nM,,5012.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.012
,12712908,[],CHEMBL2342574,Displacement of [3H]-rosiglitazone from GST-tagged PPARgammaLBD (unknown origin) after 1 hr by scintillation proximity assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)c1cc(NS(=O)(=O)c2ccc(Cl)cc2)ccc1Oc1cncc(Cl)c1,,,CHEMBL2331151,Bioorg Med Chem,2013,"{'bei': '15.19', 'le': '0.32', 'lle': '1.94', 'sei': '7.50'}",CHEMBL2331784,,CHEMBL2331784,7.10,0,http://www.openphacts.org/units/Nanomolar,1865217,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,13336177,[],CHEMBL2394992,Binding affinity to human PPARgamma receptor by radioligand displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL2390917,Bioorg Med Chem,2013,"{'bei': '22.16', 'le': '0.43', 'lle': '5.43', 'sei': '11.07'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.92,0,http://www.openphacts.org/units/Nanomolar,1898584,=,1,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
,15243770,[],CHEMBL3428440,Agonist activity at PPARgamma ligand binding domain (unknown origin) using fluormone Pan-PPAR green tracer by TR-FRET assay based competitive ligand binding method,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL3425507,Bioorg Med Chem Lett,2015,"{'bei': '19.92', 'le': '0.39', 'lle': '4.63', 'sei': '9.96'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.12,0,http://www.openphacts.org/units/Nanomolar,2296585,=,1,1,=,,IC50,nM,,75.52,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07552
,15243771,[],CHEMBL3428440,Agonist activity at PPARgamma ligand binding domain (unknown origin) using fluormone Pan-PPAR green tracer by TR-FRET assay based competitive ligand binding method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(cc1CC=C(C)C)C(=O)C[C@H](c1ccc(O)cc1)O2,,,CHEMBL3425507,Bioorg Med Chem Lett,2015,"{'bei': '18.70', 'le': '0.35', 'lle': '1.71', 'sei': '11.35'}",CHEMBL3425797,,CHEMBL3425797,6.33,0,http://www.openphacts.org/units/Nanomolar,2296584,=,1,1,=,,IC50,nM,,471.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.47120005
,15243772,[],CHEMBL3428440,Agonist activity at PPARgamma ligand binding domain (unknown origin) using fluormone Pan-PPAR green tracer by TR-FRET assay based competitive ligand binding method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2c(cc1CC=C(C)C)C(=O)C[C@@H](c1ccc(O)cc1)O2,,,CHEMBL3425507,Bioorg Med Chem Lett,2015,"{'bei': '18.35', 'le': '0.34', 'lle': '1.59', 'sei': '11.14'}",CHEMBL1551302,BAVACHININ A,CHEMBL1551302,6.21,0,http://www.openphacts.org/units/Nanomolar,2296583,=,1,1,=,,IC50,nM,,616.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.61670005
,15243773,[],CHEMBL3428440,Agonist activity at PPARgamma ligand binding domain (unknown origin) using fluormone Pan-PPAR green tracer by TR-FRET assay based competitive ligand binding method,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2cc1CC=C(C)C,,,CHEMBL3425507,Bioorg Med Chem Lett,2015,"{'bei': '18.76', 'le': '0.34', 'lle': '1.63', 'sei': '10.58'}",CHEMBL458053,BAVACHININ,CHEMBL458053,6.31,0,http://www.openphacts.org/units/Nanomolar,2296582,=,1,1,=,,IC50,nM,,488.8,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.48880002
,15657620,[],CHEMBL3598338,Agonist activity at PPARgamma (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,,,CHEMBL3596163,Bioorg Med Chem Lett,2015,"{'bei': '17.23', 'le': '0.34', 'lle': '2.98', 'sei': '8.99'}",CHEMBL595,PIOGLITAZONE,CHEMBL595,6.14,0,http://www.openphacts.org/units/Nanomolar,2489226,=,1,1,=,,IC50,nM,,720.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.72
,15657621,[],CHEMBL3598338,Agonist activity at PPARgamma (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,,CHEMBL3596163,Bioorg Med Chem Lett,2015,"{'bei': '14.65', 'le': '0.28', 'lle': '2.10', 'sei': '7.62'}",CHEMBL408,TROGLITAZONE,CHEMBL408,6.47,0,http://www.openphacts.org/units/Nanomolar,2489227,=,1,1,=,,IC50,nM,,340.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.34
,16392574,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '18.26', 'le': '0.33', 'lle': '1.88', 'sei': '13.22'}",CHEMBL602468,,CHEMBL602468,9.43,0,http://www.openphacts.org/units/Nanomolar,2735731,=,1,1,=,,IC50,nM,,0.37,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00037000002
,16392575,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '18.42', 'le': '0.33', 'lle': '2.40', 'sei': '12.62'}",CHEMBL602469,,CHEMBL602469,9.00,0,http://www.openphacts.org/units/Nanomolar,2735732,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,16392576,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CNC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.36', 'le': '0.30', 'lle': '1.31', 'sei': '11.53'}",CHEMBL3695841,,CHEMBL3695841,8.22,0,http://www.openphacts.org/units/Nanomolar,2735733,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,16392577,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3N)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.88', 'le': '0.27', 'lle': '1.31', 'sei': '7.70'}",CHEMBL3695829,,CHEMBL3695829,7.50,0,http://www.openphacts.org/units/Nanomolar,2735734,=,1,1,=,,IC50,nM,,32.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.032
,16392578,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3[N+](=O)[O-])cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.28', 'le': '0.26', 'lle': '1.11', 'sei': '6.66'}",CHEMBL3695852,,CHEMBL3695852,7.62,0,http://www.openphacts.org/units/Nanomolar,2735735,=,1,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
,16392579,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.52', 'le': '0.30', 'lle': '1.39', 'sei': '11.64'}",CHEMBL3695839,,CHEMBL3695839,8.30,0,http://www.openphacts.org/units/Nanomolar,2735736,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,16392580,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.19', 'le': '0.29', 'lle': '1.79', 'sei': '10.42'}",CHEMBL3695837,,CHEMBL3695837,8.40,0,http://www.openphacts.org/units/Nanomolar,2735737,=,1,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
,16392581,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc([N+](=O)[O-])c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.43', 'le': '0.26', 'lle': '1.19', 'sei': '6.73'}",CHEMBL3695843,,CHEMBL3695843,7.70,0,http://www.openphacts.org/units/Nanomolar,2735738,=,1,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
,16392582,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.71', 'le': '0.30', 'lle': '1.49', 'sei': '11.77'}",CHEMBL3695840,,CHEMBL3695840,8.40,0,http://www.openphacts.org/units/Nanomolar,2735739,=,1,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
,16392583,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(Br)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '13.84', 'le': '0.28', 'lle': '0.49', 'sei': '11.01'}",CHEMBL3695771,,CHEMBL3695771,7.85,0,http://www.openphacts.org/units/Nanomolar,2735740,=,1,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
,16392584,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '13.91', 'le': '0.25', 'lle': '0.91', 'sei': '6.48'}",CHEMBL3695831,,CHEMBL3695831,7.42,0,http://www.openphacts.org/units/Nanomolar,2735741,=,1,1,=,,IC50,nM,,38.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.038000003
,16392585,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '11.34', 'le': '0.21', 'lle': '-1.72', 'sei': '8.66'}",CHEMBL3695772,,CHEMBL3695772,6.18,0,http://www.openphacts.org/units/Nanomolar,2735742,=,1,1,=,,IC50,nM,,667.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.66700006
,16392586,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccs3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '18.20', 'le': '0.34', 'lle': '2.34', 'sei': '12.62'}",CHEMBL3695821,,CHEMBL3695821,9.00,0,http://www.openphacts.org/units/Nanomolar,2735743,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,16392587,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '13.43', 'le': '0.24', 'lle': '-0.60', 'sei': '10.63'}",CHEMBL3695813,,CHEMBL3695813,7.58,0,http://www.openphacts.org/units/Nanomolar,2735744,=,1,1,=,,IC50,nM,,26.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.026
,16392588,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC3CCC3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.56', 'le': '0.30', 'lle': '1.54', 'sei': '10.51'}",CHEMBL3695826,,CHEMBL3695826,7.50,0,http://www.openphacts.org/units/Nanomolar,2735745,=,1,1,=,,IC50,nM,,32.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.032
,16392589,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCC3CCCCC3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.37', 'le': '0.26', 'lle': '0.13', 'sei': '9.96'}",CHEMBL3695819,,CHEMBL3695819,7.11,0,http://www.openphacts.org/units/Nanomolar,2735746,=,1,1,=,,IC50,nM,,78.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.078
,16392590,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.50', 'le': '0.30', 'lle': '0.97', 'sei': '11.95'}",CHEMBL1230353,,CHEMBL1230353,8.52,0,http://www.openphacts.org/units/Nanomolar,2735747,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,16392591,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '19.14', 'le': '0.35', 'lle': '2.34', 'sei': '13.86'}",CHEMBL3695832,,CHEMBL3695832,9.89,0,http://www.openphacts.org/units/Nanomolar,2735748,=,1,1,=,,IC50,nM,,0.13,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00013
,16392592,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(F)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.75', 'le': '0.27', 'lle': '0.38', 'sei': '10.76'}",CHEMBL3695845,,CHEMBL3695845,7.68,0,http://www.openphacts.org/units/Nanomolar,2735749,=,1,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
,16392593,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(F)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '17.48', 'le': '0.32', 'lle': '1.80', 'sei': '12.76'}",CHEMBL3695846,,CHEMBL3695846,9.10,0,http://www.openphacts.org/units/Nanomolar,2735750,=,1,1,=,,IC50,nM,,0.79,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0007900001
,16392594,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.98', 'le': '0.31', 'lle': '1.88', 'sei': '11.23'}",CHEMBL3695776,,CHEMBL3695776,9.05,0,http://www.openphacts.org/units/Nanomolar,2735751,=,1,1,=,,IC50,nM,,0.9,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00090000004
,16392595,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '17.40', 'le': '0.32', 'lle': '2.10', 'sei': '11.50'}",CHEMBL3695780,,CHEMBL3695780,9.27,0,http://www.openphacts.org/units/Nanomolar,2735752,=,1,1,=,,IC50,nM,,0.54,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00054000004
,16392596,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.96', 'le': '0.24', 'lle': '0.03', 'sei': '6.20'}",CHEMBL3348830,,CHEMBL3348830,7.10,0,http://www.openphacts.org/units/Nanomolar,2735753,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,16392597,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.89', 'le': '0.29', 'lle': '1.63', 'sei': '7.60'}",CHEMBL3695811,,CHEMBL3695811,8.70,0,http://www.openphacts.org/units/Nanomolar,2735754,=,1,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
,16392598,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.99', 'le': '0.26', 'lle': '-0.38', 'sei': '10.59'}",CHEMBL3695760,,CHEMBL3695760,7.55,0,http://www.openphacts.org/units/Nanomolar,2735755,=,1,1,=,,IC50,nM,,28.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.028
,16392599,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.71', 'le': '0.32', 'lle': '1.21', 'sei': '12.81'}",CHEMBL3695765,,CHEMBL3695765,9.14,0,http://www.openphacts.org/units/Nanomolar,2735756,=,1,1,=,,IC50,nM,,0.73,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00073
,16392600,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '16.50', 'le': '0.30', 'lle': '1.05', 'sei': '11.95'}",CHEMBL3699396,,CHEMBL3699396,8.52,0,http://www.openphacts.org/units/Nanomolar,2735757,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,16392601,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.49', 'le': '0.28', 'lle': '0.49', 'sei': '11.53'}",CHEMBL3699399,,CHEMBL3699399,8.22,0,http://www.openphacts.org/units/Nanomolar,2735758,=,1,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
,16392602,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3Br)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.48', 'le': '0.32', 'lle': '1.07', 'sei': '12.62'}",CHEMBL3699398,,CHEMBL3699398,9.00,0,http://www.openphacts.org/units/Nanomolar,2735759,=,1,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
,16392603,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3OC(C)C)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '10.67', 'le': '0.19', 'lle': '-1.97', 'sei': '7.42'}",CHEMBL3699401,,CHEMBL3699401,5.98,0,http://www.openphacts.org/units/Nanomolar,2735760,=,1,1,=,,IC50,nM,,1046.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.046
,16392604,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(Cl)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.87', 'le': '0.30', 'lle': '0.70', 'sei': '11.95'}",CHEMBL3735987,,CHEMBL3735987,8.52,0,http://www.openphacts.org/units/Nanomolar,2735761,=,1,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
,16392605,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(F)(F)F)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.98', 'le': '0.24', 'lle': '-0.77', 'sei': '10.39'}",CHEMBL3735765,,CHEMBL3735765,7.41,0,http://www.openphacts.org/units/Nanomolar,2735762,=,1,1,=,,IC50,nM,,39.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.039
,16392606,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '13.81', 'le': '0.25', 'lle': '-0.77', 'sei': '10.55'}",CHEMBL3736229,,CHEMBL3736229,7.52,0,http://www.openphacts.org/units/Nanomolar,2735763,=,1,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
,16392607,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.03', 'le': '0.27', 'lle': '0.11', 'sei': '11.43'}",CHEMBL3699424,,CHEMBL3699424,8.15,0,http://www.openphacts.org/units/Nanomolar,2735764,=,1,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
,16392608,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)C)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.86', 'le': '0.27', 'lle': '-0.16', 'sei': '11.64'}",CHEMBL3735906,,CHEMBL3735906,8.30,0,http://www.openphacts.org/units/Nanomolar,2735765,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,16392609,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.26', 'le': '0.28', 'lle': '0.42', 'sei': '11.06'}",CHEMBL3735470,,CHEMBL3735470,7.89,0,http://www.openphacts.org/units/Nanomolar,2735766,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,16392610,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.18', 'le': '0.28', 'lle': '0.74', 'sei': '10.30'}",CHEMBL3699397,,CHEMBL3699397,8.30,0,http://www.openphacts.org/units/Nanomolar,2735767,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,16392611,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)C)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.48', 'le': '0.26', 'lle': '-0.40', 'sei': '11.06'}",CHEMBL3735674,,CHEMBL3735674,7.89,0,http://www.openphacts.org/units/Nanomolar,2735768,=,1,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
,16392612,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.86', 'le': '0.27', 'lle': '-0.16', 'sei': '11.64'}",CHEMBL3735924,,CHEMBL3735924,8.30,0,http://www.openphacts.org/units/Nanomolar,2735769,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,16392613,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)O)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '13.86', 'le': '0.25', 'lle': '0.38', 'sei': '8.49'}",CHEMBL3736075,,CHEMBL3736075,7.77,0,http://www.openphacts.org/units/Nanomolar,2735770,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,16392614,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(C(C)C)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '15.64', 'le': '0.28', 'lle': '0.57', 'sei': '11.64'}",CHEMBL3735503,,CHEMBL3735503,8.30,0,http://www.openphacts.org/units/Nanomolar,2735771,=,1,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
,16392615,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](c3cccc(C(C)C)c3)C(F)(F)F)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.98', 'le': '0.24', 'lle': '-1.06', 'sei': '10.89'}",CHEMBL3736263,,CHEMBL3736263,7.77,0,http://www.openphacts.org/units/Nanomolar,2735772,=,1,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
,16392616,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(C(C)C)c1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.40', 'le': '0.26', 'lle': '-0.63', 'sei': '11.28'}",CHEMBL3695916,,CHEMBL3695916,8.05,0,http://www.openphacts.org/units/Nanomolar,2735773,=,1,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
,16392617,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](c3cccc(C(C)C)c3)C(C)C)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.39', 'le': '0.23', 'lle': '-1.82', 'sei': '9.95'}",CHEMBL3734773,,CHEMBL3734773,7.10,0,http://www.openphacts.org/units/Nanomolar,2735774,=,1,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
,16392618,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](c3cccc(C(C)C)c3)C3CC3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '14.19', 'le': '0.26', 'lle': '-0.58', 'sei': '11.35'}",CHEMBL3736463,,CHEMBL3736463,8.10,0,http://www.openphacts.org/units/Nanomolar,2735775,=,1,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
,16392619,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(C(C)C)c1,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '12.09', 'le': '0.22', 'lle': '-2.37', 'sei': '9.94'}",CHEMBL3736501,,CHEMBL3736501,7.09,0,http://www.openphacts.org/units/Nanomolar,2735776,=,1,1,=,,IC50,nM,,81.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.081
,16392620,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](CC(C)C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '10.08', 'le': '0.18', 'lle': '-3.40', 'sei': '8.29'}",CHEMBL3736374,,CHEMBL3736374,5.91,0,http://www.openphacts.org/units/Nanomolar,2735777,=,1,1,=,,IC50,nM,,1222.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.222
,16393311,[],CHEMBL3738479,Binding affinity to GST-tagged PPAR-gamma-LBD (unknown origin) after 2 hrs by Lantha screen assay using fluormone Pan-PPAR green probe,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](Cc3ccccc3)c3cccc(C(C)C)c3)cc12,,,CHEMBL3734690,ACS Med Chem Lett,2015,"{'bei': '11.30', 'le': '0.20', 'lle': '-2.50', 'sei': '9.83'}",CHEMBL3736412,,CHEMBL3736412,7.01,0,http://www.openphacts.org/units/Nanomolar,2735778,=,1,1,=,,IC50,nM,,97.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.097
,16437790,[],CHEMBL3755386,Binding affinity to GST-tagged human PPAR-gamma receptor by FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL3751711,Eur J Med Chem,2016,"{'bei': '20.76', 'le': '0.41', 'lle': '4.93', 'sei': '10.37'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.42,0,http://www.openphacts.org/units/Nanomolar,2743171,=,1,1,=,,IC50,nM,,38.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.038000003
,16509852,[],CHEMBL3783048,Agonist activity at PPAR-gamma receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1.O=S(=O)(O)O,,,CHEMBL3779889,Bioorg Med Chem,2016,"{'bei': '16.12', 'le': '0.31', 'lle': '4.05', 'sei': '7.53'}",CHEMBL3780740,LOBEGLITAZONE SULFATE,CHEMBL3585580,7.75,0,http://www.openphacts.org/units/Nanomolar,2765326,=,1,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
,16651044,[],CHEMBL3830347,Binding affinity to human GST-tagged PPAR-gamma LBD expressed in Escherichia coli BL21 after 30 mins in presence of fluorescein ligand FLA-A by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N(CC(=O)O)[C@@H](C)c1cccc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,,,CHEMBL3826929,ACS Med Chem Lett,2016,,CHEMBL3827820,,CHEMBL3827820,,0,http://www.openphacts.org/units/Nanomolar,2789543,>,1,1,>,,IC50,nM,,15000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,15.000001
,16651045,[],CHEMBL3830347,Binding affinity to human GST-tagged PPAR-gamma LBD expressed in Escherichia coli BL21 after 30 mins in presence of fluorescein ligand FLA-A by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N(CC(=O)O)Cc1ccc(F)c(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,,,CHEMBL3826929,ACS Med Chem Lett,2016,,CHEMBL3828232,,CHEMBL3828232,,0,http://www.openphacts.org/units/Nanomolar,2789542,>,1,1,>,,IC50,nM,,15000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,15.000001
,16651046,[],CHEMBL3830347,Binding affinity to human GST-tagged PPAR-gamma LBD expressed in Escherichia coli BL21 after 30 mins in presence of fluorescein ligand FLA-A by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N(CC(=O)O)Cc1cc(F)cc(OCc2nc(-c3ccc(Cl)cc3)oc2C)c1,,,CHEMBL3826929,ACS Med Chem Lett,2016,,CHEMBL3827335,,CHEMBL3827335,,0,http://www.openphacts.org/units/Nanomolar,2789541,>,1,1,>,,IC50,nM,,15000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,15.000001
,16651047,[],CHEMBL3830347,Binding affinity to human GST-tagged PPAR-gamma LBD expressed in Escherichia coli BL21 after 30 mins in presence of fluorescein ligand FLA-A by fluorescence polarization assay,B,,,BAO_0000190,BAO_0000019,assay format,COC(=O)N(CC(=O)O)Cc1cc(OCc2nc(-c3ccc(Cl)cc3)oc2C)ccc1F,,,CHEMBL3826929,ACS Med Chem Lett,2016,,CHEMBL3828718,,CHEMBL3828718,,0,http://www.openphacts.org/units/Nanomolar,2789540,>,1,1,>,,IC50,nM,,98400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,98.4
284523,17666868,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.99', 'le': '0.26', 'lle': '-0.38', 'sei': '10.59'}",CHEMBL3695760,,CHEMBL3695760,7.55,1,http://www.openphacts.org/units/Nanomolar,2572537,=,37,1,=,,IC50,nM,,28.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.028
284524,17666869,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.13', 'le': '0.29', 'lle': '-0.46', 'sei': '24.39'}",CHEMBL3695761,,CHEMBL3695761,8.30,0,http://www.openphacts.org/units/Nanomolar,2572538,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284525,17666870,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N(C)Cc3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.30', 'le': '0.24', 'lle': '-0.25', 'sei': '10.69'}",CHEMBL3695762,,CHEMBL3695762,6.69,0,http://www.openphacts.org/units/Nanomolar,2572539,=,37,1,=,,IC50,nM,,206.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.20600002
284526,17666871,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(S(C)(=O)=O)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.71', 'le': '0.22', 'lle': '0.63', 'sei': '6.29'}",CHEMBL3695763,,CHEMBL3695763,6.64,0,http://www.openphacts.org/units/Nanomolar,2572540,=,37,1,=,,IC50,nM,,230.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.23
284527,17666872,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(OC(F)(F)F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.88', 'le': '0.22', 'lle': '-0.70', 'sei': '8.45'}",CHEMBL3695764,,CHEMBL3695764,6.80,0,http://www.openphacts.org/units/Nanomolar,2572541,=,37,1,=,,IC50,nM,,157.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.157
284528,17666873,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.74', 'le': '0.32', 'lle': '1.22', 'sei': '12.83'}",CHEMBL3695765,,CHEMBL3695765,9.15,0,http://www.openphacts.org/units/Nanomolar,2572542,=,37,1,=,,IC50,nM,,0.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00070000003
284529,17666874,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(I)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.67', 'le': '0.30', 'lle': '1.19', 'sei': '11.77'}",CHEMBL3695766,,CHEMBL3695766,8.40,0,http://www.openphacts.org/units/Nanomolar,2572543,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284530,17666875,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,[C-]#[N+]c1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '14.54', 'le': '0.26', 'lle': '0.32', 'sei': '9.87'}",CHEMBL3695767,,CHEMBL3695767,7.47,0,http://www.openphacts.org/units/Nanomolar,2572544,=,37,1,=,,IC50,nM,,34.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.034
284531,17666876,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(C(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.39', 'le': '0.26', 'lle': '-0.09', 'sei': '10.71'}",CHEMBL3695768,,CHEMBL3695768,7.64,0,http://www.openphacts.org/units/Nanomolar,2572545,=,37,1,=,,IC50,nM,,23.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.023000002
284532,17666877,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(S(C)(=O)=O)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.04', 'le': '0.21', 'lle': '0.25', 'sei': '5.93'}",CHEMBL3695769,,CHEMBL3695769,6.26,0,http://www.openphacts.org/units/Nanomolar,2572546,=,37,1,=,,IC50,nM,,553.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.55300003
284533,17666878,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(N(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.83', 'le': '0.27', 'lle': '1.22', 'sei': '10.58'}",CHEMBL3695770,,CHEMBL3695770,7.89,0,http://www.openphacts.org/units/Nanomolar,2572547,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
284534,17666879,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.84', 'le': '0.28', 'lle': '0.49', 'sei': '11.01'}",CHEMBL3695771,,CHEMBL3695771,7.85,1,http://www.openphacts.org/units/Nanomolar,2572548,=,37,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
284535,17666880,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.34', 'le': '0.21', 'lle': '-1.72', 'sei': '8.66'}",CHEMBL3695772,,CHEMBL3695772,6.18,1,http://www.openphacts.org/units/Nanomolar,2572549,=,37,1,=,,IC50,nM,,667.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.66700006
284536,17666881,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(Cl)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.06', 'le': '0.30', 'lle': '1.14', 'sei': '11.77'}",CHEMBL3695773,,CHEMBL3695773,8.40,0,http://www.openphacts.org/units/Nanomolar,2572550,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284537,17666882,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COC(=O)c1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.91', 'le': '0.29', 'lle': '2.31', 'sei': '8.91'}",CHEMBL3695774,,CHEMBL3695774,8.70,0,http://www.openphacts.org/units/Nanomolar,2572551,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284538,17666883,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(S(N)(=O)=O)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.49', 'le': '0.22', 'lle': '1.27', 'sei': '4.96'}",CHEMBL3695775,,CHEMBL3695775,6.52,0,http://www.openphacts.org/units/Nanomolar,2572552,=,37,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
284539,17666884,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '16.98', 'le': '0.31', 'lle': '1.88', 'sei': '11.23'}",CHEMBL3695776,,CHEMBL3695776,9.05,1,http://www.openphacts.org/units/Nanomolar,2572553,=,37,1,=,,IC50,nM,,0.9,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00090000004
284540,17666885,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c(OC)c1,,,CHEMBL3638687,,2015,"{'bei': '14.21', 'le': '0.26', 'lle': '1.18', 'sei': '8.68'}",CHEMBL3695777,,CHEMBL3695777,7.80,0,http://www.openphacts.org/units/Nanomolar,2572554,=,37,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
284541,17666886,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '14.81', 'le': '0.27', 'lle': '0.72', 'sei': '9.79'}",CHEMBL3695778,,CHEMBL3695778,7.89,0,http://www.openphacts.org/units/Nanomolar,2572555,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
284542,17666887,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc(OC)c1,,,CHEMBL3638687,,2015,"{'bei': '14.58', 'le': '0.27', 'lle': '1.38', 'sei': '8.91'}",CHEMBL3695779,,CHEMBL3695779,8.00,0,http://www.openphacts.org/units/Nanomolar,2572556,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284543,17666888,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '17.46', 'le': '0.32', 'lle': '2.13', 'sei': '11.55'}",CHEMBL3695780,,CHEMBL3695780,9.30,0,http://www.openphacts.org/units/Nanomolar,2572557,=,37,1,=,,IC50,nM,,0.5,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0005
284544,17666889,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1OC,,,CHEMBL3638687,,2015,"{'bei': '12.58', 'le': '0.23', 'lle': '0.28', 'sei': '7.69'}",CHEMBL3695781,,CHEMBL3695781,6.90,0,http://www.openphacts.org/units/Nanomolar,2572558,=,37,1,=,,IC50,nM,,125.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.125
284545,17666890,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)(C)c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '18.00', 'le': '0.33', 'lle': '1.96', 'sei': '13.04'}",CHEMBL3695782,,CHEMBL3695782,9.30,0,http://www.openphacts.org/units/Nanomolar,2572559,=,37,1,=,,IC50,nM,,0.5,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0005
284546,17666891,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc4ccccc4c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695783,,CHEMBL3695783,,0,http://www.openphacts.org/units/Nanomolar,2572560,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284547,17666892,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.55', 'le': '0.25', 'lle': '-0.54', 'sei': '10.20'}",CHEMBL3695784,,CHEMBL3695784,7.28,0,http://www.openphacts.org/units/Nanomolar,2572561,=,37,1,=,,IC50,nM,,53.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.053000003
284548,17666893,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(Br)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.44', 'le': '0.25', 'lle': '-0.69', 'sei': '10.15'}",CHEMBL3695785,,CHEMBL3695785,7.24,0,http://www.openphacts.org/units/Nanomolar,2572562,=,37,1,=,,IC50,nM,,58.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.058000002
284549,17666894,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCC(=O)c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.80', 'le': '0.23', 'lle': '0.33', 'sei': '7.48'}",CHEMBL3695786,,CHEMBL3695786,6.61,0,http://www.openphacts.org/units/Nanomolar,2572563,=,37,1,=,,IC50,nM,,244.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.24400002
284550,17666895,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C#N)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '18.62', 'le': '0.33', 'lle': '1.54', 'sei': '16.03'}",CHEMBL3695787,,CHEMBL3695787,9.27,0,http://www.openphacts.org/units/Nanomolar,2572564,=,37,1,=,,IC50,nM,,0.54,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00054000004
284551,17666896,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C#N)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.15', 'le': '0.27', 'lle': '-0.70', 'sei': '12.79'}",CHEMBL3695788,,CHEMBL3695788,7.40,0,http://www.openphacts.org/units/Nanomolar,2572565,=,37,1,=,,IC50,nM,,40.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.040000003
284552,17666897,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '15.21', 'le': '0.27', 'lle': '1.19', 'sei': '9.29'}",CHEMBL3695789,,CHEMBL3695789,8.22,0,http://www.openphacts.org/units/Nanomolar,2572566,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284553,17666898,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695790,,CHEMBL3695790,,0,http://www.openphacts.org/units/Nanomolar,2572567,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284554,17666899,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695791,,CHEMBL3695791,,0,http://www.openphacts.org/units/Nanomolar,2572568,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284555,17666900,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3O)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695792,,CHEMBL3695792,,0,http://www.openphacts.org/units/Nanomolar,2572569,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284556,17666901,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccc(O)cc3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,"{'bei': '13.27', 'le': '0.24', 'lle': '0.06', 'sei': '6.70'}",CHEMBL3695793,,CHEMBL3695793,6.52,0,http://www.openphacts.org/units/Nanomolar,2572570,=,37,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
284557,17666902,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695794,,CHEMBL3695794,,0,http://www.openphacts.org/units/Nanomolar,2572571,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284558,17666903,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CSc1ccc(-c2ccc(Cn3ccc4cc(C(=O)N[C@@H](C)c5ccc([N+](=O)[O-])cc5)ccc43)cc2)cc1,,,CHEMBL3638687,,2015,,CHEMBL3695795,,CHEMBL3695795,,0,http://www.openphacts.org/units/Nanomolar,2572572,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284559,17666904,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3cccc(N)c3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695796,,CHEMBL3695796,,0,http://www.openphacts.org/units/Nanomolar,2572573,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284560,17666905,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3cccc(CN)c3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695797,,CHEMBL3695797,,0,http://www.openphacts.org/units/Nanomolar,2572574,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284561,17666906,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3CO)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695798,,CHEMBL3695798,,0,http://www.openphacts.org/units/Nanomolar,2572575,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284562,17666907,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3C(=O)OC(C)(C)C)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695799,,CHEMBL3695799,,0,http://www.openphacts.org/units/Nanomolar,2572576,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284563,17666908,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(-c2ccc(Cn3ccc4cc(C(=O)N[C@@H](C)c5ccc([N+](=O)[O-])cc5)ccc43)cc2)cc1,,,CHEMBL3638687,,2015,,CHEMBL3695800,,CHEMBL3695800,,0,http://www.openphacts.org/units/Nanomolar,2572577,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284564,17666909,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3cccc(Cl)c3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695801,,CHEMBL3695801,,0,http://www.openphacts.org/units/Nanomolar,2572578,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284565,17666910,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccc(C(=O)O)cc3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695802,,CHEMBL3695802,,0,http://www.openphacts.org/units/Nanomolar,2572579,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284566,17666911,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3cccc(C(=O)O)c3)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,,CHEMBL3695803,,CHEMBL3695803,,0,http://www.openphacts.org/units/Nanomolar,2572580,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284567,17666912,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3C(=O)O)cc2)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638687,,2015,"{'bei': '11.91', 'le': '0.22', 'lle': '-0.26', 'sei': '5.41'}",CHEMBL3695804,,CHEMBL3695804,6.19,0,http://www.openphacts.org/units/Nanomolar,2572581,=,37,1,=,,IC50,nM,,646.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.646
284568,17666913,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3cccnc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.52', 'le': '0.25', 'lle': '0.05', 'sei': '7.58'}",CHEMBL3695805,,CHEMBL3695805,6.82,0,http://www.openphacts.org/units/Nanomolar,2572582,=,37,1,=,,IC50,nM,,150.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.15
284569,17666914,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2cccc(-c3ccccc3C(=O)O)c2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '16.83', 'le': '0.30', 'lle': '1.28', 'sei': '11.53'}",CHEMBL3695806,,CHEMBL3695806,8.22,0,http://www.openphacts.org/units/Nanomolar,2572583,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284570,17666915,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2cccc(-c3ccc(C(=O)O)cc3)c2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.80', 'le': '0.32', 'lle': '1.76', 'sei': '12.20'}",CHEMBL3695807,,CHEMBL3695807,8.70,0,http://www.openphacts.org/units/Nanomolar,2572584,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284571,17666916,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2ccccc2C(=O)O)c1)c1ccccc1,,,CHEMBL3638687,,2015,,CHEMBL3695808,,CHEMBL3695808,,0,http://www.openphacts.org/units/Nanomolar,2572585,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284572,17666917,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2cccc(C(=O)O)c2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.19', 'le': '0.31', 'lle': '1.46', 'sei': '11.77'}",CHEMBL3695809,,CHEMBL3695809,8.40,0,http://www.openphacts.org/units/Nanomolar,2572586,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284573,17666918,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2ccc(C(=O)O)cc2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '16.37', 'le': '0.30', 'lle': '1.06', 'sei': '11.22'}",CHEMBL3695810,,CHEMBL3695810,8.00,0,http://www.openphacts.org/units/Nanomolar,2572587,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284574,17666919,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.89', 'le': '0.29', 'lle': '1.63', 'sei': '7.60'}",CHEMBL3695811,,CHEMBL3695811,8.70,1,http://www.openphacts.org/units/Nanomolar,2572588,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284575,17666920,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.96', 'le': '0.24', 'lle': '0.03', 'sei': '6.20'}",CHEMBL3348830,,CHEMBL3348830,7.10,1,http://www.openphacts.org/units/Nanomolar,2572589,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284576,17666921,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC[C@H](C)c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.78', 'le': '0.25', 'lle': '-0.09', 'sei': '9.98'}",CHEMBL3695812,,CHEMBL3695812,7.12,0,http://www.openphacts.org/units/Nanomolar,2572590,=,37,1,=,,IC50,nM,,76.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.076000005
284577,17666922,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(c3ccccc3)c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.43', 'le': '0.24', 'lle': '-0.60', 'sei': '10.63'}",CHEMBL3695813,,CHEMBL3695813,7.58,1,http://www.openphacts.org/units/Nanomolar,2572591,=,37,1,=,,IC50,nM,,26.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.026
284578,17666923,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.39', 'le': '0.30', 'lle': '1.56', 'sei': '11.64'}",CHEMBL3695814,,CHEMBL3695814,8.30,0,http://www.openphacts.org/units/Nanomolar,2572592,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284579,17666924,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(F)c(F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.31', 'le': '0.26', 'lle': '0.63', 'sei': '10.53'}",CHEMBL3695815,,CHEMBL3695815,7.51,0,http://www.openphacts.org/units/Nanomolar,2572593,=,37,1,=,,IC50,nM,,31.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.031000001
284580,17666925,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc4c(c3)OCO4)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.05', 'le': '0.26', 'lle': '1.15', 'sei': '8.33'}",CHEMBL3695816,,CHEMBL3695816,7.48,0,http://www.openphacts.org/units/Nanomolar,2572594,=,37,1,=,,IC50,nM,,33.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.033
284581,17666926,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](CO)c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.33', 'le': '0.26', 'lle': '1.29', 'sei': '8.12'}",CHEMBL3695817,,CHEMBL3695817,7.43,0,http://www.openphacts.org/units/Nanomolar,2572595,=,37,1,=,,IC50,nM,,37.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.037
284582,17666927,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(N)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.66', 'le': '0.28', 'lle': '1.71', 'sei': '8.10'}",CHEMBL3695818,,CHEMBL3695818,7.89,0,http://www.openphacts.org/units/Nanomolar,2572596,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
284583,17666928,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCC3CCCCC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.37', 'le': '0.26', 'lle': '0.13', 'sei': '9.96'}",CHEMBL3695819,,CHEMBL3695819,7.11,1,http://www.openphacts.org/units/Nanomolar,2572597,=,37,1,=,,IC50,nM,,78.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.078
284584,17666929,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(CN)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695820,,CHEMBL3695820,,0,http://www.openphacts.org/units/Nanomolar,2572598,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284585,17666930,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccs3)cc12,,,CHEMBL3638687,,2015,"{'bei': '18.20', 'le': '0.34', 'lle': '2.34', 'sei': '12.62'}",CHEMBL3695821,,CHEMBL3695821,9.00,1,http://www.openphacts.org/units/Nanomolar,2572599,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284586,17666931,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)o1,,,CHEMBL3638687,,2015,"{'bei': '16.08', 'le': '0.29', 'lle': '1.42', 'sei': '9.38'}",CHEMBL3695822,,CHEMBL3695822,7.92,0,http://www.openphacts.org/units/Nanomolar,2572600,=,37,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
284587,17666932,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCCN3CCOCC3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695823,,CHEMBL3695823,,0,http://www.openphacts.org/units/Nanomolar,2572601,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284588,17666933,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC3COc4ccccc4C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.08', 'le': '0.27', 'lle': '1.59', 'sei': '9.93'}",CHEMBL3699442,,CHEMBL3699442,8.00,0,http://www.openphacts.org/units/Nanomolar,2576588,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284589,17666934,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCC3COc4ccccc4C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.27', 'le': '0.26', 'lle': '1.12', 'sei': '9.64'}",CHEMBL3695824,,CHEMBL3695824,7.77,0,http://www.openphacts.org/units/Nanomolar,2572602,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284590,17666935,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCC3COc4ccccc4O3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.56', 'le': '0.27', 'lle': '1.72', 'sei': '8.86'}",CHEMBL3695825,,CHEMBL3695825,7.96,0,http://www.openphacts.org/units/Nanomolar,2572603,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284591,17666936,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC3CCC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.56', 'le': '0.30', 'lle': '1.54', 'sei': '10.51'}",CHEMBL3695826,,CHEMBL3695826,7.50,1,http://www.openphacts.org/units/Nanomolar,2572604,=,37,1,=,,IC50,nM,,32.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.032
284592,17666937,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC3CCCC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.29', 'le': '0.30', 'lle': '1.26', 'sei': '10.66'}",CHEMBL3695827,,CHEMBL3695827,7.60,0,http://www.openphacts.org/units/Nanomolar,2572605,=,37,1,=,,IC50,nM,,25.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.025
284593,17666938,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COCCNC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '17.02', 'le': '0.31', 'lle': '2.72', 'sei': '9.64'}",CHEMBL3695828,,CHEMBL3695828,7.77,0,http://www.openphacts.org/units/Nanomolar,2572606,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284594,17666939,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '18.42', 'le': '0.33', 'lle': '2.40', 'sei': '12.62'}",CHEMBL602469,,CHEMBL602469,9.00,1,http://www.openphacts.org/units/Nanomolar,2576589,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284595,17666940,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3N)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.88', 'le': '0.27', 'lle': '1.31', 'sei': '7.70'}",CHEMBL3695829,,CHEMBL3695829,7.50,1,http://www.openphacts.org/units/Nanomolar,2572607,=,37,1,=,,IC50,nM,,32.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.032
284596,17666941,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(N)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.68', 'le': '0.30', 'lle': '2.22', 'sei': '8.63'}",CHEMBL3695830,,CHEMBL3695830,8.40,0,http://www.openphacts.org/units/Nanomolar,2572608,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284597,17666942,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.91', 'le': '0.25', 'lle': '0.91', 'sei': '6.48'}",CHEMBL3695831,,CHEMBL3695831,7.42,1,http://www.openphacts.org/units/Nanomolar,2572609,=,37,1,=,,IC50,nM,,38.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.038000003
284598,17666943,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '19.36', 'le': '0.35', 'lle': '2.45', 'sei': '14.02'}",CHEMBL3695832,,CHEMBL3695832,10.00,0,http://www.openphacts.org/units/Nanomolar,2572610,=,37,1,=,,IC50,nM,,0.1,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.000100000005
284599,17666944,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '16.50', 'le': '0.30', 'lle': '0.97', 'sei': '11.95'}",CHEMBL1230353,,CHEMBL1230353,8.52,1,http://www.openphacts.org/units/Nanomolar,2572611,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284600,17666945,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(N)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.79', 'le': '0.23', 'lle': '-0.12', 'sei': '6.80'}",CHEMBL3695833,,CHEMBL3695833,6.62,0,http://www.openphacts.org/units/Nanomolar,2572612,=,37,1,=,,IC50,nM,,240.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.24000001
284601,17666946,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(C(F)(F)F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.07', 'le': '0.22', 'lle': '-0.90', 'sei': '9.42'}",CHEMBL3695834,,CHEMBL3695834,6.72,0,http://www.openphacts.org/units/Nanomolar,2572613,=,37,1,=,,IC50,nM,,191.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.19100001
284602,17666947,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(C(F)(F)F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.01', 'le': '0.22', 'lle': '-0.94', 'sei': '9.37'}",CHEMBL3695835,,CHEMBL3695835,6.68,0,http://www.openphacts.org/units/Nanomolar,2572614,=,37,1,=,,IC50,nM,,208.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.208
284603,17666948,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccc(-c4ccccc4)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.70', 'le': '0.21', 'lle': '-1.66', 'sei': '9.26'}",CHEMBL3695836,,CHEMBL3695836,6.61,0,http://www.openphacts.org/units/Nanomolar,2572615,=,37,1,=,,IC50,nM,,247.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.24700001
284604,17666949,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '16.19', 'le': '0.29', 'lle': '1.79', 'sei': '10.42'}",CHEMBL3695837,,CHEMBL3695837,8.40,1,http://www.openphacts.org/units/Nanomolar,2572616,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284605,17666950,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.72', 'le': '0.29', 'lle': '1.54', 'sei': '10.12'}",CHEMBL3695838,,CHEMBL3695838,8.15,0,http://www.openphacts.org/units/Nanomolar,2572617,=,37,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
284606,17666951,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '16.52', 'le': '0.30', 'lle': '1.39', 'sei': '11.64'}",CHEMBL3695839,,CHEMBL3695839,8.30,1,http://www.openphacts.org/units/Nanomolar,2572618,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284607,17666952,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '16.71', 'le': '0.30', 'lle': '1.49', 'sei': '11.77'}",CHEMBL3695840,,CHEMBL3695840,8.40,1,http://www.openphacts.org/units/Nanomolar,2572619,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284608,17666953,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CNC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '16.36', 'le': '0.30', 'lle': '1.31', 'sei': '11.53'}",CHEMBL3695841,,CHEMBL3695841,8.22,1,http://www.openphacts.org/units/Nanomolar,2572620,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284609,17666954,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.72', 'le': '0.30', 'lle': '0.96', 'sei': '11.53'}",CHEMBL3695842,,CHEMBL3695842,8.22,0,http://www.openphacts.org/units/Nanomolar,2572621,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284610,17666955,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc(Cl)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.63', 'le': '0.31', 'lle': '1.44', 'sei': '12.20'}",CHEMBL3639947,,CHEMBL3639947,8.70,0,http://www.openphacts.org/units/Nanomolar,2572622,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284611,17666956,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc([N+](=O)[O-])c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.43', 'le': '0.26', 'lle': '1.19', 'sei': '6.73'}",CHEMBL3695843,,CHEMBL3695843,7.70,1,http://www.openphacts.org/units/Nanomolar,2572623,=,37,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
284612,17666957,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1F,,,CHEMBL3638687,,2015,"{'bei': '14.70', 'le': '0.27', 'lle': '1.14', 'sei': '9.79'}",CHEMBL3695844,,CHEMBL3695844,7.89,0,http://www.openphacts.org/units/Nanomolar,2572624,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
284613,17666958,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.75', 'le': '0.27', 'lle': '0.38', 'sei': '10.76'}",CHEMBL3695845,,CHEMBL3695845,7.68,1,http://www.openphacts.org/units/Nanomolar,2572625,=,37,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
284614,17666959,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '17.47', 'le': '0.32', 'lle': '1.80', 'sei': '12.75'}",CHEMBL3695846,,CHEMBL3695846,9.10,1,http://www.openphacts.org/units/Nanomolar,2572626,=,37,1,=,,IC50,nM,,0.8,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00080000004
284615,17666960,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.14', 'le': '0.31', 'lle': '1.16', 'sei': '12.75'}",CHEMBL3695847,,CHEMBL3695847,9.10,0,http://www.openphacts.org/units/Nanomolar,2572627,=,37,1,=,,IC50,nM,,0.8,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00080000004
284616,17666961,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3cccc4ccccc34)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.36', 'le': '0.24', 'lle': '-0.56', 'sei': '10.09'}",CHEMBL3695848,,CHEMBL3695848,7.19,0,http://www.openphacts.org/units/Nanomolar,2572628,=,37,1,=,,IC50,nM,,64.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.064
284617,17666962,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)c3cccc4ccccc34)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.74', 'le': '0.28', 'lle': '0.38', 'sei': '12.20'}",CHEMBL3695849,,CHEMBL3695849,8.70,0,http://www.openphacts.org/units/Nanomolar,2572629,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284618,17666963,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)CCc3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.06', 'le': '0.29', 'lle': '1.10', 'sei': '11.95'}",CHEMBL3695850,,CHEMBL3695850,8.52,0,http://www.openphacts.org/units/Nanomolar,2572630,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284619,17666964,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3Br)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.69', 'le': '0.28', 'lle': '0.41', 'sei': '10.89'}",CHEMBL3695851,,CHEMBL3695851,7.77,0,http://www.openphacts.org/units/Nanomolar,2572631,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284620,17666965,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NCc3ccccc3[N+](=O)[O-])cc12,,,CHEMBL3638687,,2015,"{'bei': '14.28', 'le': '0.26', 'lle': '1.11', 'sei': '6.66'}",CHEMBL3695852,,CHEMBL3695852,7.62,1,http://www.openphacts.org/units/Nanomolar,2572632,=,37,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
284621,17666966,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccccc1-c1cccc(C(=O)O)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '13.56', 'le': '0.25', 'lle': '-0.55', 'sei': '9.82'}",CHEMBL3695853,,CHEMBL3695853,7.00,0,http://www.openphacts.org/units/Nanomolar,2572633,=,37,1,=,,IC50,nM,,99.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.09900001
284622,17666967,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3C(=O)O)cc2)c1)c1ccc(Br)cc1,,,CHEMBL3638687,,2015,"{'bei': '12.26', 'le': '0.25', 'lle': '-0.52', 'sei': '9.52'}",CHEMBL3695854,,CHEMBL3695854,6.79,0,http://www.openphacts.org/units/Nanomolar,2572634,=,37,1,=,,IC50,nM,,163.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.163
284623,17666968,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccc(-c3ccccc3C(=O)O)cc2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '16.83', 'le': '0.30', 'lle': '1.28', 'sei': '11.53'}",CHEMBL3695855,,CHEMBL3695855,8.22,0,http://www.openphacts.org/units/Nanomolar,2572635,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284624,17666969,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.43', 'le': '0.27', 'lle': '0.00', 'sei': '10.68'}",CHEMBL3695856,,CHEMBL3695856,7.62,0,http://www.openphacts.org/units/Nanomolar,2572636,=,37,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
284625,17666970,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)cn2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.31', 'le': '0.31', 'lle': '1.46', 'sei': '12.20'}",CHEMBL3695857,,CHEMBL3695857,8.70,0,http://www.openphacts.org/units/Nanomolar,2572637,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284626,17666971,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.93', 'le': '0.24', 'lle': '0.14', 'sei': '6.03'}",CHEMBL3695858,,CHEMBL3695858,6.90,0,http://www.openphacts.org/units/Nanomolar,2572638,=,37,1,=,,IC50,nM,,126.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.126
284627,17666972,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2cc(C(=O)N[C@@H](C)c3ccc(Br)cc3)ccc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '12.51', 'le': '0.26', 'lle': '-0.52', 'sei': '9.95'}",CHEMBL3695859,,CHEMBL3695859,7.10,0,http://www.openphacts.org/units/Nanomolar,2572639,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284628,17666973,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)cc(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.31', 'le': '0.31', 'lle': '1.46', 'sei': '12.20'}",CHEMBL602263,,CHEMBL602263,8.70,0,http://www.openphacts.org/units/Nanomolar,2576590,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284629,17666974,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.03', 'le': '0.27', 'lle': '-1.07', 'sei': '22.11'}",CHEMBL3695860,,CHEMBL3695860,7.52,0,http://www.openphacts.org/units/Nanomolar,2572640,=,37,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
284630,17666975,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.96', 'le': '0.25', 'lle': '-1.57', 'sei': '21.12'}",CHEMBL3695861,,CHEMBL3695861,7.19,0,http://www.openphacts.org/units/Nanomolar,2572641,=,37,1,=,,IC50,nM,,65.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.065000005
284631,17666976,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](c3cccc(C(C)C)c3)C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.01', 'le': '0.26', 'lle': '-1.36', 'sei': '22.83'}",CHEMBL3695862,,CHEMBL3695862,7.77,0,http://www.openphacts.org/units/Nanomolar,2572642,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284632,17666977,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](c3cccc(C(C)C)c3)C3CC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.37', 'le': '0.28', 'lle': '-0.88', 'sei': '23.79'}",CHEMBL3695863,,CHEMBL3695863,8.10,0,http://www.openphacts.org/units/Nanomolar,2572643,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284633,17666978,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3c(Cl)cccc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.26', 'le': '0.28', 'lle': '-1.25', 'sei': '22.11'}",CHEMBL3695864,,CHEMBL3695864,7.52,0,http://www.openphacts.org/units/Nanomolar,2572644,=,37,1,=,,IC50,nM,,30.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.030000001
284634,17666979,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3c(Cl)cccc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.82', 'le': '0.27', 'lle': '-1.48', 'sei': '21.43'}",CHEMBL3695865,,CHEMBL3695865,7.29,0,http://www.openphacts.org/units/Nanomolar,2572645,=,37,1,=,,IC50,nM,,51.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.051000003
284635,17666980,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc4c3OCO4)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.92', 'le': '0.29', 'lle': '0.81', 'sei': '15.24'}",CHEMBL3695866,,CHEMBL3695866,8.00,0,http://www.openphacts.org/units/Nanomolar,2572646,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284636,17666981,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccn3)cc12,,,CHEMBL3638687,,2015,"{'bei': '18.93', 'le': '0.34', 'lle': '1.84', 'sei': '18.54'}",CHEMBL3695867,,CHEMBL3695867,8.70,0,http://www.openphacts.org/units/Nanomolar,2572647,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284637,17666982,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(F)cccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2)cc1,,,CHEMBL3638687,,2015,,CHEMBL3695868,,CHEMBL3695868,,0,http://www.openphacts.org/units/Nanomolar,2572648,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284638,17666983,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(F)cc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '15.63', 'le': '0.28', 'lle': '0.31', 'sei': '18.31'}",CHEMBL3695869,,CHEMBL3695869,7.92,0,http://www.openphacts.org/units/Nanomolar,2572649,=,37,1,=,,IC50,nM,,12.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.012
284639,17666984,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(OC)cc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '14.84', 'le': '0.27', 'lle': '0.22', 'sei': '14.67'}",CHEMBL3695870,,CHEMBL3695870,7.70,0,http://www.openphacts.org/units/Nanomolar,2572650,=,37,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
284640,17666985,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccncc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.95', 'le': '0.28', 'lle': '-0.12', 'sei': '15.74'}",CHEMBL3695871,,CHEMBL3695871,7.39,0,http://www.openphacts.org/units/Nanomolar,2572651,=,37,1,=,,IC50,nM,,41.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.041
284641,17666986,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccnc4ccccc34)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.13', 'le': '0.29', 'lle': '0.21', 'sei': '17.52'}",CHEMBL3695872,,CHEMBL3695872,8.22,0,http://www.openphacts.org/units/Nanomolar,2572652,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284642,17666987,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(F)cc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.78', 'le': '0.31', 'lle': '0.56', 'sei': '24.39'}",CHEMBL3695873,,CHEMBL3695873,8.30,0,http://www.openphacts.org/units/Nanomolar,2572653,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284643,17666988,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '15.27', 'le': '0.28', 'lle': '-0.18', 'sei': '17.75'}",CHEMBL3695874,,CHEMBL3695874,7.68,0,http://www.openphacts.org/units/Nanomolar,2572654,=,37,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
284644,17666989,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc4ccccc34)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.96', 'le': '0.23', 'lle': '-2.03', 'sei': '19.37'}",CHEMBL3695875,,CHEMBL3695875,6.59,0,http://www.openphacts.org/units/Nanomolar,2572655,=,37,1,=,,IC50,nM,,256.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.256
284645,17666990,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.92', 'le': '0.26', 'lle': '-0.81', 'sei': '17.46'}",CHEMBL3695876,,CHEMBL3695876,7.55,0,http://www.openphacts.org/units/Nanomolar,2572656,=,37,1,=,,IC50,nM,,28.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.028
284646,17666991,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.70', 'le': '0.25', 'lle': '-1.27', 'sei': '21.20'}",CHEMBL3695877,,CHEMBL3695877,7.21,0,http://www.openphacts.org/units/Nanomolar,2572657,=,37,1,=,,IC50,nM,,61.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.061000004
284647,17666992,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](CC(C)C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.89', 'le': '0.20', 'lle': '-3.70', 'sei': '17.38'}",CHEMBL3695878,,CHEMBL3695878,5.91,0,http://www.openphacts.org/units/Nanomolar,2572658,=,37,1,=,,IC50,nM,,1222.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.222
284648,17666993,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](c3cccc(C(C)C)c3)C(C)C)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695879,,CHEMBL3695879,,0,http://www.openphacts.org/units/Nanomolar,2572659,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284649,17666994,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](c3cccc(C(C)C)c3)C(C)C)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.42', 'le': '0.24', 'lle': '-2.12', 'sei': '20.85'}",CHEMBL3695880,,CHEMBL3695880,7.10,0,http://www.openphacts.org/units/Nanomolar,2572660,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284650,17666995,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.99', 'le': '0.31', 'lle': '0.50', 'sei': '23.79'}",CHEMBL3695881,,CHEMBL3695881,8.10,0,http://www.openphacts.org/units/Nanomolar,2572661,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284651,17666996,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3Cl)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695882,,CHEMBL3695882,,0,http://www.openphacts.org/units/Nanomolar,2572662,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284652,17666997,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '17.11', 'le': '0.31', 'lle': '0.55', 'sei': '23.96'}",CHEMBL3695883,,CHEMBL3695883,8.15,0,http://www.openphacts.org/units/Nanomolar,2572663,=,37,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
284653,17666998,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc([C@@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '17.80', 'le': '0.32', 'lle': '1.23', 'sei': '20.11'}",CHEMBL3695884,,CHEMBL3695884,8.70,0,http://www.openphacts.org/units/Nanomolar,2572664,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284654,17666999,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(Cl)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695885,,CHEMBL3695885,,0,http://www.openphacts.org/units/Nanomolar,2572665,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284655,17667000,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.17', 'le': '0.29', 'lle': '-0.49', 'sei': '23.79'}",CHEMBL3695886,,CHEMBL3695886,8.10,0,http://www.openphacts.org/units/Nanomolar,2572666,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284656,17667001,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)NCc3ccc(F)cc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.07', 'le': '0.29', 'lle': '0.54', 'sei': '22.69'}",CHEMBL3695887,,CHEMBL3695887,7.72,0,http://www.openphacts.org/units/Nanomolar,2572667,=,37,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
284657,17667002,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)NCc3ccc(Cl)cc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.90', 'le': '0.30', 'lle': '0.12', 'sei': '25.56'}",CHEMBL3695888,,CHEMBL3695888,8.70,0,http://www.openphacts.org/units/Nanomolar,2572668,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284658,17667003,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695889,,CHEMBL3695889,,0,http://www.openphacts.org/units/Nanomolar,2572669,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284659,17667004,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3ccncc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '17.32', 'le': '0.31', 'lle': '1.10', 'sei': '16.96'}",CHEMBL3695890,,CHEMBL3695890,7.96,0,http://www.openphacts.org/units/Nanomolar,2572670,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284660,17667005,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(F)c3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.43', 'le': '0.31', 'lle': '0.14', 'sei': '24.68'}",CHEMBL3695891,,CHEMBL3695891,8.40,0,http://www.openphacts.org/units/Nanomolar,2572671,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284661,17667006,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(Cl)c3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.74', 'le': '0.31', 'lle': '-0.47', 'sei': '24.39'}",CHEMBL3695892,,CHEMBL3695892,8.30,0,http://www.openphacts.org/units/Nanomolar,2572672,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284662,17667007,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(C(F)(F)F)ccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.53', 'le': '0.26', 'lle': '-1.45', 'sei': '23.64'}",CHEMBL3695893,,CHEMBL3695893,8.05,0,http://www.openphacts.org/units/Nanomolar,2572673,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
284663,17667008,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cc(C(F)(F)F)ccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.12', 'le': '0.27', 'lle': '-1.10', 'sei': '24.68'}",CHEMBL3695894,,CHEMBL3695894,8.40,0,http://www.openphacts.org/units/Nanomolar,2572674,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284664,17667009,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(Cl)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '17.29', 'le': '0.32', 'lle': '0.40', 'sei': '25.05'}",CHEMBL3695895,,CHEMBL3695895,8.52,0,http://www.openphacts.org/units/Nanomolar,2572675,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284665,17667010,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.95', 'le': '0.29', 'lle': '0.33', 'sei': '18.02'}",CHEMBL3695896,,CHEMBL3695896,7.80,0,http://www.openphacts.org/units/Nanomolar,2572676,=,37,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
284666,17667011,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(F)(F)F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.07', 'le': '0.26', 'lle': '-1.07', 'sei': '21.77'}",CHEMBL3695897,,CHEMBL3695897,7.41,0,http://www.openphacts.org/units/Nanomolar,2572677,=,37,1,=,,IC50,nM,,39.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.039
284667,17667012,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(F)cccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.15', 'le': '0.28', 'lle': '0.07', 'sei': '17.75'}",CHEMBL3695898,,CHEMBL3695898,7.68,0,http://www.openphacts.org/units/Nanomolar,2572678,=,37,1,=,,IC50,nM,,21.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.021000002
284668,17667013,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2)cc1)c1cccc(C(C)C)c1,,,CHEMBL3638687,,2015,"{'bei': '13.07', 'le': '0.24', 'lle': '-2.67', 'sei': '20.84'}",CHEMBL3695899,,CHEMBL3695899,7.09,0,http://www.openphacts.org/units/Nanomolar,2572679,=,37,1,=,,IC50,nM,,81.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.081
284669,17667014,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '16.69', 'le': '0.30', 'lle': '0.12', 'sei': '23.17'}",CHEMBL3695900,,CHEMBL3695900,7.89,0,http://www.openphacts.org/units/Nanomolar,2572680,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
284670,17667015,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)NC(C)(C)c3ccc(Br)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.32', 'le': '0.33', 'lle': '0.60', 'sei': '26.45'}",CHEMBL3695901,,CHEMBL3695901,9.00,0,http://www.openphacts.org/units/Nanomolar,2572681,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284671,17667016,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3ccnc4ccccc34)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.34', 'le': '0.22', 'lle': '-1.72', 'sei': '13.41'}",CHEMBL3695902,,CHEMBL3695902,6.29,0,http://www.openphacts.org/units/Nanomolar,2572682,=,37,1,=,,IC50,nM,,512.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.512
284672,17667017,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)NCc3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '17.06', 'le': '0.31', 'lle': '0.27', 'sei': '24.39'}",CHEMBL3695903,,CHEMBL3695903,8.30,0,http://www.openphacts.org/units/Nanomolar,2572683,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284673,17667018,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](Cc3ccccc3)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.16', 'le': '0.22', 'lle': '-2.80', 'sei': '20.61'}",CHEMBL3695904,,CHEMBL3695904,7.01,0,http://www.openphacts.org/units/Nanomolar,2572684,=,37,1,=,,IC50,nM,,97.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.097
284674,17667019,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(Br)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3695905,,CHEMBL3695905,,0,http://www.openphacts.org/units/Nanomolar,2572685,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284675,17667020,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.12', 'le': '0.25', 'lle': '0.48', 'sei': '9.04'}",CHEMBL3695906,,CHEMBL3695906,8.00,0,http://www.openphacts.org/units/Nanomolar,2572686,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284676,17667021,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2ccc(C(=O)O)cc2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '14.33', 'le': '0.26', 'lle': '0.06', 'sei': '9.81'}",CHEMBL3695907,,CHEMBL3695907,7.00,0,http://www.openphacts.org/units/Nanomolar,2572687,=,37,1,=,,IC50,nM,,100.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.1
284677,17667022,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2ccc(C(=O)O)cc2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '16.99', 'le': '0.31', 'lle': '1.36', 'sei': '11.64'}",CHEMBL3695908,,CHEMBL3695908,8.30,0,http://www.openphacts.org/units/Nanomolar,2572688,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284678,17667023,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2cccc(C(=O)O)c2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '14.53', 'le': '0.26', 'lle': '0.16', 'sei': '9.95'}",CHEMBL3695909,,CHEMBL3695909,7.10,0,http://www.openphacts.org/units/Nanomolar,2572689,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284679,17667024,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(ccn2Cc2ccccc2-c2cccc(C(=O)O)c2)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '17.19', 'le': '0.31', 'lle': '1.46', 'sei': '11.77'}",CHEMBL3695910,,CHEMBL3695910,8.40,0,http://www.openphacts.org/units/Nanomolar,2572690,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284680,17667025,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccccc1-c1cccc(C(=O)O)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '14.90', 'le': '0.27', 'lle': '0.15', 'sei': '10.79'}",CHEMBL3695911,,CHEMBL3695911,7.70,0,http://www.openphacts.org/units/Nanomolar,2572691,=,37,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
284681,17667026,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccccc1-c1cccc(C(=O)O)c1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '13.74', 'le': '0.25', 'lle': '-0.45', 'sei': '9.95'}",CHEMBL3695912,,CHEMBL3695912,7.10,0,http://www.openphacts.org/units/Nanomolar,2572692,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284682,17667027,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccccc1-c1ccc(C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,"{'bei': '13.74', 'le': '0.25', 'lle': '-0.45', 'sei': '9.95'}",CHEMBL3695913,,CHEMBL3695913,7.10,0,http://www.openphacts.org/units/Nanomolar,2572693,=,37,1,=,,IC50,nM,,80.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.080000006
284683,17667028,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccccc1-c1ccc(C(=O)O)cc1)c1ccccc1,,,CHEMBL3638687,,2015,,CHEMBL3695914,,CHEMBL3695914,,0,http://www.openphacts.org/units/Nanomolar,2572694,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284684,17667029,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1Cl,,,CHEMBL3638687,,2015,"{'bei': '13.70', 'le': '0.26', 'lle': '-0.05', 'sei': '9.64'}",CHEMBL3695915,,CHEMBL3695915,7.77,0,http://www.openphacts.org/units/Nanomolar,2572695,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284685,17667030,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H](NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1)c1cccc(C(C)C)c1,,,CHEMBL3638687,,2015,"{'bei': '14.40', 'le': '0.26', 'lle': '-0.63', 'sei': '11.28'}",CHEMBL3695916,,CHEMBL3695916,8.05,1,http://www.openphacts.org/units/Nanomolar,2572696,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
284686,17667031,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(OC(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.77', 'le': '0.25', 'lle': '-0.23', 'sei': '9.58'}",CHEMBL3699345,,CHEMBL3699345,7.72,0,http://www.openphacts.org/units/Nanomolar,2576490,=,37,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
284687,17667032,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(OC(C)(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.04', 'le': '0.20', 'lle': '-1.99', 'sei': '7.88'}",CHEMBL3699346,,CHEMBL3699346,6.35,0,http://www.openphacts.org/units/Nanomolar,2576491,=,37,1,=,,IC50,nM,,449.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.44900003
284688,17667033,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(OC(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.32', 'le': '0.24', 'lle': '-0.48', 'sei': '9.27'}",CHEMBL3699347,,CHEMBL3699347,7.47,0,http://www.openphacts.org/units/Nanomolar,2576492,=,37,1,=,,IC50,nM,,34.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.034
284689,17667034,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)C3CCN(C(=O)OCc4ccccc4)CC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.58', 'le': '0.21', 'lle': '-0.38', 'sei': '7.39'}",CHEMBL3699348,,CHEMBL3699348,7.46,0,http://www.openphacts.org/units/Nanomolar,2576493,=,37,1,=,,IC50,nM,,35.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.035
284690,17667035,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)C3CCN(C(=O)NCc4ccccc4)CC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '9.48', 'le': '0.17', 'lle': '-1.32', 'sei': '5.88'}",CHEMBL3699349,,CHEMBL3699349,6.09,0,http://www.openphacts.org/units/Nanomolar,2576494,=,37,1,=,,IC50,nM,,805.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.80500007
284691,17667036,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H]3CCN(C(=O)OCc4ccccc4)C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.42', 'le': '0.19', 'lle': '-0.54', 'sei': '6.22'}",CHEMBL3699350,,CHEMBL3699350,6.27,0,http://www.openphacts.org/units/Nanomolar,2576495,=,37,1,=,,IC50,nM,,536.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.536
284692,17667037,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)cc1[C@@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.08', 'le': '0.28', 'lle': '0.99', 'sei': '10.30'}",CHEMBL3699351,,CHEMBL3699351,8.30,0,http://www.openphacts.org/units/Nanomolar,2576496,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284693,17667038,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(F)cc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '13.78', 'le': '0.25', 'lle': '0.28', 'sei': '9.42'}",CHEMBL3699352,,CHEMBL3699352,7.58,0,http://www.openphacts.org/units/Nanomolar,2576497,=,37,1,=,,IC50,nM,,26.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.026
284694,17667039,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.77', 'le': '0.29', 'lle': '0.82', 'sei': '12.62'}",CHEMBL3699353,,CHEMBL3699353,9.00,0,http://www.openphacts.org/units/Nanomolar,2576498,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284695,17667040,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.42', 'le': '0.25', 'lle': '-0.52', 'sei': '10.74'}",CHEMBL3699354,,CHEMBL3699354,7.66,0,http://www.openphacts.org/units/Nanomolar,2576499,=,37,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
284696,17667041,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(C(F)(F)F)cc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.46', 'le': '0.24', 'lle': '-1.24', 'sei': '11.16'}",CHEMBL3699355,,CHEMBL3699355,7.96,0,http://www.openphacts.org/units/Nanomolar,2576500,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284697,17667042,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.36', 'le': '0.20', 'lle': '-2.58', 'sei': '9.28'}",CHEMBL3699356,,CHEMBL3699356,6.62,0,http://www.openphacts.org/units/Nanomolar,2576501,=,37,1,=,,IC50,nM,,241.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.24100001
284698,17667043,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(F)c([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '15.38', 'le': '0.28', 'lle': '0.61', 'sei': '11.53'}",CHEMBL3699357,,CHEMBL3699357,8.22,0,http://www.openphacts.org/units/Nanomolar,2576502,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284699,17667044,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)C3CCCCC3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.51', 'le': '0.30', 'lle': '1.03', 'sei': '11.77'}",CHEMBL3699358,,CHEMBL3699358,8.40,0,http://www.openphacts.org/units/Nanomolar,2576503,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284700,17667045,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)C3COc4ccccc4O3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.20', 'le': '0.28', 'lle': '1.89', 'sei': '9.49'}",CHEMBL3699359,,CHEMBL3699359,8.52,0,http://www.openphacts.org/units/Nanomolar,2576504,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284701,17667046,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)C3COc4ccccc4O3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.56', 'le': '0.25', 'lle': '0.97', 'sei': '8.47'}",CHEMBL3699360,,CHEMBL3699360,7.60,0,http://www.openphacts.org/units/Nanomolar,2576505,=,37,1,=,,IC50,nM,,25.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.025
284702,17667047,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3c(F)cncc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.07', 'le': '0.22', 'lle': '-0.33', 'sei': '7.73'}",CHEMBL3699361,,CHEMBL3699361,6.51,0,http://www.openphacts.org/units/Nanomolar,2576506,=,37,1,=,,IC50,nM,,309.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.30900002
284703,17667048,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3c(F)cncc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.87', 'le': '0.26', 'lle': '0.64', 'sei': '8.88'}",CHEMBL3699362,,CHEMBL3699362,7.48,0,http://www.openphacts.org/units/Nanomolar,2576507,=,37,1,=,,IC50,nM,,33.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.033
284704,17667049,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)nc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.61', 'le': '0.22', 'lle': '-0.94', 'sei': '7.88'}",CHEMBL3699363,,CHEMBL3699363,6.64,0,http://www.openphacts.org/units/Nanomolar,2576508,=,37,1,=,,IC50,nM,,230.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.23
284705,17667050,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc4c(c3)CCO4)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.21', 'le': '0.22', 'lle': '-0.45', 'sei': '8.26'}",CHEMBL3699364,,CHEMBL3699364,6.65,0,http://www.openphacts.org/units/Nanomolar,2576509,=,37,1,=,,IC50,nM,,223.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.223
284706,17667051,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(Cl)cc(Cl)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.69', 'le': '0.27', 'lle': '-0.65', 'sei': '10.97'}",CHEMBL3699365,,CHEMBL3699365,7.82,0,http://www.openphacts.org/units/Nanomolar,2576510,=,37,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
284707,17667052,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)c(Cl)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.00', 'le': '0.27', 'lle': '-0.47', 'sei': '11.22'}",CHEMBL3699366,,CHEMBL3699366,8.00,0,http://www.openphacts.org/units/Nanomolar,2576511,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284708,17667053,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(C(F)(F)F)ccc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.52', 'le': '0.25', 'lle': '-0.36', 'sei': '11.16'}",CHEMBL3699367,,CHEMBL3699367,7.96,0,http://www.openphacts.org/units/Nanomolar,2576512,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284709,17667054,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)c(C(F)(F)F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.93', 'le': '0.25', 'lle': '-1.01', 'sei': '10.97'}",CHEMBL3699368,,CHEMBL3699368,7.82,0,http://www.openphacts.org/units/Nanomolar,2576513,=,37,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
284710,17667055,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(F)(F)F)ccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '11.88', 'le': '0.22', 'lle': '-1.05', 'sei': '8.86'}",CHEMBL3699369,,CHEMBL3699369,7.14,0,http://www.openphacts.org/units/Nanomolar,2576514,=,37,1,=,,IC50,nM,,73.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07300001
284711,17667056,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(F)(F)F)ccc1[C@@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '14.48', 'le': '0.27', 'lle': '0.51', 'sei': '10.80'}",CHEMBL3699370,,CHEMBL3699370,8.70,0,http://www.openphacts.org/units/Nanomolar,2576515,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284712,17667057,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '13.88', 'le': '0.25', 'lle': '-0.36', 'sei': '10.33'}",CHEMBL3699371,,CHEMBL3699371,7.37,0,http://www.openphacts.org/units/Nanomolar,2576516,=,37,1,=,,IC50,nM,,43.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.043
284713,17667058,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc(Cl)ccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.69', 'le': '0.29', 'lle': '-0.47', 'sei': '23.39'}",CHEMBL3699372,,CHEMBL3699372,7.96,0,http://www.openphacts.org/units/Nanomolar,2576517,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284714,17667059,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(F)cc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.67', 'le': '0.25', 'lle': '-1.18', 'sei': '21.87'}",CHEMBL3699373,,CHEMBL3699373,7.44,0,http://www.openphacts.org/units/Nanomolar,2576518,=,37,1,=,,IC50,nM,,36.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.036000002
284715,17667060,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)c(F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.36', 'le': '0.25', 'lle': '-1.34', 'sei': '21.38'}",CHEMBL3699374,,CHEMBL3699374,7.28,0,http://www.openphacts.org/units/Nanomolar,2576519,=,37,1,=,,IC50,nM,,53.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.053000003
284716,17667061,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(F)c3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.27', 'le': '0.30', 'lle': '0.31', 'sei': '23.64'}",CHEMBL3699375,,CHEMBL3699375,8.05,0,http://www.openphacts.org/units/Nanomolar,2576520,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
284717,17667062,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(F)(F)F)c3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.45', 'le': '0.24', 'lle': '-2.15', 'sei': '20.53'}",CHEMBL3699376,,CHEMBL3699376,6.99,0,http://www.openphacts.org/units/Nanomolar,2576521,=,37,1,=,,IC50,nM,,103.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.10300001
284718,17667063,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(C(F)(F)F)c3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.50', 'le': '0.30', 'lle': '-0.44', 'sei': '25.56'}",CHEMBL3699377,,CHEMBL3699377,8.70,0,http://www.openphacts.org/units/Nanomolar,2576522,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284719,17667064,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(Cl)c3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.15', 'le': '0.29', 'lle': '-0.52', 'sei': '22.76'}",CHEMBL3699378,,CHEMBL3699378,7.75,0,http://www.openphacts.org/units/Nanomolar,2576523,=,37,1,=,,IC50,nM,,18.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.018000001
284720,17667065,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(F)c(F)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.27', 'le': '0.30', 'lle': '0.31', 'sei': '23.64'}",CHEMBL3699379,,CHEMBL3699379,8.05,0,http://www.openphacts.org/units/Nanomolar,2576524,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
284721,17667066,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(C(F)(F)F)c(F)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699380,,CHEMBL3699380,,0,http://www.openphacts.org/units/Nanomolar,2576525,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284722,17667067,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3c(F)ccc(F)c3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '16.63', 'le': '0.31', 'lle': '0.64', 'sei': '25.05'}",CHEMBL3699381,,CHEMBL3699381,8.52,0,http://www.openphacts.org/units/Nanomolar,2576526,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284723,17667068,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3c(F)ccc(F)c3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.16', 'le': '0.28', 'lle': '-0.11', 'sei': '22.83'}",CHEMBL3699382,,CHEMBL3699382,7.77,0,http://www.openphacts.org/units/Nanomolar,2576527,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284724,17667069,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)[C@@H]3CCCN3C(=O)OCc3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.83', 'le': '0.22', 'lle': '-0.96', 'sei': '10.90'}",CHEMBL3699383,,CHEMBL3699383,6.93,0,http://www.openphacts.org/units/Nanomolar,2576528,=,37,1,=,,IC50,nM,,118.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.11800001
284725,17667070,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)[C@H]3CCCN3C(=O)OCc3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.14', 'le': '0.24', 'lle': '-0.19', 'sei': '12.11'}",CHEMBL3699384,,CHEMBL3699384,7.70,0,http://www.openphacts.org/units/Nanomolar,2576529,=,37,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
284726,17667071,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@H](C)c3cc(F)ccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.27', 'le': '0.27', 'lle': '-0.85', 'sei': '22.83'}",CHEMBL3699385,,CHEMBL3699385,7.77,0,http://www.openphacts.org/units/Nanomolar,2576530,=,37,1,=,,IC50,nM,,17.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.017
284727,17667072,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)[C@@H]3CCN(C(=O)OCc4ccccc4)C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.35', 'le': '0.22', 'lle': '-0.51', 'sei': '11.38'}",CHEMBL3699386,,CHEMBL3699386,7.24,0,http://www.openphacts.org/units/Nanomolar,2576531,=,37,1,=,,IC50,nM,,58.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.058000002
284728,17667073,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(F)ccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.30', 'le': '0.25', 'lle': '-1.38', 'sei': '21.29'}",CHEMBL3699387,,CHEMBL3699387,7.24,0,http://www.openphacts.org/units/Nanomolar,2576532,=,37,1,=,,IC50,nM,,57.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.057000004
284729,17667074,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.46', 'le': '0.24', 'lle': '-0.11', 'sei': '8.65'}",CHEMBL3699388,,CHEMBL3699388,7.66,0,http://www.openphacts.org/units/Nanomolar,2576533,=,37,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
284730,17667075,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3noc(=O)[nH]3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.65', 'le': '0.23', 'lle': '-0.53', 'sei': '7.96'}",CHEMBL3699389,,CHEMBL3699389,7.40,0,http://www.openphacts.org/units/Nanomolar,2576534,=,37,1,=,,IC50,nM,,40.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.040000003
284731,17667076,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3-c3n[nH]c(=O)o3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.95', 'le': '0.25', 'lle': '0.22', 'sei': '8.78'}",CHEMBL3699390,,CHEMBL3699390,8.15,0,http://www.openphacts.org/units/Nanomolar,2576535,=,37,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
284732,17667077,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3S(=O)(=O)NC(C)(C)C)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699391,,CHEMBL3699391,,0,http://www.openphacts.org/units/Nanomolar,2576536,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284733,17667078,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3S(N)(=O)=O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699392,,CHEMBL3699392,,0,http://www.openphacts.org/units/Nanomolar,2576537,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284734,17667079,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(C)c(C)c3cc(C(=O)N[C@@H](C)c4cccc(C(C)C)c4)ccc32)cc1,,,CHEMBL3638687,,2015,,CHEMBL3699393,,CHEMBL3699393,,0,http://www.openphacts.org/units/Nanomolar,2576538,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284735,17667080,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC3COc4ccccc4C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.43', 'le': '0.26', 'lle': '1.25', 'sei': '9.51'}",CHEMBL3699442,,CHEMBL3699442,7.66,0,http://www.openphacts.org/units/Nanomolar,2576588,=,37,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
284736,17667081,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H]3COc4ccccc4C3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.30', 'le': '0.24', 'lle': '0.65', 'sei': '8.76'}",CHEMBL3699394,,CHEMBL3699394,7.06,0,http://www.openphacts.org/units/Nanomolar,2576539,=,37,1,=,,IC50,nM,,88.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.08800001
284737,17667082,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCCc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '13.58', 'le': '0.25', 'lle': '-0.72', 'sei': '10.37'}",CHEMBL3699395,,CHEMBL3699395,7.40,0,http://www.openphacts.org/units/Nanomolar,2576540,=,37,1,=,,IC50,nM,,40.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.040000003
284738,17667083,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '16.50', 'le': '0.30', 'lle': '1.05', 'sei': '11.95'}",CHEMBL3699396,,CHEMBL3699396,8.52,1,http://www.openphacts.org/units/Nanomolar,2576541,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284739,17667084,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.18', 'le': '0.28', 'lle': '0.74', 'sei': '10.30'}",CHEMBL3699397,,CHEMBL3699397,8.30,1,http://www.openphacts.org/units/Nanomolar,2576542,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
284740,17667085,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3Br)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.48', 'le': '0.32', 'lle': '1.07', 'sei': '12.62'}",CHEMBL3699398,,CHEMBL3699398,9.00,1,http://www.openphacts.org/units/Nanomolar,2576543,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284741,17667086,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccccc1[C@H](C)NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1,,,CHEMBL3638687,,2015,"{'bei': '15.49', 'le': '0.28', 'lle': '0.49', 'sei': '11.53'}",CHEMBL3699399,,CHEMBL3699399,8.22,1,http://www.openphacts.org/units/Nanomolar,2576544,=,37,1,=,,IC50,nM,,6.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.006
284742,17667087,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3OC(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.65', 'le': '0.24', 'lle': '-0.64', 'sei': '9.21'}",CHEMBL3699400,,CHEMBL3699400,7.42,0,http://www.openphacts.org/units/Nanomolar,2576545,=,37,1,=,,IC50,nM,,38.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.038000003
284743,17667088,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccccc3OC(C)C)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.67', 'le': '0.19', 'lle': '-1.97', 'sei': '7.42'}",CHEMBL3699401,,CHEMBL3699401,5.98,1,http://www.openphacts.org/units/Nanomolar,2576546,=,37,1,=,,IC50,nM,,1046.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.046
284744,17667089,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(S(C)(=O)=O)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.67', 'le': '0.20', 'lle': '-0.37', 'sei': '5.88'}",CHEMBL3699402,,CHEMBL3699402,6.20,0,http://www.openphacts.org/units/Nanomolar,2576547,=,37,1,=,,IC50,nM,,636.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.63600004
284745,17667090,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)c3cncc(C4CC4)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.20', 'le': '0.26', 'lle': '0.28', 'sei': '9.17'}",CHEMBL3699403,,CHEMBL3699403,7.72,0,http://www.openphacts.org/units/Nanomolar,2576548,=,37,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
284746,17667091,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cn3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.93', 'le': '0.30', 'lle': '1.38', 'sei': '10.33'}",CHEMBL3699404,,CHEMBL3699404,8.70,0,http://www.openphacts.org/units/Nanomolar,2576549,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284747,17667092,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C4CC4)cn3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.45', 'le': '0.28', 'lle': '0.96', 'sei': '9.97'}",CHEMBL3699405,,CHEMBL3699405,8.40,0,http://www.openphacts.org/units/Nanomolar,2576550,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284748,17667093,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)nc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.72', 'le': '0.24', 'lle': '-0.37', 'sei': '8.12'}",CHEMBL3699406,,CHEMBL3699406,6.84,0,http://www.openphacts.org/units/Nanomolar,2576551,=,37,1,=,,IC50,nM,,144.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.14400001
284749,17667094,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C4CC4)nc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.30', 'le': '0.24', 'lle': '-0.21', 'sei': '8.58'}",CHEMBL3639982,,CHEMBL3639982,7.23,0,http://www.openphacts.org/units/Nanomolar,2576552,=,37,1,=,,IC50,nM,,59.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.059000004
284750,17667095,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(C4CC4)nc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.79', 'le': '0.25', 'lle': '0.05', 'sei': '8.90'}",CHEMBL3699407,,CHEMBL3699407,7.50,0,http://www.openphacts.org/units/Nanomolar,2576553,=,37,1,=,,IC50,nM,,32.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.032
284751,17667096,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(Cl)ccn3)cc12,,,CHEMBL3638687,,2015,"{'bei': '15.61', 'le': '0.29', 'lle': '1.19', 'sei': '9.97'}",CHEMBL3699408,,CHEMBL3699408,8.40,0,http://www.openphacts.org/units/Nanomolar,2576554,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284752,17667097,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(C4CC4)ccn3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.89', 'le': '0.27', 'lle': '0.66', 'sei': '9.61'}",CHEMBL3699409,,CHEMBL3699409,8.10,0,http://www.openphacts.org/units/Nanomolar,2576555,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284753,17667098,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccnc(Br)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.03', 'le': '0.25', 'lle': '-0.31', 'sei': '8.32'}",CHEMBL3699410,,CHEMBL3699410,7.01,0,http://www.openphacts.org/units/Nanomolar,2576556,=,37,1,=,,IC50,nM,,98.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.098000005
284754,17667099,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccnc(C4CC4)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.87', 'le': '0.21', 'lle': '-0.99', 'sei': '7.66'}",CHEMBL3699411,,CHEMBL3699411,6.45,0,http://www.openphacts.org/units/Nanomolar,2576557,=,37,1,=,,IC50,nM,,352.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.35200003
284755,17667100,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccnc(Br)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.90', 'le': '0.28', 'lle': '0.78', 'sei': '9.61'}",CHEMBL3699412,,CHEMBL3699412,8.10,0,http://www.openphacts.org/units/Nanomolar,2576558,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284756,17667101,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccnc(C4CC4)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.39', 'le': '0.26', 'lle': '0.38', 'sei': '9.29'}",CHEMBL3699413,,CHEMBL3699413,7.82,0,http://www.openphacts.org/units/Nanomolar,2576559,=,37,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
284757,17667102,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(Br)n3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.93', 'le': '0.30', 'lle': '1.38', 'sei': '10.33'}",CHEMBL3699414,,CHEMBL3699414,8.70,0,http://www.openphacts.org/units/Nanomolar,2576560,=,37,1,=,,IC50,nM,,2.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.002
284758,17667103,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)c3cccc(C4CC4)n3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699415,,CHEMBL3699415,,0,http://www.openphacts.org/units/Nanomolar,2576561,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284759,17667104,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(Br)n3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.43', 'le': '0.27', 'lle': '0.50', 'sei': '9.29'}",CHEMBL3699416,,CHEMBL3699416,7.82,0,http://www.openphacts.org/units/Nanomolar,2576562,=,37,1,=,,IC50,nM,,15.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.015000001
284760,17667105,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)n3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.20', 'le': '0.26', 'lle': '0.28', 'sei': '9.17'}",CHEMBL3699417,,CHEMBL3699417,7.72,0,http://www.openphacts.org/units/Nanomolar,2576563,=,37,1,=,,IC50,nM,,19.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.019000001
284761,17667106,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)NC(C)c3cncc(Br)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.90', 'le': '0.28', 'lle': '0.78', 'sei': '9.61'}",CHEMBL3699418,,CHEMBL3699418,8.10,0,http://www.openphacts.org/units/Nanomolar,2576564,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284762,17667107,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3ccc(S(C)(=O)=O)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.70', 'le': '0.26', 'lle': '1.39', 'sei': '7.55'}",CHEMBL3699419,,CHEMBL3699419,7.96,0,http://www.openphacts.org/units/Nanomolar,2576565,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284763,17667108,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C#N)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(OC(C)C)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.25', 'le': '0.20', 'lle': '-2.03', 'sei': '9.09'}",CHEMBL3699420,,CHEMBL3699420,6.09,0,http://www.openphacts.org/units/Nanomolar,2576566,=,37,1,=,,IC50,nM,,808.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.808
284764,17667109,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.88', 'le': '0.27', 'lle': '0.70', 'sei': '10.74'}",CHEMBL3699421,,CHEMBL3699421,7.66,0,http://www.openphacts.org/units/Nanomolar,2576567,=,37,1,=,,IC50,nM,,22.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.022000002
284765,17667110,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc([C@H](C)NC(=O)c2ccc3c(c2)c(C)c(C)n3Cc2ccc(-c3ccccc3C(=O)O)cc2)c1,,,CHEMBL3638687,,2015,"{'bei': '15.40', 'le': '0.28', 'lle': '0.49', 'sei': '11.16'}",CHEMBL3699422,,CHEMBL3699422,7.96,0,http://www.openphacts.org/units/Nanomolar,2576568,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284766,17667111,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@H](C)c3cccc(Br)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699423,,CHEMBL3699423,,0,http://www.openphacts.org/units/Nanomolar,2576569,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
284767,17667112,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.74', 'le': '0.27', 'lle': '-0.04', 'sei': '11.22'}",CHEMBL3699424,,CHEMBL3699424,8.00,0,http://www.openphacts.org/units/Nanomolar,2576570,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
284768,17667113,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.52', 'le': '0.25', 'lle': '-0.36', 'sei': '11.16'}",CHEMBL3699425,,CHEMBL3699425,7.96,0,http://www.openphacts.org/units/Nanomolar,2576571,=,37,1,=,,IC50,nM,,11.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.011000001
284769,17667114,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(F)(F)F)c3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.86', 'le': '0.24', 'lle': '-0.75', 'sei': '10.61'}",CHEMBL3699426,,CHEMBL3699426,7.57,0,http://www.openphacts.org/units/Nanomolar,2576572,=,37,1,=,,IC50,nM,,27.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.027
284770,17667115,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3c(F)cccc3C(F)(F)F)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.67', 'le': '0.26', 'lle': '-0.27', 'sei': '11.28'}",CHEMBL3699427,,CHEMBL3699427,8.05,0,http://www.openphacts.org/units/Nanomolar,2576573,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
284771,17667116,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(F)c(F)cc3F)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.55', 'le': '0.27', 'lle': '0.52', 'sei': '11.35'}",CHEMBL3699428,,CHEMBL3699428,8.10,0,http://www.openphacts.org/units/Nanomolar,2576574,=,37,1,=,,IC50,nM,,8.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.008
284772,17667117,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cc(C(F)(F)F)ccc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.09', 'le': '0.27', 'lle': '-0.31', 'sei': '11.95'}",CHEMBL3699429,,CHEMBL3699429,8.52,0,http://www.openphacts.org/units/Nanomolar,2576575,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
284773,17667118,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)cc3Cl)cc12,,,CHEMBL3638687,,2015,"{'bei': '14.69', 'le': '0.29', 'lle': '-0.07', 'sei': '11.77'}",CHEMBL3699430,,CHEMBL3699430,8.40,0,http://www.openphacts.org/units/Nanomolar,2576576,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
284774,17667119,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C4CC4)cc3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.45', 'le': '0.24', 'lle': '-0.74', 'sei': '10.24'}",CHEMBL3699431,,CHEMBL3699431,7.30,0,http://www.openphacts.org/units/Nanomolar,2576577,=,37,1,=,,IC50,nM,,50.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.05
284775,17667120,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NC3CC3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.04', 'le': '0.22', 'lle': '-1.45', 'sei': '11.13'}",CHEMBL3699432,,CHEMBL3699432,7.03,0,http://www.openphacts.org/units/Nanomolar,2576578,=,37,1,=,,IC50,nM,,94.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.094000004
284776,17667121,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)N3CC[C@H](O)C3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699433,,CHEMBL3699433,,0,http://www.openphacts.org/units/Nanomolar,2576579,>,37,1,>,,IC50,nM,,500.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.5
284777,17667122,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NCCO)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.59', 'le': '0.19', 'lle': '-1.09', 'sei': '7.46'}",CHEMBL3699434,,CHEMBL3699434,6.22,0,http://www.openphacts.org/units/Nanomolar,2576580,=,37,1,=,,IC50,nM,,600.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.6
284778,17667123,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NC[C@@H](O)C(=O)N(C)C)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699435,,CHEMBL3699435,,0,http://www.openphacts.org/units/Nanomolar,2576581,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284779,17667124,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NCCN(C)C)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,,CHEMBL3699436,,CHEMBL3699436,,0,http://www.openphacts.org/units/Nanomolar,2576582,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
284780,17667125,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccccc1-c1ccc(Cn2c(C)c(C)c3cc(C(=O)N[C@@H](C)c4cccc(C(C)C)c4)ccc32)cc1,,,CHEMBL3638687,,2015,"{'bei': '12.76', 'le': '0.23', 'lle': '-0.83', 'sei': '11.28'}",CHEMBL3699437,,CHEMBL3699437,7.12,0,http://www.openphacts.org/units/Nanomolar,2576583,=,37,1,=,,IC50,nM,,76.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.076000005
284781,17667126,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)N(C)C)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '11.94', 'le': '0.22', 'lle': '-1.46', 'sei': '12.57'}",CHEMBL3699438,,CHEMBL3699438,6.83,0,http://www.openphacts.org/units/Nanomolar,2576584,=,37,1,=,,IC50,nM,,148.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.148
284782,17667127,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NO)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '12.71', 'le': '0.23', 'lle': '-0.60', 'sei': '8.53'}",CHEMBL3699439,,CHEMBL3699439,7.11,0,http://www.openphacts.org/units/Nanomolar,2576585,=,37,1,=,,IC50,nM,,77.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07700001
284783,17667128,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)NS(C)(=O)=O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '10.53', 'le': '0.20', 'lle': '-0.73', 'sei': '6.73'}",CHEMBL3699440,,CHEMBL3699440,6.54,0,http://www.openphacts.org/units/Nanomolar,2576586,=,37,1,=,,IC50,nM,,285.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.28500003
284784,17667129,[],CHEMBL3706273,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 μL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(N)=O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638687,,2015,"{'bei': '13.26', 'le': '0.24', 'lle': '-0.48', 'sei': '9.35'}",CHEMBL3699441,,CHEMBL3699441,7.21,0,http://www.openphacts.org/units/Nanomolar,2576587,=,37,1,=,,IC50,nM,,62.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.062000003
304401,17685262,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(ccn3Cc3ccc(F)cc3F)c2)c(OC)c1,,,CHEMBL3638934,,2015,"{'bei': '14.89', 'le': '0.28', 'lle': '1.58', 'sei': '12.38'}",CHEMBL3678080,,CHEMBL3678080,6.50,0,http://www.openphacts.org/units/Nanomolar,2553881,=,37,1,=,,IC50,nM,,317.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.317
304402,17685263,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1cccc(OC(F)(F)F)c1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,,CHEMBL3678081,,CHEMBL3678081,,0,http://www.openphacts.org/units/Nanomolar,2553882,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304403,17685264,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNC(=O)c2ccc3c(ccn3Cc3ccc(F)cc3F)c2)cc1OC,,,CHEMBL3638934,,2015,"{'bei': '14.94', 'le': '0.28', 'lle': '1.60', 'sei': '12.43'}",CHEMBL3678082,,CHEMBL3678082,6.52,0,http://www.openphacts.org/units/Nanomolar,2553883,=,37,1,=,,IC50,nM,,300.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.3
304404,17685265,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638934,,2015,"{'bei': '15.01', 'le': '0.28', 'lle': '1.16', 'sei': '8.47'}",CHEMBL3678083,,CHEMBL3678083,6.54,0,http://www.openphacts.org/units/Nanomolar,2553884,=,37,1,=,,IC50,nM,,292.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.29200003
304405,17685266,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc(Br)cc1,,,CHEMBL3638934,,2015,"{'bei': '14.52', 'le': '0.31', 'lle': '0.59', 'sei': '20.02'}",CHEMBL3678084,,CHEMBL3678084,6.81,0,http://www.openphacts.org/units/Nanomolar,2553885,=,37,1,=,,IC50,nM,,154.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.15400001
304406,17685267,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc(Br)cc1,,,CHEMBL3638934,,2015,"{'bei': '17.14', 'le': '0.37', 'lle': '1.83', 'sei': '23.64'}",CHEMBL3678085,,CHEMBL3678085,8.05,0,http://www.openphacts.org/units/Nanomolar,2553886,=,37,1,=,,IC50,nM,,9.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.009000001
304407,17685268,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '22.25', 'le': '0.41', 'lle': '3.15', 'sei': '26.45'}",CHEMBL3678086,,CHEMBL3678086,9.00,0,http://www.openphacts.org/units/Nanomolar,2553887,=,37,1,=,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
304408,17685269,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1ccccc1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,"{'bei': '22.05', 'le': '0.40', 'lle': '3.40', 'sei': '24.39'}",CHEMBL3678087,,CHEMBL3678087,8.30,0,http://www.openphacts.org/units/Nanomolar,2553888,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
304409,17685270,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL3638934,,2015,"{'bei': '17.24', 'le': '0.32', 'lle': '2.14', 'sei': '9.73'}",CHEMBL3678088,,CHEMBL3678088,7.51,0,http://www.openphacts.org/units/Nanomolar,2553889,=,37,1,=,,IC50,nM,,31.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.031000001
304410,17685271,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '20.76', 'le': '0.38', 'lle': '2.77', 'sei': '24.68'}",CHEMBL3678089,,CHEMBL3678089,8.40,0,http://www.openphacts.org/units/Nanomolar,2553890,=,37,1,=,,IC50,nM,,4.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.004
304411,17685272,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCc1cccs1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,"{'bei': '21.32', 'le': '0.41', 'lle': '3.19', 'sei': '23.96'}",CHEMBL3678090,,CHEMBL3678090,8.15,0,http://www.openphacts.org/units/Nanomolar,2553891,=,37,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
304412,17685273,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCC1COc2ccccc2O1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,,CHEMBL3678091,,CHEMBL3678091,,0,http://www.openphacts.org/units/Nanomolar,2553892,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304413,17685274,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CC(NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1cccc2ccccc12,,,CHEMBL3638934,,2015,"{'bei': '16.59', 'le': '0.30', 'lle': '0.70', 'sei': '21.48'}",CHEMBL3678092,,CHEMBL3678092,7.31,0,http://www.openphacts.org/units/Nanomolar,2553893,=,37,1,=,,IC50,nM,,49.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.049000002
304414,17685275,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc(F)cc1,,,CHEMBL3638934,,2015,"{'bei': '19.23', 'le': '0.36', 'lle': '2.25', 'sei': '23.08'}",CHEMBL3678093,,CHEMBL3678093,7.85,0,http://www.openphacts.org/units/Nanomolar,2553894,=,37,1,=,,IC50,nM,,14.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.014
304415,17685276,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,C[C@@H](NC(=O)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1)c1ccc(F)cc1,,,CHEMBL3638934,,2015,,CHEMBL3678094,,CHEMBL3678094,,0,http://www.openphacts.org/units/Nanomolar,2553895,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
304416,17685277,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC1CCCC1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,,CHEMBL3678095,,CHEMBL3678095,,0,http://www.openphacts.org/units/Nanomolar,2553896,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304417,17685278,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(N[C@@H]1C[C@H]1c1ccccc1)c1ccc2c(ccn2Cc2ccc(F)cc2F)c1,,,CHEMBL3638934,,2015,"{'bei': '12.86', 'le': '0.24', 'lle': '-0.08', 'sei': '15.20'}",CHEMBL3678096,,CHEMBL3678096,5.17,0,http://www.openphacts.org/units/Nanomolar,2553897,=,37,1,=,,IC50,nM,,6700.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.7000003
304418,17685279,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Nc1ccc(CNC(=O)c2ccc3c(ccn3Cc3ccc(F)cc3F)c2)cc1,,,CHEMBL3638934,,2015,"{'bei': '17.46', 'le': '0.32', 'lle': '2.35', 'sei': '11.38'}",CHEMBL3678097,,CHEMBL3678097,6.83,0,http://www.openphacts.org/units/Nanomolar,2553898,=,37,1,=,,IC50,nM,,147.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.147
304419,17685280,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(F)cc1F)c1ccccc1,,,CHEMBL3638934,,2015,,CHEMBL3678098,,CHEMBL3678098,,0,http://www.openphacts.org/units/Nanomolar,2553899,<,37,1,<,,IC50,nM,,1.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.001
304420,17685281,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(c1)c(C)c(C)n2Cc1ccc(Cl)cc1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '17.49', 'le': '0.33', 'lle': '0.70', 'sei': '22.15'}",CHEMBL3678099,,CHEMBL3678099,7.54,0,http://www.openphacts.org/units/Nanomolar,2553900,=,37,1,=,,IC50,nM,,29.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.029000001
304421,17685282,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2CCc2cccc(Cl)c2)c1)c1ccccc1,,,CHEMBL3638934,,2015,,CHEMBL3678100,,CHEMBL3678100,,0,http://www.openphacts.org/units/Nanomolar,2553901,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304422,17685283,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2C(=O)c2ccccc2)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '15.69', 'le': '0.28', 'lle': '0.79', 'sei': '11.74'}",CHEMBL3678101,,CHEMBL3678101,6.00,0,http://www.openphacts.org/units/Nanomolar,2553902,=,37,1,=,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304423,17685284,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2C(=O)c2ccc([N+](=O)[O-])cc2)c1)c1ccccc1,,,CHEMBL3638934,,2015,,CHEMBL3678102,,CHEMBL3678102,,0,http://www.openphacts.org/units/Nanomolar,2553903,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304424,17685285,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2C(=O)c2cccc(F)c2F)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '14.94', 'le': '0.28', 'lle': '0.76', 'sei': '12.23'}",CHEMBL3678103,,CHEMBL3678103,6.25,0,http://www.openphacts.org/units/Nanomolar,2553904,=,37,1,=,,IC50,nM,,563.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.563
304425,17685286,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2S(=O)(=O)c2ccc(C)cc2)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '16.20', 'le': '0.31', 'lle': '1.94', 'sei': '10.28'}",CHEMBL3678104,,CHEMBL3678104,7.01,0,http://www.openphacts.org/units/Nanomolar,2553905,=,37,1,=,,IC50,nM,,98.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.098000005
304426,17685287,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2S(=O)(=O)c2cccc3ccccc23)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '17.40', 'le': '0.33', 'lle': '2.24', 'sei': '11.96'}",CHEMBL3678105,,CHEMBL3678105,8.15,0,http://www.openphacts.org/units/Nanomolar,2553906,=,37,1,=,,IC50,nM,,7.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.007
304427,17685288,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,CCC(NC(=O)c1ccc2c(ccn2Cc2ccc(Cl)nc2)c1)c1ccccc1,,,CHEMBL3638934,,2015,"{'bei': '21.10', 'le': '0.40', 'lle': '2.90', 'sei': '18.16'}",CHEMBL3678106,,CHEMBL3678106,8.52,0,http://www.openphacts.org/units/Nanomolar,2553907,=,37,1,=,,IC50,nM,,3.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.003
304428,17685289,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(C3(C(=O)O)CC3)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.46', 'le': '0.26', 'lle': '0.32', 'sei': '10.31'}",CHEMBL3678107,,CHEMBL3678107,7.36,0,http://www.openphacts.org/units/Nanomolar,2553908,=,37,1,=,,IC50,nM,,44.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.044000003
304429,17685290,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(OCC(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.89', 'le': '0.25', 'lle': '0.76', 'sei': '8.56'}",CHEMBL3678108,,CHEMBL3678108,6.90,0,http://www.openphacts.org/units/Nanomolar,2553909,=,37,1,=,,IC50,nM,,126.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.126
304430,17685291,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(OCC(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.85', 'le': '0.25', 'lle': '0.53', 'sei': '8.57'}",CHEMBL3678109,,CHEMBL3678109,6.91,0,http://www.openphacts.org/units/Nanomolar,2553910,=,37,1,=,,IC50,nM,,124.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.124000005
304431,17685292,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(OCC(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.55', 'le': '0.23', 'lle': '-0.13', 'sei': '7.98'}",CHEMBL3678110,,CHEMBL3678110,6.43,0,http://www.openphacts.org/units/Nanomolar,2553911,=,37,1,=,,IC50,nM,,370.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.37
304432,17685293,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OCC(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.60', 'le': '0.27', 'lle': '1.11', 'sei': '9.00'}",CHEMBL3678111,,CHEMBL3678111,7.25,0,http://www.openphacts.org/units/Nanomolar,2553912,=,37,1,=,,IC50,nM,,56.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.056
304433,17685294,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OCC(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.36', 'le': '0.26', 'lle': '0.78', 'sei': '8.89'}",CHEMBL3678112,,CHEMBL3678112,7.16,0,http://www.openphacts.org/units/Nanomolar,2553913,=,37,1,=,,IC50,nM,,69.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.069000006
304434,17685295,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OCC(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.43', 'le': '0.25', 'lle': '0.32', 'sei': '8.54'}",CHEMBL3678113,,CHEMBL3678113,6.88,0,http://www.openphacts.org/units/Nanomolar,2553914,=,37,1,=,,IC50,nM,,131.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.13100001
304435,17685296,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.21', 'le': '0.22', 'lle': '-0.51', 'sei': '7.77'}",CHEMBL3678114,,CHEMBL3678114,6.26,0,http://www.openphacts.org/units/Nanomolar,2553915,=,37,1,=,,IC50,nM,,550.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.55
304436,17685297,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,,CHEMBL3678115,,CHEMBL3678115,,0,http://www.openphacts.org/units/Nanomolar,2553916,>,37,1,>,,IC50,nM,,1000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,1.0
304437,17685298,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.89', 'le': '0.26', 'lle': '0.35', 'sei': '8.84'}",CHEMBL3678116,,CHEMBL3678116,7.12,0,http://www.openphacts.org/units/Nanomolar,2553917,=,37,1,=,,IC50,nM,,76.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.076000005
304438,17685299,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.71', 'le': '0.25', 'lle': '0.27', 'sei': '8.96'}",CHEMBL3678117,,CHEMBL3678117,7.22,0,http://www.openphacts.org/units/Nanomolar,2553918,=,37,1,=,,IC50,nM,,60.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.060000002
304439,17685300,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.16', 'le': '0.26', 'lle': '0.70', 'sei': '8.97'}",CHEMBL3678118,,CHEMBL3678118,7.23,0,http://www.openphacts.org/units/Nanomolar,2553919,=,37,1,=,,IC50,nM,,59.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.059000004
304440,17685301,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OC(C)(C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.24', 'le': '0.24', 'lle': '-0.19', 'sei': '8.65'}",CHEMBL3678119,,CHEMBL3678119,6.97,0,http://www.openphacts.org/units/Nanomolar,2553920,=,37,1,=,,IC50,nM,,107.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.10700001
304441,17685302,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OC(C)(C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.01', 'le': '0.22', 'lle': '-0.85', 'sei': '8.06'}",CHEMBL3678120,,CHEMBL3678120,6.49,0,http://www.openphacts.org/units/Nanomolar,2553921,=,37,1,=,,IC50,nM,,321.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.321
304442,17685303,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OCC#N)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.87', 'le': '0.27', 'lle': '0.31', 'sei': '10.64'}",CHEMBL3678121,,CHEMBL3678121,7.13,0,http://www.openphacts.org/units/Nanomolar,2553922,=,37,1,=,,IC50,nM,,74.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.074
304443,17685304,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(OCC#N)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.12', 'le': '0.26', 'lle': '-0.03', 'sei': '10.40'}",CHEMBL3639769,,CHEMBL3639769,6.97,0,http://www.openphacts.org/units/Nanomolar,2553923,=,37,1,=,,IC50,nM,,107.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.10700001
304444,17685305,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(O[C@@H](C)C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.69', 'le': '0.23', 'lle': '-0.27', 'sei': '8.07'}",CHEMBL3678122,,CHEMBL3678122,6.50,0,http://www.openphacts.org/units/Nanomolar,2553924,=,37,1,=,,IC50,nM,,313.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.31300002
304445,17685306,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(O[C@H](C)C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.60', 'le': '0.25', 'lle': '0.20', 'sei': '8.65'}",CHEMBL3678123,,CHEMBL3678123,6.97,0,http://www.openphacts.org/units/Nanomolar,2553925,=,37,1,=,,IC50,nM,,107.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.10700001
304446,17685307,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(OC(C)(C)C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.28', 'le': '0.24', 'lle': '-0.16', 'sei': '8.68'}",CHEMBL3678124,,CHEMBL3678124,7.00,0,http://www.openphacts.org/units/Nanomolar,2553926,=,37,1,=,,IC50,nM,,101.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.101
304447,17685308,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '16.86', 'le': '0.32', 'lle': '1.79', 'sei': '11.45'}",CHEMBL3678125,,CHEMBL3678125,9.22,0,http://www.openphacts.org/units/Nanomolar,2553927,=,37,1,=,,IC50,nM,,0.6,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0006
304448,17685309,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '16.92', 'le': '0.32', 'lle': '2.04', 'sei': '11.45'}",CHEMBL3678126,,CHEMBL3678126,9.22,0,http://www.openphacts.org/units/Nanomolar,2553928,=,37,1,=,,IC50,nM,,0.6,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0006
304449,17685310,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.68', 'le': '0.34', 'lle': '2.08', 'sei': '11.36'}",CHEMBL3678127,,CHEMBL3678127,9.15,0,http://www.openphacts.org/units/Nanomolar,2553929,=,37,1,=,,IC50,nM,,0.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00070000003
304450,17685311,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '17.29', 'le': '0.33', 'lle': '2.10', 'sei': '12.04'}",CHEMBL3678128,,CHEMBL3678128,9.70,0,http://www.openphacts.org/units/Nanomolar,2553930,=,37,1,=,,IC50,nM,,0.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00020000001
304451,17685312,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.68', 'le': '0.30', 'lle': '1.20', 'sei': '10.92'}",CHEMBL3678129,,CHEMBL3678129,8.80,0,http://www.openphacts.org/units/Nanomolar,2553931,=,37,1,=,,IC50,nM,,1.6,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0016000001
304452,17685313,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(OC(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.74', 'le': '0.28', 'lle': '1.21', 'sei': '9.24'}",CHEMBL3678130,,CHEMBL3678130,8.30,0,http://www.openphacts.org/units/Nanomolar,2553932,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
304453,17685314,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '18.68', 'le': '0.36', 'lle': '2.79', 'sei': '12.69'}",CHEMBL3678131,,CHEMBL3678131,10.22,0,http://www.openphacts.org/units/Nanomolar,2553933,=,37,1,=,,IC50,nM,,0.06,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,6.0000002e-05
304454,17685315,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '16.92', 'le': '0.32', 'lle': '2.04', 'sei': '11.45'}",CHEMBL3678132,,CHEMBL3678132,9.22,0,http://www.openphacts.org/units/Nanomolar,2553934,=,37,1,=,,IC50,nM,,0.6,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0006
304455,17685316,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '16.31', 'le': '0.35', 'lle': '2.45', 'sei': '11.82'}",CHEMBL3678133,,CHEMBL3678133,9.52,0,http://www.openphacts.org/units/Nanomolar,2553935,=,37,1,=,,IC50,nM,,0.3,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0003
304456,17685317,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '17.29', 'le': '0.33', 'lle': '2.10', 'sei': '12.04'}",CHEMBL3678134,,CHEMBL3678134,9.70,0,http://www.openphacts.org/units/Nanomolar,2553936,=,37,1,=,,IC50,nM,,0.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.00020000001
304457,17685318,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.68', 'le': '0.30', 'lle': '1.20', 'sei': '10.92'}",CHEMBL3678135,,CHEMBL3678135,8.80,0,http://www.openphacts.org/units/Nanomolar,2553937,=,37,1,=,,IC50,nM,,1.6,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0016000001
304458,17685319,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3cccc(OC(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.74', 'le': '0.28', 'lle': '1.21', 'sei': '9.24'}",CHEMBL3678136,,CHEMBL3678136,8.30,0,http://www.openphacts.org/units/Nanomolar,2553938,=,37,1,=,,IC50,nM,,5.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0050000004
304459,17685320,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(C3(C(=O)O)CC3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.77', 'le': '0.28', 'lle': '0.83', 'sei': '10.53'}",CHEMBL3678137,,CHEMBL3678137,7.51,0,http://www.openphacts.org/units/Nanomolar,2553939,=,37,1,=,,IC50,nM,,31.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.031000001
304460,17685321,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(C3(C(=O)O)CC3)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.77', 'le': '0.23', 'lle': '-0.54', 'sei': '9.11'}",CHEMBL3678138,,CHEMBL3678138,6.50,0,http://www.openphacts.org/units/Nanomolar,2553940,=,37,1,=,,IC50,nM,,318.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.31800002
304461,17685322,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(Cl)cc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.06', 'le': '0.25', 'lle': '-0.06', 'sei': '8.84'}",CHEMBL3678139,,CHEMBL3678139,7.12,0,http://www.openphacts.org/units/Nanomolar,2553941,=,37,1,=,,IC50,nM,,76.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.076000005
304462,17685323,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(Cl)cc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.55', 'le': '0.26', 'lle': '0.00', 'sei': '9.44'}",CHEMBL3678140,,CHEMBL3678140,7.60,0,http://www.openphacts.org/units/Nanomolar,2553942,=,37,1,=,,IC50,nM,,25.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.025
304463,17685324,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(O[C@@H](C)C(=O)O)c(Cl)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.16', 'le': '0.25', 'lle': '-0.01', 'sei': '8.91'}",CHEMBL3678141,,CHEMBL3678141,7.17,0,http://www.openphacts.org/units/Nanomolar,2553943,=,37,1,=,,IC50,nM,,67.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.067
304464,17685325,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(O[C@@H](C)C(=O)O)c(Cl)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.20', 'le': '0.23', 'lle': '-0.76', 'sei': '8.50'}",CHEMBL3678142,,CHEMBL3678142,6.84,0,http://www.openphacts.org/units/Nanomolar,2553944,=,37,1,=,,IC50,nM,,143.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.143
304465,17685326,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2Cl)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '11.84', 'le': '0.23', 'lle': '-0.73', 'sei': '8.01'}",CHEMBL3678143,,CHEMBL3678143,6.46,0,http://www.openphacts.org/units/Nanomolar,2553945,=,37,1,=,,IC50,nM,,351.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.351
304466,17685327,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2Cl)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '9.62', 'le': '0.18', 'lle': '-2.20', 'sei': '6.70'}",CHEMBL3678144,,CHEMBL3678144,5.40,0,http://www.openphacts.org/units/Nanomolar,2553946,=,37,1,=,,IC50,nM,,4000.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.0
304467,17685328,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(Cl)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '11.73', 'le': '0.22', 'lle': '-1.02', 'sei': '8.17'}",CHEMBL3678128,,CHEMBL3678128,6.58,0,http://www.openphacts.org/units/Nanomolar,2553930,=,37,1,=,,IC50,nM,,263.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.263
304468,17685329,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2Cl)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.16', 'le': '0.23', 'lle': '-0.78', 'sei': '8.47'}",CHEMBL3678134,,CHEMBL3678134,6.82,0,http://www.openphacts.org/units/Nanomolar,2553936,=,37,1,=,,IC50,nM,,151.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.15100001
304469,17685330,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.24', 'le': '0.23', 'lle': '-0.50', 'sei': '8.00'}",CHEMBL3678117,,CHEMBL3678117,6.45,0,http://www.openphacts.org/units/Nanomolar,2553918,=,37,1,=,,IC50,nM,,358.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.358
304470,17685331,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(C(C)(C)C#N)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.13', 'le': '0.26', 'lle': '-0.56', 'sei': '11.97'}",CHEMBL3678145,,CHEMBL3678145,6.92,0,http://www.openphacts.org/units/Nanomolar,2553947,=,37,1,=,,IC50,nM,,120.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.120000005
304471,17685332,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(C(C)(C)C(N)=O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.06', 'le': '0.24', 'lle': '0.19', 'sei': '8.60'}",CHEMBL3678146,,CHEMBL3678146,6.63,0,http://www.openphacts.org/units/Nanomolar,2553948,=,37,1,=,,IC50,nM,,233.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.23300001
304472,17685333,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(C(C)(C)C(N)=O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.01', 'le': '0.27', 'lle': '1.18', 'sei': '9.88'}",CHEMBL3678146,,CHEMBL3678146,7.62,0,http://www.openphacts.org/units/Nanomolar,2553948,=,37,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
304473,17685334,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(C(C)c2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.37', 'le': '0.25', 'lle': '-0.08', 'sei': '8.71'}",CHEMBL3678147,,CHEMBL3678147,7.01,0,http://www.openphacts.org/units/Nanomolar,2553949,=,37,1,=,,IC50,nM,,97.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.097
304474,17685335,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(C(C)c2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.19', 'le': '0.23', 'lle': '-0.92', 'sei': '8.18'}",CHEMBL3678148,,CHEMBL3678148,6.59,0,http://www.openphacts.org/units/Nanomolar,2553950,=,37,1,=,,IC50,nM,,255.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.25500003
304475,17685336,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(OC(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.67', 'le': '0.25', 'lle': '0.79', 'sei': '8.05'}",CHEMBL3678149,,CHEMBL3678149,7.23,0,http://www.openphacts.org/units/Nanomolar,2553951,=,37,1,=,,IC50,nM,,59.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.059000004
304476,17685337,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C(C)(C)C)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '13.45', 'le': '0.25', 'lle': '0.14', 'sei': '8.80'}",CHEMBL3678150,,CHEMBL3678150,7.09,0,http://www.openphacts.org/units/Nanomolar,2553952,=,37,1,=,,IC50,nM,,82.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.082
304477,17685338,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(Br)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.71', 'le': '0.26', 'lle': '0.57', 'sei': '8.67'}",CHEMBL3678151,,CHEMBL3678151,6.98,0,http://www.openphacts.org/units/Nanomolar,2553953,=,37,1,=,,IC50,nM,,104.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.104
304478,17685339,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '12.39', 'le': '0.23', 'lle': '0.00', 'sei': '8.28'}",CHEMBL3678152,,CHEMBL3678152,6.67,0,http://www.openphacts.org/units/Nanomolar,2553954,=,37,1,=,,IC50,nM,,213.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.21300001
304479,17685340,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(Cl)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.29', 'le': '0.27', 'lle': '0.91', 'sei': '8.96'}",CHEMBL3678153,,CHEMBL3678153,7.21,0,http://www.openphacts.org/units/Nanomolar,2553955,=,37,1,=,,IC50,nM,,61.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.061000004
304480,17685341,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(Cl)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.03', 'le': '0.27', 'lle': '0.79', 'sei': '8.80'}",CHEMBL3678154,,CHEMBL3678154,7.09,0,http://www.openphacts.org/units/Nanomolar,2553956,=,37,1,=,,IC50,nM,,82.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.082
304481,17685342,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccccc3Cl)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.65', 'le': '0.28', 'lle': '1.10', 'sei': '9.18'}",CHEMBL3678155,,CHEMBL3678155,7.40,0,http://www.openphacts.org/units/Nanomolar,2553957,=,37,1,=,,IC50,nM,,40.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.040000003
304482,17685343,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cn2c(C)c(C)c3cc(C(=O)N[C@@H](C)c4ccc(C(C)(C)C)cc4)ccc32)cc1O[C@@H](C)C(=O)O,,,CHEMBL3638934,,2015,"{'bei': '12.96', 'le': '0.24', 'lle': '0.25', 'sei': '8.04'}",CHEMBL3678156,,CHEMBL3678156,7.21,0,http://www.openphacts.org/units/Nanomolar,2553958,=,37,1,=,,IC50,nM,,61.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.061000004
304483,17685344,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cn2c(C)c(C)c3cc(C(=O)N[C@@H](C)c4cccc(C5CC5)c4)ccc32)cc1O[C@@H](C)C(=O)O,,,CHEMBL3638934,,2015,"{'bei': '13.23', 'le': '0.24', 'lle': '0.61', 'sei': '7.97'}",CHEMBL3678157,,CHEMBL3678157,7.16,0,http://www.openphacts.org/units/Nanomolar,2553959,=,37,1,=,,IC50,nM,,70.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07
304484,17685345,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cc(O[C@@H](C)C(=O)O)ccc2F)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.69', 'le': '0.27', 'lle': '0.91', 'sei': '9.93'}",CHEMBL3678158,,CHEMBL3678158,8.00,0,http://www.openphacts.org/units/Nanomolar,2553960,=,37,1,=,,IC50,nM,,10.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.010000001
304485,17685346,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(F)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3ccc(C(C)(C)C)cc3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.31', 'le': '0.27', 'lle': '0.71', 'sei': '9.68'}",CHEMBL3678159,,CHEMBL3678159,7.80,0,http://www.openphacts.org/units/Nanomolar,2553961,=,37,1,=,,IC50,nM,,16.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.016
304486,17685347,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(F)c(O[C@@H](C)C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '14.56', 'le': '0.27', 'lle': '1.03', 'sei': '9.56'}",CHEMBL3678160,,CHEMBL3678160,7.70,0,http://www.openphacts.org/units/Nanomolar,2553962,=,37,1,=,,IC50,nM,,20.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.020000001
304487,17685348,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(C3(C(=O)O)CC3)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.57', 'le': '0.28', 'lle': '1.10', 'sei': '11.06'}",CHEMBL3678161,,CHEMBL3678161,7.89,0,http://www.openphacts.org/units/Nanomolar,2553963,=,37,1,=,,IC50,nM,,13.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.013
304488,17685349,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2cccc(C(=O)O)c2)c2ccc(C(=O)N[C@@H](C)c3cccc(C4CC4)c3)cc12,,,CHEMBL3638934,,2015,"{'bei': '15.88', 'le': '0.29', 'lle': '1.04', 'sei': '10.39'}",CHEMBL3678162,,CHEMBL3678162,7.41,0,http://www.openphacts.org/units/Nanomolar,2553964,=,37,1,=,,IC50,nM,,39.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.039
304489,17685350,[],CHEMBL3706350,"Lanthascreen Competitive Binding Assay: The assay was performed according to manufacturer protocol. A mixture of 5 nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan- PPAR Green, and serial dilutions of the experimental compound, beginning at 10 μΜ downwards, was added to wells of black 384-well low- volume plates (Greiner) to a total volume of 18 xL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium.",B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(Cn2c(C)c(C)c3cc(C(=O)N[C@@H](C)c4cccc(C(C)C)c4)ccc32)cc1O[C@@H](C)C(=O)O,,,CHEMBL3638934,,2015,"{'bei': '13.11', 'le': '0.24', 'lle': '0.33', 'sei': '7.92'}",CHEMBL3678163,,CHEMBL3678163,7.11,0,http://www.openphacts.org/units/Nanomolar,2553965,=,37,1,=,,IC50,nM,,77.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.07700001
,18758364,[],CHEMBL4265665,Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-FRET competitive binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1,,,CHEMBL4261653,Bioorg Med Chem,2018,"{'bei': '13.40', 'le': '0.25', 'lle': '1.55', 'sei': '6.22'}",CHEMBL186179,MURAGLITAZAR,CHEMBL186179,6.92,0,http://www.openphacts.org/units/Nanomolar,3116886,=,1,1,=,,IC50,nM,,120.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.120000005
,19478498,[],CHEMBL4480104,Binding affinity to human 6xHis-tagged PPARgamma ligand binding domain (206 to 477 residues) by TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,,,CHEMBL4477262,Bioorg Med Chem Lett,2016,"{'bei': '17.93', 'le': '0.33', 'lle': '2.53', 'sei': '15.31'}",CHEMBL13045,CHELERYTHRINE,CHEMBL13045,6.25,0,http://www.openphacts.org/units/Nanomolar,3257181,=,1,1,=,,IC50,nM,,566.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.56600004
,22773172,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL4704909,Agonist activity at PPARg-LBD (unknown origin) expressed in HEK293 cells assessed as displacement of NCoR incubated for 16 hrs by luciferase reporter gene based mammalian two hybrid assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL4699618,J Med Chem,2020,"{'bei': '19.73', 'le': '0.39', 'lle': '4.56', 'sei': '9.86'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.05,0,http://www.openphacts.org/units/Nanomolar,3535763,=,1,1,=,,IC50,nM,,88.4,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.08840001
,22773173,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL4704909,Agonist activity at PPARg-LBD (unknown origin) expressed in HEK293 cells assessed as displacement of NCoR incubated for 16 hrs by luciferase reporter gene based mammalian two hybrid assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCOc1ccc(C(=O)N[C@H](C(=O)O)C(C)C)cc1,,,CHEMBL4699618,J Med Chem,2020,"{'bei': '17.22', 'le': '0.33', 'lle': '1.76', 'sei': '7.96'}",CHEMBL4743677,,CHEMBL4743677,6.02,0,http://www.openphacts.org/units/Nanomolar,3535764,=,1,1,=,,IC50,nM,,956.2,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.95620006
,22773174,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL4704910,Agonist activity at PPARg-LBD (unknown origin) expressed in HEK293 cells assessed as displacement of SMRT incubated for 16 hrs by luciferase reporter gene based mammalian two hybrid assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL4699618,J Med Chem,2020,"{'bei': '22.70', 'le': '0.44', 'lle': '5.62', 'sei': '11.34'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,8.11,0,http://www.openphacts.org/units/Nanomolar,3535763,=,1,1,=,,IC50,nM,,7.7,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.0077
,22773175,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL4704910,Agonist activity at PPARg-LBD (unknown origin) expressed in HEK293 cells assessed as displacement of SMRT incubated for 16 hrs by luciferase reporter gene based mammalian two hybrid assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCOc1ccc(C(=O)N[C@H](C(=O)O)C(C)C)cc1,,,CHEMBL4699618,J Med Chem,2020,"{'bei': '16.16', 'le': '0.31', 'lle': '1.39', 'sei': '7.47'}",CHEMBL4743677,,CHEMBL4743677,5.65,0,http://www.openphacts.org/units/Nanomolar,3535764,=,1,1,=,,IC50,nM,,2248.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,2.2480001
,23385915,[],CHEMBL4888385,PPARgamma In-house nuclear receptor screen,B,,,BAO_0000190,BAO_0000357,single protein format,COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1,,,CHEMBL4800728,,2021,,CHEMBL4802042,JNJ-54119936,CHEMBL4802042,,0,http://www.openphacts.org/units/Nanomolar,3589608,,54,1,,,IC50,nM,,5400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,5.4
,24427381,[],CHEMBL5050709,Binding affinity to PPARgamma (unknown origin) by lanthascreen TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '19.71', 'le': '0.38', 'lle': '4.56', 'sei': '9.85'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,7.05,0,http://www.openphacts.org/units/Nanomolar,3785506,=,1,1,=,,IC50,nM,,90.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.09
,24427382,[],CHEMBL5050709,Binding affinity to PPARgamma (unknown origin) by lanthascreen TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '12.44', 'le': '0.23', 'lle': '-0.26', 'sei': '5.95'}",CHEMBL3348830,,CHEMBL3348830,6.81,0,http://www.openphacts.org/units/Nanomolar,3785507,=,1,1,=,,IC50,nM,,154.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.15400001
,24427383,[],CHEMBL5050709,Binding affinity to PPARgamma (unknown origin) by lanthascreen TR-FRET assay,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1nn(Cc2ccc(Cl)c(Cl)c2)c(=O)c2cc(Oc3ccccc3)ccc12,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '17.27', 'le': '0.35', 'lle': '2.38', 'sei': '9.36'}",CHEMBL5070753,,CHEMBL5070753,7.62,0,http://www.openphacts.org/units/Nanomolar,3785508,=,1,1,=,,IC50,nM,,24.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.024
,24427412,[],CHEMBL5050734,Inhibition of PPARgamma (unknown origin) phosphorylation at pS273 residue,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '14.99', 'le': '0.29', 'lle': '2.87', 'sei': '7.49'}",CHEMBL121,ROSIGLITAZONE,CHEMBL121,5.36,0,http://www.openphacts.org/units/Nanomolar,3785506,=,1,1,=,,IC50,nM,,4400.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,4.4
,24427413,[],CHEMBL5050734,Inhibition of PPARgamma (unknown origin) phosphorylation at pS273 residue,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2ccc(C(=O)N[C@@H](C)c3ccc([N+](=O)[O-])cc3)cc12,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '11.39', 'le': '0.21', 'lle': '-0.83', 'sei': '5.45'}",CHEMBL3348830,,CHEMBL3348830,6.24,0,http://www.openphacts.org/units/Nanomolar,3785507,=,1,1,=,,IC50,nM,,580.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.58000004
,24427414,[],CHEMBL5050734,Inhibition of PPARgamma (unknown origin) phosphorylation at pS273 residue,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(O)c1nn(Cc2ccc(Cl)c(Cl)c2)c(=O)c2cc(Oc3ccccc3)ccc12,,,CHEMBL5046321,ACS Med Chem Lett,2022,"{'bei': '15.40', 'le': '0.31', 'lle': '1.56', 'sei': '8.35'}",CHEMBL5070753,,CHEMBL5070753,6.80,0,http://www.openphacts.org/units/Nanomolar,3785508,=,1,1,=,,IC50,nM,,160.0,CHEMBL235,Homo sapiens,Peroxisome proliferator-activated receptor gamma,9606,,,IC50,nM,UO_0000065,,0.16000001
